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LIST OF ACRONYMS 
 
DMN  default mode network 
ERS  environmental risk score 
GMV  grey matter volume 
GWAS genome-wide associations study 
GxE  gene by environment 
ITG  inferior temporal gyrus 
IQ  intelligence quotient 
PC  precuneus 
PCC  posterior cingulate cortex 
PLEs  psychotic-like experiences 
PRS  polygenic risk score 
SBM  surface-based morphometry 
SCL90-R symptom checklist 90 – revised 
SNP  single nucleotide polymorphism 
SNS  schizophrenia nuclear signs 
SPQ  schizotypal personality questionnaire 
SPQ-B schizotypal personality questionnaire - brief 
STS  schizotypal signs 





The development of pathological functions in a system is quite consistent 
with its usual performance of normal function. 
W.B. Cannon, 1953  
 
1.1. Schizotypy as a dimensional risk phenotype: a rationale 
Schizotypy describes a complex multimodal phenotype in humans, comprising 
of trait characteristics resembling key features of psychotic disorders across 
emotional, behavioural and cognitive dimensions. Those are generally grouped 
into the three facets positive (magical thinking, unusual experiences, beliefs and 
perceptions), negative (introversion, anhedonia, diminished positive affect and 
reward) and disorganised/cognitive (eccentricity, cognitive disorganisation).  
The term schizotypy was originally coined by Rado (1953), abbreviating 
“schizophrenic phenotype”, to describe subclinical levels of schizophrenic 
symptoms preceding the disorder, but also stable conditions, not leading into 
clinical states. Schizotypy is distributed in the general population and thought to 
represent both an underlying liability to the schizophrenia spectrum (particularly 
negative and disorganised facets) or “psychosis proneness” (positive facet), and 
variation of healthy function (Claridge 1997; Kwapil & Barrantes-Vidal 2015). 
This view is explicated by the continuum model of the psychosis spectrum, 
assuming a normal distribution of schizotypy, with spectrum disorders at the 
extreme end (Claridge 1997). Thus, it can also account for schizotypy being 
associated with beneficial characteristics like enhanced creativity, visual 
imagery, and personality correlates (Mohr & Claridge 2015; Baas et al. 2016).  
Determining the position on an underlying dimension of adaptive to maladaptive 
manifestations, protective conditions/resilience mechanisms are thought to play 
an important role, as shown for e.g. intelligence (Brod 1997; Grant et al. 2014a).  
There are different approaches to characterising risk phenotypes in the 
subclinical psychosis spectrum. Schizotypy as a stable personality construct 
can be distinguished from the (usually) transient expression of psychotic 
experiences in the absence of the clinical disorder (“psychotic-like experiences”, 
PLEs, van Os et al. 2009) and the set of clinical features and risk factors 
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constituting clinical high risk (CHR) status (Schultze-Lutter et al. 2015). PLEs, 
e.g. hallucinations or delusions, are conceptually closest to the positive facet, 
and also discussed as expression of positive schizotypy (Barrantes-Vidal et al. 
2015). CHR status includes attenuated and psychotic symptoms and indications 
of cognitive deficits, associated with positive and negative facets of schizotypy 
(Gooding et al. 2005; Flückiger et al. 2019). The concepts show phenotypic 
overlap and are not orthogonal, as has been shown for schizotypy and PLEs 
(Debbané et al. 2015), and schizotypy and high risk (Flückiger et al. 2019). 
Partially shared genetic and neurobiological correlates among the constructs 
(Linscott & van Os 2013; Ettinger et al. 2014) further support the idea of a 
dimensional psychosis continuum.  
Continuous, complex phenotypes generally constitute a valuable framework for 
the study of fundamental neurobiological mechanisms of both psychiatric 
disorders and interindividual differences. Allowing the analysis of aetiological 
mechanisms in the absence of confounding factors (e.g. illness progression, 
medication effects), they surpass animal models in illustrating complex, 
psychological constructs. Facilitating the deconstruction of psychiatric entities 
(Gottesman & Gould 2003), they also enable the consideration of resilience 
factors, preventing conversion into clinical spectra. Within the subclinical 
psychosis spectrum, schizotypy is best suited as model-phenotype due to its 
relative temporal stability (opposed to PLEs), and its differentiation into 
continuous domains (opposed to risk/no risk state). 
Similarly, current constructs of psychopathology describe psychiatric 
phenomena as dimensional continua, from healthy variation to clinical relevance 
(Cuthbert 2014; Kotov et al. 2017). Schizotypy thus not only plays a significant 
role in the study of genetic and neurobiological mechanisms of the 
schizophrenia spectrum (Barrantes-Vidal et al. 2015), but also provides a 
general framework for a dimensional and translational approach to psychiatric 
research, and the study of pathways from health to dysfunction. 
 
1.2. Genetic and neuronal networks of schizotypy 
The genetic and neuronal architectures of schizotypy have also increasingly 
been viewed in the context of continuum models. A shared genetic basis of 
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schizotypy and the schizophrenia spectrum has long been speculated. Meehl 
first proposed the existence of a single dominant schizogene leading to 
schizotaxia, a dysfunctional neuronal integration. This gene would, dependent 
on environmental factors and social learning history, be the prerequisite for 
schizotypy and, in its extreme form, schizophrenia-spectrum disorders (Meehl 
1962). Opposing Meehl’s single gene proposal, recent molecular genetic 
studies have identified a large number of relevant genetic loci in genome-wide 
association studies (GWAS), suggesting a polygenic architecture of 
schizophrenia. Those include both commonly occurring single nucleotid 
polymorphisms (SNPs) identified with small effects (Pardiñas et al. 2018) and 
rare genetic variations (e.g. copy number variants, CNVs) with larger impact 
(Mowry & Gratten 2013; Marshall et al. 2017). 
A polygenic architecture suggests a dimensional rather than a taxonic view of 
the psychosis spectrum, yet the inherent idea of a (partially) shared genetic 
architecture is still supported by current literature. Several SNPs (i.e. variations 
in a single base-pair at a specific genomic position) that are established risk 
variants for schizophrenia (e.g. in genes CACNA1C, COMT, DRD2, ZNF804A), 
are also associated with schizotypy (Walter et al. 2016), and SNP-based 
heritability for schizotypal trait dimensions has been reported between 16-30% 
(Ortega-Alonso et al. 2017). Evidence for relatively independent, underlying 
latent genetic factors highlights the importance of dimension-specific modelling 
(Linney et al. 2003; Tarbox et al. 2012). 
In addition, familial risk for schizophrenia spectrum disorders, i.e. affected close 
relatives, is associated with elevated levels of schizotypy (Miller et al. 2002; 
Soler et al. 2017). However, familial risk does not equal genetic risk per se, but 
includes shared environmental factors and interactional processes. Evidence 
indicates that about 20% of familial risk for schizophrenia is mediated through 
(i.e. explained by) polygenic risk (Agerbo et al. 2015). Polygenic risk scores 
(PRS) quantify genetic risk based on a set of multiple genetic markers by 
calculating (on individual level) a sum of allele dosages associated with the trait 
in question, weighted by GWAS-based effect sizes (Dudbridge 2013). Evidence 
for associations of schizotypy dimensions with schizophrenia PRS is, however, 
inconsistent, with null findings as well as effects in opposing directions 
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(Sieradzka et al. 2014; Zammit et al. 2014; Hatzimanolis et al. 2018; van Os et 
al. 2019).  
Heterogeneous findings indicate that a certain genetic risk is not linearly 
translated into phenotypic variation, highlighting the urge to consider modulating 
factors (Ronald & Pain 2018). This has been sporadically (but successfully) 
done for both single SNP- (de Castro-Catala et al. 2017) and (cumulative) PRS-
based (Hatzimanolis et al. 2018) genetic risk, but pathways of how genotypes 
and genetic patterns impact schizotypal variance are largely unclear.  
In Meehl’s tradition – and reiterated, albeit refined, in later models (Siever & 
Davis 2004; Howes & Murray 2014) –, it might be speculated that genetic 
effects are mediated through aberrant neuronal development and should thus 
be detectable in brain morphometry (Jones & Murray 1991). Indeed, many 
genetic variants carrying schizophrenia risk are involved in brain development 
(Toulopoulou et al. 2015), and a neurodevelopmental approach is supported by 
data from animal models (Kanyuch & Anderson 2017). In line with this, there is 
increasing evidence for brain structural correlates of schizotypy, in regions 
overlapping with those impaired across the schizophrenia spectrum (Nelson et 
al. 2013; Ettinger et al. 2014; Modenato & Draganski 2015).  
While studies indicate some heterogeneity concerning the direction of 
associations, they allow to assume the implication of prefrontal (Ettinger et al. 
2012; Kühn et al. 2012; DeRosse et al. 2015; Nenadić et al. 2015; Wang et al. 
2015; Wiebels et al. 2016; Modinos et al. 2018), precuneus and anterior and 
posterior cingulate cortex (Modinos et al. 2010, 2018; Nenadić et al. 2015; Tijms 
et al. 2015; Wiebels et al. 2016), superior and medial temporal (DeRosse et al. 
2015; Evans et al. 2016; Wiebels et al. 2016; Modinos et al. 2018) grey matter 
volume (GMV) changes in schizotypy.  
Only few studies have not only looked at volumetric changes of grey matter in 
terms of voxel-based morphometry (VBM), but also considered variation in 
surface-based morphometry (SBM), e.g. patterns of cortical surface folding 
(Stanfield et al. 2008). Those are, however, discussed as important indicators of 
early developmental disruptions (Spalthoff et al. 2018), as cortical folding 
happens very early during brain development (Chi et al. 1977). Alterations of 
those markers in schizophrenia spectrum disorders and high risk individuals 
6 
further indicate relevance for the psychosis spectrum (Nenadic et al. 2014; 
Zuliani et al. 2018).  
This dissertation will focus on grey matter structure, but it should be mentioned 
that there is also evidence for white matter changes associated with schizotypy, 
particularly in fronto-temporal connectivity (Volpe et al. 2008; Nelson et al. 
2011; DeRosse et al. 2015; Schmidt et al. 2015; Grazioplene et al. 2016; 
Lemaitre et al. 2018), mirroring findings in clinical domains (Lener et al. 2015). 
Taken together, the above presented studies indicate that pathological changes 
in neurobiological networks of schizophrenia lie on a continuum with functional, 
healthy variation. However, as not all studies have distinguished schizotypal 
facets, it is unclear whether those findings represent a general vulnerability for 
schizophrenia spectrum disorders, or define specific functions. It is further 
unclear at which point exactly on the pathway from genotype to phenotype 
morphometric variations (and other endophenotypes, e.g. cognition) are 
situated.  
A current model of schizophrenia aetiology integrates neurodevelopmental 
disruptions facilitated by genetic variants, environmental challenges and 
adversities with resulting sensitised and subsequently dysfunctional 
neurotransmission and cognitive biases, leading to the formation and 
progression of psychotic symptoms (Howes & Murray 2014). This approach can 
also be applied to other entities of the psychosis spectrum, including schizotypy. 
Statistical models, incorporating the proposed interacting and mediating 
pathways are, however, scarce. Hence, a key challenge is to develop and test 





1.3. Aims and hypotheses 
The work in this dissertation aimed to identify neurobiological determinants of 
schizotypal traits in healthy individuals, for their subsequent use as dimensional 
phenotypes in biological psychiatry research.  
The subsequent objective was to develop a statistically testable model linking 
genetic and environmental risk markers with brain structural variation to explain 
phenotypic variation in schizotypy, suited to extrapolate to other continua.  
 
More specifically, the following hypotheses were tested: 
H1: Psychometrically-assessed schizotypy is associated with genetic risk 
markers of schizophrenia (single nucleotide polymorphisms, polygenic risk) with 
cognition as a putative intermediate phenotype in this association. 
H2: Schizotypy dimensions show associations with variation in volume- and 
surface-based brain structural parameters, specifically in the precuneus and the 
fronto-striatal network (lateral and medial prefrontal cortices, striatum, and 
thalamus).  
H3: A multivariate moderation/mediation model accounts for the interaction of 




2. AGGREGATION OF STUDY RESULTS 
2.1. STUDY I: Schizotypy shows sex-dependent associations with risk 
genes ZNF804A and CACNA1C and altered attention 
Reference: Meller T., Schmitt S., Stein F., Brosch K., Mosebach J., Yüksel D., Zaremba D., 
Grotegerd D., Dohm K., Meinert S., Förster K., Redlich R., Opel N., Repple J., Hahn T., Jansen 
A., Andlauer T.F.M., Forstner A.J., Heilmann-Heimbach S., Streit F., Witt S.H., Rietschel M., 
Müller-Myhsok B., Nöthen M.M., Dannlowski U., Krug A., Kircher T., & Nenadić I. (2019). 
Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and 
modulation of attention in healthy subjects. Schizophrenia Research 208, 67–75. (IF: 4.6) 
While schizotypy shares several risk alleles with schizophrenia, pathways and 
interactions with additional factors are poorly understood. Recent genetic 
modelling studies in clinical psychosis conclude cognitive deficits and 
schizophrenia symptoms to share a substantial part of genetic variance 
(Toulopoulou et al. 2007, 2015). This might also be the case for schizotypy, 
which is associated with relatively decreased cognitive functions (Siddi et al. 
2017), especially (sustained and selective) attention (Gooding et al. 2006; 
Fuggetta et al. 2015; Moreno-Samaniego et al. 2017), and linked to attention 
deficit hyperactivity disorder (Ettinger et al. 2006; Legge et al. 2019). Cognitive 
functions, e.g. attention, may represent an intermediate endophenotype of 
schizophrenia (risk) genotype and (risk) phenotype (Toulopoulou et al. 2015, 
2018). Yet, it is unclear how genetic influences, schizotypy, and cognition in 
healthy subjects can be integrated into a joint model. (A dimension of) 
schizotypy may constitute a mediator on the path between genes and cognition 
or, vice versa, altered cognitive function may facilitate schizotypal development. 
Candidate genes for such associations are ZNF804A and CACNA1C, whose 
SNPs rs1344706 and rs1006737 have been associated with both schizotypy 
and attention (Yasuda et al. 2011; Roussos et al. 2013; Stefanis et al. 2013). 
In STUDY I, we aimed to (1) clarify the associations of the two SNPs with 
dimensional schizotypy and attention, and (2) integrate the reported bivariate 
associations into a joint framework by testing the two opposing mediation 
models of (a) schizotypy mediating the association between genetic variation 
and attention (Stotesbury et al. 2018) vs. (b) attention explaining the 
relationship of genetic influence and schizotypy, as suggested for schizophrenia 
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(Toulopoulou et al. 2018). Sex differences have been reported for effects of 
ZNF804A and CACNA1C (Strohmaier et al. 2013; de Castro-Catala et al. 2017), 
schizophrenia (Abel et al. 2010), and schizotypy profiles (Kremen et al. 1998), 
so sex was included as a potential moderator in the regression models.  
The results of STUDY I indicate sex-specific effects of both SNPs on different 
schizotypy dimensions, with a higher number of ZNF804A rs1344706 C (non-
risk) alleles linked to increased positive schizotypy in women, and the effect of 
CACNA1C rs1006737 A (risk) alleles on decreased negative schizotypy 
restricted to male participants (Figure I/1, p. 40). Sex-differences in 
schizophrenia are discussed as result of oestrogenic versus androgenic 
influences on dopaminergic pathways (Godar & Bortolato 2014). Such 
processes may also be relevant in the subclinical spectrum, explaining the sex-
specific effects of both SNPs on schizotypy. Extending the model by including 
attention suggests preferential support for a sex-moderated mediation model, 
with positive schizotypy partially explaining the association between ZNF804A 
rs1344706 and attentional performance in women (Figure I/2, p. 40) – as 
opposed to the reverse pathway proposed for schizophrenia (Figure I/3, p. 41, 
Toulopoulou et al. 2018). This indicates partially overlapping, but differential 
pathways along the schizophrenia spectrum and should spark future studies 
further dissecting this association.   
In short, STUDY I further supports the idea of a shared genetic basis of both 
schizophrenia and schizotypy, and offers a model for the association of genetic 
risk, schizotypy, and cognitive alterations in dimensions also impaired in 
schizophrenia. Notably, the study highlights the relevance of accounting for 
secondary factors, like sex, in modulating those associations.  
 
2.2. STUDY II: Intelligence moderates the association between positive 
schizotypy and striatal structure in healthy individuals 
Reference: Meller, T., Ettinger, U., Grant, P., & Nenadić, I. (2019). The association of striatal 
volume and positive schizotypy in healthy subjects: Intelligence as a moderating factor. 
Psychological Medicine 2019 Sep 18:1-9, doi: 10.1017/S0033291719002459P (IF: 5.6) 
According to aetiological models, beneficial factors may buffer the impact of 
brain structural variations on phenotypic variance. Besides variation in parietal 
and temporal structures, increasing evidence suggests fronto-striatal networks 
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to be critically involved in the generation of psychotic(-like) experiences. This is 
supported by findings of associations of (primarily positive) schizotypy with 
brain-structural and -functional alterations in those networks (Mittal et al. 2013; 
Rössler et al. 2018; Wang et al. 2018; Waltmann et al. 2019), but also with 
expression levels of dopaminergic genes and alterations of dopaminergic 
neurotransmission (Ettinger et al. 2013; Grant et al. 2014b; Mohr & Ettinger 
2014). Current studies, however, report heterogeneous direction of effects. 
Striatal size has been discussed as endophenotype for psychosis (Chemerinski 
2013), and fronto-striatal mechanisms might lie on a possible pathway from 
genetic risk through altered neurotransmission and neuronal structure, to 
phenotypic psychosis-proneness.  
Similar propositions are made by a model by Siever and Davis (Siever & Davis 
2004): Authors further suggested that enhanced vulnerability to environmental 
insults caused by genetic risk variants, leading to altered brain structure (and 
function), might be buffered by resilience factors like cognitive capacity (e.g. 
intelligence), thus leading to attenuated symptom levels and preventing 
conversion into the disorder. Such a pattern has in fact been reported for 
processes of perception in positive schizotypy (Grant et al. 2014a).  
STUDY II, in line with this model, analysed the association of schizotypy with 
brain structural parameters, and tested a statistical model with intelligence as a 
putative moderator of this association. The results of STUDY II indeed confirm 
this model: The detected association of positive schizotypy with greater GMV in 
a cluster containing the right putamen and pallidum (see Figure II/1(a), page 50) 
was moderated by intelligence. With increasing levels of IQ, the strength of the 
association decreased, indicating a protective influence of general intelligence 
on the association of striatal structure and positive schizotypy (see Figure II/2, 
page 51). The negative dimension was further positively associated with GMV 
in a cluster in the left precentral gyrus, but intelligence did not influence this 
association (see Figure II/1(b), page 50). There is limited evidence for the role 
of paracentral cortices in schizotypy, although STUDY III detected a similar 
association. Gyrification analyses only yielded significant associations of total 
schizotypy and gyrification in the precuneus and postcentral gyrus in an 
uncorrected, exploratory approach. 
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In conclusion, STUDY II supports the role of the fronto-striatal network also in the 
healthy domain of the psychosis spectrum, extending the dopamine hypothesis 
of schizophrenia (Howes et al. 2017), and presents a pathway for protective 
influence of resilience factors like general cognitive capacity. 
 
2.3. STUDY III: Psychotic-like, distress-based symptoms are associated 
with structural variation in brain areas impaired in schizophrenia 
Reference: Meller, T., Schmitt S., Ettinger, U., Grant, P., Stein, F., Brosch, K., Grotegerd, D., 
Dohm, K., Meinert, S., Förster, K., Hahn, T., Jansen, A., Dannlowski, U., Krug, A., Kircher, T., & 
Nenadić, I. Brain structural correlates of schizotypal signs and subclinical schizophrenia nuclear 
symptoms in healthy individuals. (submitted manuscript) 
It is unclear how distress due to psychotic experiences, as opposed to the 
frequency of symptoms, is associated with brain structural variation. In healthy 
individuals, higher levels of trait schizotypy confer greater liability to psychotic-
like experiences (Gooding et al. 2005; Debbané et al. 2015). However, distress 
associated with PLEs, rather than their frequency, has greater prognostic value 
for conversion into psychosis (Hanssen et al. 2005). The intensity and 
associated distress of such experiences varies vastly, both inter- and intra-
individually (Rössler et al. 2007; Linscott & van Os 2013). This variability is 
thought to be attributable to latent, stable traits (Rössler et al. 2013), 
representing the “trait in action” in response to current environmental challenges 
(Barrantes-Vidal et al. 2015). The schizophrenia nuclear symptoms (SNS) and 
schizotypal signs (STS) scales, constructed using items of the Symptom-
Checklist-90-R (SCL90-R Derogatis 1977; Rössler et al. 2007), assess the level 
of distress caused by PLEs over the course of four weeks – thus closing a gap 
between highly variable mood and stable personality traits. While 
psychometrically well-validated, their neurobiological correlates are yet unclear.  
STUDY III tested the association of SNS and STS with voxel- and surface-based 
brain structural parameters in healthy individuals, to explore whether they show 
similar morphometric correlates as reported for instruments assessing trait-like 
personality characteristics. We assessed both rather quickly adaptable (VBM) 
and more stable, early-determined (SBM) patterns of brain structure.  
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Results of STUDY III show differential patterns for the scales: SNS, assessing 
positive, psychotic symptoms, was associated with decreased grey matter 
volume (GMV) in the right inferior temporal gyrus (ITG), and increased GMV in 
the left superior parietal lobe including the precuneus (see Figure III/2, p. 66). 
STS, capturing a milder, personality-like blend of positive and negative 
symptoms, was negatively associated with GMV in the right and left precentral 
gyrus (see Figure III/2, p. 66). Gyrification analyses did not detect significant 
clusters after correction for multiple testing, however, exploratory uncorrected 
analyses showed positive correlations of gyrification in the left insula and rostral 
middle frontal gyrus with SNS, as well as gyrification in the right insula and 
precuneus with STS, and a negative correlation of STS with gyrification in the 
right inferior/middle temporal gyrus (see Figure III/3, page 67).  
Both precuneus and ITG are involved in higher-order, integrative cognitive 
processes and have previously been linked to symptoms of the psychosis 
spectrum. The precuneus has repeatedly been associated with 
psychometrically-assessed schizotypy (Modinos et al. 2010, 2018; Nenadic et 
al. 2015), and our results support its association with a more acute higher-risk 
state of increased distress. Similarly, structural reductions within the  ITG have 
also been associated with PLEs (van Lutterveld et al. 2014), and are part of an 
anatomical pattern predicting later conversion in at-risk individuals (Koutsouleris 
et al. 2010).  
The blending (rather than distinguishing) of negative and positive schizotypy 
facets in STS might explain its restricted associations. Precentral variation, as 
associated with STS, has been linked to motor dysfunction in schizophrenia 
(Tanskanen et al. 2010), however, its role in schizotypy remains unclear.  
In conclusion, the findings of STUDY III demonstrate that, similar to measures of 
schizotypy and PLEs, distress-related markers are associated with variation in 
precuneus and ITG, underlining the importance of these structures for the 
positive symptom dimension. Pointing to distress as a putative mediating factor, 
they illustrate the relevance of emotional appraisal of psychotic experiences, a 
process which in turn can be influenced by personality characteristics like 




2.4. STUDY IV: Polygenic risk for schizophrenia, depression and bipolar 
disorder is not associated with schizotypy in non-clinical adults 
Reference: Nenadić, I.*, Meller, T*., Streit, F., Schmitt S., Stein, F., Brosch, K., Mosebach, J., 
Ettinger, U.,  Grant, P., Meinert S., Opel, N., Lemke, H., Fingas, S., Förster, K., Hahn, T., 
Jansen, A., Andlauer, T.F.M., Forstner, A.J., Heilmann-Heimbach, S., Hall, A., Awasthi, S., 
Ripke, S., Witt, S.H., Rietschel, M., Müller-Myhsok, B., Nöthen, M.M., Dannlowski, U., Krug, A., 
Kircher, T. Polygenic risk for schizophrenia and schizotypal traits in non-clinical subjects. 
*contributed equally (unpublished manuscript) 
Schizotypal traits are assumed to be heritable (Ronald & Pain 2018), yet single 
common genetic variants (like SNPs) only explain smaller parts of its variance. 
Cumulative genetic risk scores, calculated on the basis of known SNPs, may 
have greater explanatory power (Mistry et al. 2018). Several studies have 
successfully linked schizotypy dimensions to genetic variants associated with 
schizophrenia risk (Walter et al. 2016), indicating additive effects (Grant et al. 
2015). The impact of polygenic risk for schizophrenia on schizotypy, however, is 
still poorly understood, with current evidence restricted to studies with 
inconsistent results (Hatzimanolis et al. 2018; van Os et al. 2019).  
The aim of STUDY IV was to test the hypothesis that schizotypy is associated 
with a SNP-based polygenic risk score (PRS) for schizophrenia. To test for 
specificity, those analyses were extended to PRS for major depressive disorder 
and bipolar disorder, conducted in two independent samples of psychiatrically 
healthy adults.  
Results of STUDY IV show no significant associations of schizotypy (either total 
score or dimensions) with PRS for schizophrenia or bipolar disorder, consistent 
across the discovery and replication sample, confirmed by meta-analytical 
combination of bootstrapped results. Only in one sample, major depression 
PRS was associated with increases schizotypy levels.  
These findings add important insights to our understanding of the psychosis 
spectrum by indicating that schizotypy is not linearly and independently linked to 
polygenic risk for schizophrenia; in spite of partial overlap in single risk genes. 
However, it has to be considered that PRS only subsumes SNP-based risk of 
common genetic variants, with limited explanatory value (Marshall et al. 2017).  
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In conclusion, the results of STUDY IV suggest only a minor overlap of 
schizotypy and (clinical) genetic risk profiles as accounted for in PRS. As the 
lack of a direct association may also indicate moderating influences, they 
emphasise the need to consider additional modulating factors in statistical 
models analysing associations of the neurobiological fundaments of schizotypy.  
 
2.5. STUDY V: An explanatory model: Genes and environment have an 
interactive impact on schizotypy through changes in brain structure 
Reference: Meller, T., Schmitt S., Stein, F., Brosch, K., Andlauer, T.F.M., Grotegerd, D., Dohm, 
K., Meinert, S., Förster, K., Forstner, A.J., Heilmann-Heimbach, S., Streit, F., Witt, S.H., 
Rietschel, M., Müller-Myhsok, B., Nöthen, M.M., Hahn, T., Jansen, A., Dannlowski, U., Krug, A., 
Kircher, T., & Nenadić, I. The impact of polygenic and poly-environmental risk factors on a 
psychosis risk phenotype is mediated through brain structure. (unpublished manuscript) 
One of the main challenges in biological psychiatry is to clarify the pathway 
between genetic risk variants and phenotypic variation. Current aetiology 
models of psychotic disorders suggest interactive effects of genetic and 
environmental risk markers impacting on neurodevelopmental processes, and 
leading to phenotypic variation, with buffering influences of protective factors 
(Howes & Murray 2014; Carpenter & Strauss 2017). Progressing from simple 
bivariate association studies, emerging evidence of gene by environment (GxE) 
studies in phenotypes (Bernardo et al. 2017; Leighton et al. 2017; Misiak et al. 
2018) and brain structure (Geoffroy et al. 2013) has added valuable insight to 
our understanding of processes and networks. However, those interactions, too, 
have mostly been limited to single genes and risk factors. There is a lack of 
multivariate models, integrating cumulative GxE effects, neuronal biomarkers, 
cognition, and phenotypes into explanatory pathways. 
STUDY V used statistical moderation and mediation analysis to test a model in 
which GxE effects on the dimensional risk phenotype schizotypy are explained 
through brain structural changes, allowing for buffering influences of executive 
function (see Figure V/1, p. 107). To maximise the input of known risk factors 
for the psychosis spectrum, we approximated genetic risk as PRS for 
schizophrenia, while aggregating multiple environmental risks in a cumulative, 
weighted environmental risk score for psychosis (ERS, Vassos et al. 2019). 
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Results of STUDY V support the multivariate model with complex interactive 
associations of GxE on positive schizotypy (see Figure V/3, p. 115). This 
association is mediated by GMV in a cluster in the precuneus and posterior 
cingulate gyrus (Pc/pcG, see Figure V/2, p. 113) and moderated by executive 
function, strengthening the role of the precuneus for positive schizotypy.  
While neither PRS nor ERS show a main effect on Pc/pcG GMV, their 
interaction is significant, with the intensity and direction of the PRS effect 
depending on ERS levels (positive slope for low ERS, negative slope for high 
ERS). Similarly, the association of Pc/pcG GMV and positive schizotypy is 
moderated by executive function (positive slope for low, negative slope for high 
executive function). This supports the notion that in healthy individuals, genetic 
risk affects brain structure and, subsequently, phenotype dependent on 
additional factors (Van der Auwera et al. 2017). Our findings may explain 
previous heterogeneous and null findings, highlighting the relevance of complex 
variance structures and multivariate models. 
The reported bidirectional interaction effects advocate moving on from 
traditional diathesis-stress models to models of differential susceptibility. The 
latter propose a general modulation of susceptibility to environmental influence 
(both adverse and protective) through genetic disposition (Leighton et al. 2017; 
Assary et al. 2018), replacing “vulnerability factors” with “plasticity factors” 
(Belsky & Pluess 2009). 
In conclusion, STUDY V provides a biological framework, integrating the genetic 
and environmental associations of schizotypy as a psychosis risk phenotype 
into a testable model. This approach can also be extended to other genotype-
phenotype associations of psychiatric disorder spectra.  
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3. GENERAL DISCUSSION 
This dissertation presents a neurobiological characterisation of genetic and 
brain structural markers of schizotypy and psychosis-related symptoms.  
STUDIES I and IV established an association of schizotypy with selected single 
risk genes (CACNA1C and ZNF804A, STUDY I), while failing to show a direct 
association with polygenic risk for schizophrenia (STUDY IV) – thus only partly 
confirming hypothesis H1. STUDY I additionally indicates that schizotypy 
mediates effects of genetic variants on cognition, rather than vice versa.   
In MR-morphometric STUDIES II and III, brain structural correlates of schizotypy 
dimensions were analysed, providing further support for the precuneus and the 
fronto-striatal network, as well as the inferior temporal gyrus to underlie 
symptoms of the positive dimension, in line with hypothesis H2. STUDY II shows 
a protective effect of increased cognitive functioning, while Study III extends 
these associations to distress-based schizotypy-like phenotypes, highlighting 
the relevance of emotional appraisal of symptoms.  
STUDY V integrates the above findings to consider genetic and environmental 
influences, brain structure, cognition, and schizotypy in a multivariate model, 
showing that the interaction effect of genes and environment on the phenotype 
is explained through brain structural variation. The significant model fit confirms 
hypothesis H3 and statistically supports current aetiological models of the 
schizophrenia spectrum.  
Taken together, the five studies add new insights for two neurobiological 
domains of the dimensional psychosis phenotype schizotypy, i.e. its genetic 
basis and its neural networks, as well as their integration into a joint framework.  
 
3.1. Genetic basis of schizotypy 
Schizotypy dimensions show heritability estimates between 30-50% (Linney et 
al. 2003; Macare et al. 2012), and current evidence suggests an underlying 
polygenic architecture (Grant et al. 2013; Brambilla et al. 2014). Several SNPs 
have been associated with schizotypy (Walter et al. 2016), and STUDY I finds 
further evidence for links to risk variants in ZNF804A and CACNA1C. Similar to 
other genes associated with schizotypy (e.g. BDNF, DTBNP1, NRG1), both are 
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relevant for neuronal development: In the human brain, ZNF804A is expressed 
in the dorsolateral prefrontal cortex and hippocampus, involved in neurite 
growth and synapse formation, and SNP rs1344706 affects its expression, 
particularly during prenatal brain development (Hill & Bray 2011, 2012). 
CACNA1C is expressed in the hippocampus and the entire central nervous 
system. It codes for calcium channel subunit Cav1.2, mediating synaptic 
plasticity and also showing altered expression in SNP rs1006737 (Bigos et al. 
2010). Functionally, both SNPs have been linked to more basal cognitive 
dysfunctions, as well as altered processing of emotional and social information 
and associated brain activity and structure (Voineskos et al. 2011; Soeiro-de-
Souza et al. 2012; Mohnke et al. 2014; Paulus et al. 2014). Implicated in 
fundamental interpersonal processes, it is not surprising that although ZNF804A 
and CACNA1C are established risk genes for schizophrenia, this association is 
not unique, but extends to other psychiatric and neurodevelopmental disorders 
(Chang et al. 2017; Moon et al. 2018). Similarly, while schizotypy is primarily 
discussed as schizophrenia endophenotype, it also predicts later occurrence of 
other psychiatric disorders, social functioning, and general mental health 
outcomes (Rössler et al. 2011; Kwapil et al. 2013).  
This suggests that although several risk genes are shared between schizotypy 
and schizophrenia, their genetic architectures only partially overlap, as 
supported by the lack of a direct association in STUDY IV. However, regarding 
this finding, some aspects need to be considered. Firstly, PRS scores (based 
on GWAS-identified, common SNPs) can only account for a moderate portion of 
underlying genetic variance and underestimate phenomenological and 
biological heterogeneity within cases and controls (Marín 2016). Secondly, 
additional factors may modulate the expression of the phenotype, e.g. biological 
sex (STUDY I), cognitive function (STUDY II), or environmental influences (STUDY 
V). In fact, recent evidence suggests interactive effects of schizophrenia PRS 
with stressful contexts and shared environment in siblings on schizotypy 
(Hatzimanolis et al. 2018; van Os et al. 2019).  
A prominent approach to explain GxE interactions is the diathesis-stress-model, 
hypothesising that the impact of environmental events on the development of 
the actual disorder is potentiated by genetically-determined vulnerabilities 
(Howes et al. 2017). However, STUDY V suggests that, depending on 
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environmental conditions, high PRS can also have inverse effects, leading to 
increased function. This is in line with a concept of differential susceptibility or 
environmental sensitivity, proposing that genetic “risk” variants may render 
sensitivity to environmental influences in general – including favourable ones 
(Leighton et al. 2017; Assary et al. 2018).  
 
3.2. Neural networks of schizotypy 
Schizotypy describes manifestations across multiple domains of cognition, 
emotion, and behaviour. This dissertation shows that these are associated with 
variation in highly connected, integrative regions throughout the brain.  
STUDIES III and V find associations of positive schizotypal phenotypes with 
precuneus structure. In fact, structural variation in the precuneus is one of the 
most robust findings in (positive) schizotypy (Modinos et al. 2010, 2018; 
Nenadic et al. 2015; Wiebels et al. 2016). The precuneus is extensively 
connected throughout the brain and can be divided into three anatomical and 
functional subsections (Cavanna & Trimble 2006). The detected clusters are 
localised in the central part, functionally connected to parietal, temporal, and 
prefrontal cortices and attributed to cognitive processes producing a conscious 
self-percept in relationship to the world (Margulies et al. 2009). Those include 
cause and effect judgements, attributional evaluation and (mis)attribution of 
personal reference (see Jones & Bhattacharya 2014 for an overview). While the 
precuneus, also an important node of the default-mode network, has shown to 
be of transdiagnostic relevance in schizophrenia, anxiety, depression, and 
obsessive-compulsive disorder (Jones & Bhattacharya 2014), these functions 
show a striking overlap with characteristics of the positive schizotypy dimension. 
Findings of STUDY V indicate that this association arises from interactions of 
genes and environment, as the precuneus cluster is detected in a GxE model 
independently of the phenotype, yet associated with it.  
A second central associative network in the human brain constitutes circuits of 
the fronto-striatal system, connecting striatum, thalamus, orbifrontal, and 
cingulate regions, and linked to a variety of cognitive, emotional, and 
behavioural functions (Tekin & Cummings 2002). STUDY II finds an association 
of striatal structures putamen and pallidum with positive schizotypy. Striatal 
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function (greatly modulated by dopaminergic neurotransmission) is essential for 
behavioural regulation through reward processing and associative learning 
(linking it to anhedonic, negative characteristics), but also for salience attribution 
and (un)certainty judgements. Inappropriate attributions of salience and 
certainty are implicated in the formation of delusional thoughts and positive 
symptoms (Broyd et al. 2017), yet the buffering effect of intelligence shown in 
STUDY II indicates protective influence of preserved or compensatory frontal 
functioning (Colom et al. 2013). Central for striatal functioning, dopaminergic 
neurotransmission and its genetic fundaments are altered in schizotypy (Mohr & 
Ettinger 2014), suggesting an extension of the dopamine hypothesis of 
schizophrenia to the healthy spectrum (Howes et al. 2017).  
While dopamine receptors show high density in the striatum, they are also 
found in other brain regions, including the inferior temporal gyrus (ITG). The ITG 
(connected to both precuneus and prestriate regions) is involved in visual 
imagery, perceptive integration and attributions of intention in others (Brunet et 
al. 2000; Hamamé et al. 2012). In this area, STUDY III also finds altered GMV 
associated with more state-like, distress-based symptoms within the positive 
dimension, in line with it being discussed as underlying neuronal correlate of 
hallucinations in schizophrenia (Goldsmith et al. 1997).  
Consistent across STUDIES II and III, surface parameters of cortical folding did 
not exhibit strong enough effects to survive correction, even though they were 
detected in regions relevant for schizotypy. Given that schizotypy is linked to 
several genetic factors implicated in neuronal development, this is surprising. 
Folding parameters are determined early in brain development and, in contrast 
to grey matter volumes, thought to be relatively stable over time (Chi et al. 
1977). Comparatively weak associations with schizotypal dimensions indicate 
certain predispositions, yet suggest that those can be functionally “overwritten” 
by later developmental processes, and masked by compensatory mechanisms.  
 
3.3. Limitations and implications for future research 
Across the studies reported in this dissertation, some limitations have to be 
considered that bear implications for future research. Firstly, all studies were 
based on healthy individuals, who on average showed (expectedly) low to 
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moderate schizotypy. This may restrict variance, but does not invalidate 
findings, rather speaking for the strength of the effect of even subtle variations. 
Clinical studies might include individuals with subthreshold or manifest symptom 
levels to extend these findings across a clinical spectrum (at the cost of higher 
risk of confounding factors).  
Additionally, although PRS and ERS represent cumulative risk estimates, they 
can each only account for additive effects. PRS scores rely on GWAS-identified, 
common SNPs with small individual effects, and can only account for a portion 
(~20%) of underlying genetic variance. In a differential susceptibility approach, 
a similar genetic predisposition might in one case lead to a clinical disorder 
while in another prevent exactly that, depending on environmental conditions 
and translated through different neurodevelopmental correlates. Investigation of 
associations with rare variants, de novo mutations, epigenetic effects, or gene x 
gene interactions promises extended insights. Lastly, the consideration of GxE 
correlations could help identify additional processes, as genetic predisposition 
resulting in personality traits would also influence the individual’s active creation 
of environmental conditions (Dick 2011), as has been indicated for schizotypal 
traits preceding cannabis consume (Schiffman et al. 2005). 
 
3.4. Integration 
This dissertation shows that schizotypy is linked to genetic variants that impact 
neuronal development and function and carry risk for schizophrenia. Beyond the 
single gene approach, the lack of a direct association with schizophrenia PRS 
suggests limited overlap of the polygenetic architectures of the phenotypes. 
However, there is evidence for an indirect effect through altered brain structure, 
depending on environmental conditions and cognitive functions. This suggests 
that in healthy individuals, the impact of genetic predisposition on schizotypy is 
modulated by intra- and extrapersonal factors and associated with 
neurodevelopment. In line with this, schizotypy is associated with variation in 
brain structures implicated in (higher-level) interpretation and evaluation of 
sensory information, imaginary processes, and behavioural regulation. 
Developmental disturbances of neuronal organisation seem bound to sensitive 
time windows during which activity-dependent modulations cause long-term 
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alterations in brain circuits (Marín 2016). Genetic variants may alter the onset 
and duration of these windows, and render plasticity at glutamatergic and 
dopaminergic synapses (Hall et al. 2015; Genovese et al. 2016). However, not 
only can plastic changes occur beyond those periods (Hübener & Bonhoeffer 
2014), but associations are further modulated by buffering factors like cognitive 
function (which in turn might be indicative of latent genetic and environmental 
effects). Conceptualised as stable personality trait, schizotypy can be seen as 
underlying source of more acute responses to environmental challenges 
expressed in state-like experiences (Barrantes-Vidal et al. 2015), while 
associated distress and its neuronal correlates have predictive value for 
progression into clinically relevant states. However, favourable environmental 
conditions and/or compensatory processes can equally lead to the expression 
of schizotypal predispositions in functionally adaptive behaviours, possibly 
leading to evolutionary advantages (Nettle & Clegg 2006) and explaining the 
perseverance of genetic profiles carrying liability to harmful outcomes.  
In conclusion, schizotypy is a valuable endophenotype of the psychosis 
spectrum, demonstrating that even severe pathophysiological disruptions lie on 
a continuum with subtle variations of healthy function (Venables 1975). 
However, beyond that, it is an expression of multifaceted behavioural, cognitive, 
and emotional interindividual variation, with its underlying mechanisms 
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Complex, dimensional phenotypes represent a valuable framework for the 
analysis of fundamental neurobiological mechanisms of psychiatric disorders. 
They facilitate the deconstruction of diagnostic entities and the study of 
protective processes that prevent progression into clinical domains. Within the 
psychosis spectrum, schizotypy describes a multidimensional personality 
construct with behavioural, cognitive, and emotional characteristics similar to 
key symptoms of schizophrenia, that can equally be grouped into the 
dimensions positive (magical thinking, unusual perceptions and beliefs), 
negative (introversion, anhedonia), and disorganised (cognitive disorganisation, 
eccentricity). Within a continuum model of psychosis, schizotypy is discussed 
as variation of healthy function, and as risk phenotype of schizophrenia and 
psychosis proneness, assuming a (partially) overlapping genetic architecture 
along the spectrum. Current aetiological models propose an impact of genetic 
liability, in interaction with environmental risk and modulated by protective 
factors like cognitive function, through disruptions in neuronal development. In 
fact, recent studies show that schizotypy is associated with brain structural 
variation, partially overlapping with regions that are also impaired in patients 
with schizophrenia spectrum disorders.  
This dissertation characterised neurobiological determinants of schizotypy 
regarding its genetic basis and neural networks, aiming to develop a multimodal 
model to integrate those into a joint framework.  
STUDIES I and IV investigated the genetic structure of schizotypy, demonstrating 
its association with common variants (single nucleotide polymorphisms, SNPs) 
in genes (CACNA1C and ZNF804A) involved in processes of neuronal 
development and identified as risk genes for schizophrenia and other 
psychiatric disorders (STUDY I). In this association, biological sex has a 
moderating role. However, a direct association of a polygenic schizophrenia risk 
score, based on cumulative SNP-risk, was not established (STUDY IV). 
STUDIES II and III analysed brain structural correlates of schizotypy dimensions, 
finding an association of the positive dimension (and symptom-associated 
distress) with grey matter volume in associative brain areas precuneus, striatum 
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and inferior temporal gyrus. STUDY II further indicates that this relationship can 
be buffered by above average general cognitive function.  
Study V ultimately integrates the previous results into a joint multivariate model 
that proves to explain a substantial amount of phenotypic variance. The model 
shows that the interaction effect of polygenic and poly-environmental risk on 
positive schizotypy is mediated through brain structural variation in the 
precuneus, and modulated by the level of executive function.  
In conclusion, this dissertation shows that schizotypy is associated with genetic 
polymorphisms involved in neuronal development and function. While those are 
identified as schizophrenia risk variants, the lack of an association with 
polygenic schizophrenia risk suggests a limited overlap of the genetic 
architectures of the phenotypes. The confirmation of the multivariate model, 
however, indicates an indirect effect through variations in brain structure and 
modulated by intra- and extrapersonal factors. Accordingly, particularly positive 
schizotypy is associated with structural alterations in brain regions central for 
the integration, evaluation, and attribution of perceptual information within 
associative neuronal networks.  
Thus, schizotypy is a valuable endophenotype of the schizophrenia spectrum, 
showing that pathophysiological aberrations lie on a continuum with variation of 
healthy functioning. Schizotypy, however, also describes the manifestation of 
interindividual variation in behaviour, cognition, and emotion, with its underlying 
mechanisms representing an exemplary framework for the study of 




Komplexe, dimensionale Phänotypen stellen ein wertvolles Paradigma für die 
Untersuchung fundamentaler neurobiologischer Mechanismen psychiatrischer 
Erkrankungen dar. Sie vereinfachen die Dekonstruktion von diagnostischen 
Einheiten und die Untersuchung von protektiven Prozessen, die vor dem 
Übergang in klinische Störungen schützen. Innerhalb des Psychosespektrums 
beschreibt Schizotypie ein multidimensionales Persönlichkeitskonstrukt, dessen 
Merkmale in Verhalten, Kognition und Emotion den Kernsymptomen der 
Schizophrenie ähneln und ebenfalls auf den Dimensionen positiv (magisches 
Denken, ungewöhnliche Wahrnehmungen und Überzeugungen), negativ 
(Introversion, Anhedonie) und desorganisiert (kognitive Desorganisation, 
Exzentrizität) beschrieben werden können. Im Rahmen des Kontinuum-Modells 
der Psychose wird Schizotypie sowohl als Variation gesunder Funktion, als 
auch als Risiko-Phänotyp für Schizophrenie und Psychose-Nähe diskutiert, und 
von einer (zumindest teilweisen) Überlappung genetischer Grundlagen über das 
Spektrum hinweg ausgegangen. Aktuelle ätiologische Modelle gehen davon 
aus, dass genetische Effekte, in Interaktion mit umweltbedingten Risikofaktoren 
und moduliert durch protektive Faktoren wie kognitive Leistungsfähigkeit, über 
Veränderungen der neuronalen Entwicklung wirken. Tatsächlich zeigen aktuelle 
Studien, dass die Ausprägung von Schizotypie bei Gesunden mit 
hirnstruktureller Variation assoziiert ist. Diese findet sich in Arealen, welche 
teilweise mit Regionen, die auch bei Patienten mit Erkrankungen des 
Schizophreniespektrums betroffen sind, überlappen. 
Die vorliegende Dissertation hat in fünf Studien neurobiologische  Grundlagen 
der Schizotypie auf genetischer und hirnstruktureller Ebene untersucht, mit dem 
Ziel der Entwicklung eines multimodalen Modells, welches diese Ebenen in 
einen gemeinsamen Rahmen integriert.  
STUDIEN I und IV haben die genetischen Grundlagen der Schizotypie untersucht 
und können demonstrieren, dass Schizotypie mit häufigen genetischen 
Varianten (Single Nucleotide Polymorphismen, kurz SNPs) in Genen 
(CACNA1C, ZF804A) assoziiert ist, welche wichtige Funktionen für neuronale 
Entwicklungsprozesse innehaben, und als Risikogene für Schizophrenie, aber 
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auch andere psychiatrische Erkrankungen identifiziert wurden (STUDIE I). 
Geschlecht wirkt hier als moderierender Faktor. Ein direkter Zusammenhang 
mit einem polygenen Risikoscore für Schizophrenie, basierend auf kumulativem 
SNP-Risiko, ist jedoch nicht nachweisbar (STUDIE IV).  
STUDIEN II und III haben hirnstrukturelle Korrelate der Schizotypiedimensionen 
analysiert und finden einen Zusammenhang insbesondere der positiven 
Dimension (und damit assoziierter Belastung) mit dem Volumen der grauen 
Substanz in den assoziativen Hirnarealen Precuneus, Striatum und inferiorer 
Temporalgyrus. STUDIE II zeigt zudem, dass dieser Zusammenhang durch 
überdurchschnittliche kognitive Leistungsfähigkeit abgemildert werden kann.  
STUDIE V schließlich integriert die vorangegangenen Befunde in ein 
gemeinsames, multivariates Modell, welches substantiell phänotypische 
Varianz aufklärt. Es zeigt sich, dass der Interaktionseffekt von polygenem und 
kumulativem Umweltrisiko auf (positive) Schizotypie durch Veränderungen der 
Hirnstruktur im Precuneus vermittelt und durch das Level an exekutiver 
Funktion moduliert wird.  
Zusammenfassend zeigt diese Dissertation, dass Schizotypie mit genetischen 
Polymorhphismen assoziiert ist, welche Einfluss auf neuronale Entwicklung und 
Funktion haben. Zwar stellen diese auch Risikogene für Schizophrenie dar, die 
fehlende Assoziation mit polygenem Risiko spricht jedoch für eine 
eingeschränkte Überlappung in der genetischen Architektur der Phänotypen. 
Die Bestätigung des multimodalen Modells indiziert allerdings einen indirekten 
Effekt auf Schizotypie, vermittelt über veränderte Hirnstruktur, und beeinflusst 
durch das Wirken intra- und extrapersoneller Faktoren. Übereinstimmend ist 
insbesondere die positive Schizotypiedimension mit Veränderungen in 
Hirnregionen assoziiert, die zentral in die Integration, Evaluation und Attribution 
perzeptueller Information in assoziativen Netzwerken involviert sind.  
Schizotypie ist ein wertvoller Endophänotyp des Schizophreniespektrums und 
zeigt, dass auch pathophysiologische Veränderungen auf einem Kontinuum mit 
Variation gesunder Funktionen liegen. Darüber hinaus repräsentiert sie die 
Manifestation von interindividueller Variation in Verhalten, Kognition und 
Emotion, deren zugrundeliegende Mechanismen ein exemplarisches 
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Schizotypy is amultidimensional risk phenotype distributed in the general population, constituting of subclinical,
psychotic-like symptoms. It is associatedwith psychosis proneness, and several risk genes for psychosis are asso-
ciated with schizotypy in non-clinical populations. Schizotypy might also modulate cognitive abilities as it is as-
sociated with attentional deficits in healthy subjects. In this study, we tested the hypothesis that established
genetic risk variants ZNF804A rs1344706 and CACNA1C rs1006737 are associated with psychometric schizotypy
and that schizotypy mediates their effect on attention or vice versa. In 615 healthy subjects from the FOR2107
cohort study, we analysed the genetic risk variants ZNF804A rs1344706 and CACNA1C rs1006737, psychometric
schizotypy (schizotypal personality questionnaire-brief SPQ\\B), and a neuropsychologicalmeasure of sustained
and selective attention (d2 test). ZNF804A rs1344706 C (non-risk) alleles were significantly associated with
higher SPQ-B Cognitive-Perceptual subscores inwomen andwith attention deficits in both sexes. This schizotypy
dimension also mediated the effect of ZNF804A on attention in women, but not in men. CACNA1C rs1006737-A
showed a significant sex-modulated negative association with Interpersonal schizotypy only in men, and no ef-
fect on attention. Our multivariate model demonstrates differential genetic contributions of two psychosis risk
genes to dimensions of schizotypy and, partly, to attention. This supports amodel of shared genetic influence be-
tween schizotypy and cognitive functions impaired in schizophrenia.








Schizotypy is a multidimensional construct of personality traits phe-
nomenologically resembling subclinical schizophrenia symptoms. It is
considered a phenotypic marker of psychosis proneness and schizo-
phrenia risk (Barrantes-Vidal et al., 2015) and elevated in patients
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with psychotic disorders (Brosey and Woodward, 2015). Schizotypy,
having predictive value for conversion probability into schizophrenia-
spectrum disorders (Chapman et al., 1994; Gooding et al., 2005;
Kwapil et al., 2013), is also considered a high-risk marker in early inter-
vention research.
The phenotype comprises aspects of deviations in cognition, emo-
tion, speech, and perception (Ettinger et al., 2015), but is also associated
with higher creativity (Fink et al., 2014; Mohr and Claridge, 2015), pos-
sibly even constituting an evolutionary advantage (Nettle and Clegg,
2006). Schizotypy is often delineated into three dimensions (Dodell-
Feder et al., 2019), namely positive/cognitive-perceptual (magical think-
ing, referential ideas, unusual perceptual experiences, and paranoid ide-
ation), negative/interpersonal (difficulties in social interaction and
blunted affect) and disorganised (“odd” speech and behaviour).
While different cognitive dimensions have been linked to schizotypy
(Siddi et al., 2017), relative deficits in sustained and selective attention
have been robustly reported (Breeze et al., 2011; Fuggetta et al., 2015;
Gooding et al., 2006; Moreno-Samaniego et al., 2017). Findings even
point to a possible genetic link between attention-deficit hyperactivity
disorder and schizotypy (Ettinger et al., 2006). While impaired atten-
tion has often been associated with the negative schizotypy dimension
(Alvarez-Moya et al., 2007; Chen and Faraone, 2000; Smyrnis et al.,
2007), recent evidence also suggests the cognitive-perceptual dimen-
sion as a risk factor for attentional difficulties (Gooding et al., 2006;
Stotesbury et al., 2018). Attention deficits are also found in schizophre-
nia patients compared to healthy controls (Elvevåg andGoldberg, 2000;
Hill et al., 2008; Lee et al., 2017; Nuechterlein et al., 2004), and in first-
degree relatives of schizophrenia patients (Snitz et al., 2005), indicating
genetic effects. Attention therefore represents a putative cognitive link
between these risk genotypes and phenotypes.
Growing evidence also suggests a partially shared genetic basis be-
tween schizotypy and psychotic disorders. Genome-wide association
studies (GWAS) have currently identified N120 common genetic varia-
tions contributing to the risk for schizophrenia (Pardiñas et al., 2018),
and while at least some risk genes are shared among clinical psychosis
phenotypes (Craddock et al., 2009; Sheldrick et al., 2008), it seems
that polygenic risk scores for psychosis are only marginally associated
with schizotypy (Hatzimanolis et al., 2018; Jones et al., 2016). However,
recent studies reporting significant associations of schizophrenia risk
variants with schizotypy measures support a partially mutual genetic
background (Barrantes-Vidal et al., 2015).
Among themost prominent susceptibility genes for schizophrenia is
ZNF804A, involved in neurodevelopmental processes (Lencz et al.,
2010) and coding for the zinc-finger binding protein 804A (Voineskos
et al., 2011). The major A allele of the single-nucleotide polymorphism
(SNP) rs1344706 was initially reported to be associated with schizo-
phrenia in a GWAS by O'Donovan et al., with an even stronger associa-
tion to a broader psychosis phenotype that includes bipolar disorder
(O'Donovan et al., 2008). This association has since been replicated
and shown to be one of the strongest susceptibility variants for schizo-
phrenia (Pardiñas et al., 2018; Riley et al., 2010; Williams et al., 2011).
Rs1344706-A has been associated with decreased expression of
ZNF804A in fetal brain tissue (Hill and Bray, 2012) and with
neurocognitive and brain structural variations in schizophrenia patients
and in healthy controls (Chang et al., 2017; Donohoe et al., 2011;
Nenadic et al., 2015). Two recent studies linked ZNF804A rs1344706
with schizotypy (Stefanis et al., 2013; Yasuda et al., 2011), but with het-
erogeneous dimensional associations: While Yasuda and colleagues
found carriers of the rs1344706 major A-allele to have higher
disorganised schizotypal levels, Stefanis et al. reported the opposite ef-
fect, i.e., a positive association of the minor C-allele with positive
schizotypy, calling for further research.
A second gene strongly associated with the psychosis spectrum is
CACNA1C, encoding a subunit of the calcium channel Cav1.2, which is in-
volved in the modulation of gene transcription, synaptic plasticity and
cell survival in the brain (Bhat et al., 2012). CACNA1C's intronic SNP
rs1006737with risk allele A has been established as a susceptibility var-
iant for schizophrenia (Jiang et al., 2015; Ripke et al., 2013; Ruderfer
et al., 2014) and bipolar disorder (Ferreira et al., 2008; Moon et al.,
2018; Ruderfer et al., 2014). It has been associated with cognitive varia-
tion like decreased attentional performance and reduced corresponding
neural activity in risk-allele carriers (Thimm et al., 2011), impaired
working memory (Zhang et al., 2012), but also impaired facial emotion
recognition (Soeiro-de-Souza et al., 2012) and increased interpersonal
distress (Erk et al., 2010). In two previous studies, rs1006737-A has
also been linked to elevated positive schizotypy and schizotypal person-
ality disorder (Roussos et al., 2013, 2011). While the influence of
CACNA1C variants on cognition and its neural correlates has been
shown repeatedly (Dietsche et al., 2014; Krug et al., 2014), it is unclear
whether the gene is also linked to variation in cognitive function in
schizotypy.
Taken together, current research suggests an association of psycho-
sis risk genes ZNF804A and CACNA1C with impaired cognition and
schizotypy in the general population, and an association of both schizo-
phrenia and schizotypy with cognitive deficits. It is, however, lacking
models integrating those univariate associations into a joint framework.
As there are sex differences in schizophrenia prevalence and symptom
profiles (Abel et al., 2010) as well as schizotypy (Kremen et al., 1998;
Raine, 1992), and sex-specific effects have recently been reported for
both genes (de Castro-Catala et al., 2017; Strohmaier et al., 2013), a dif-
ferential impact for males and females should be considered.
Therefore, thefirst aimof thepresent studywas to analyse thediffer-
ential effects of ZNF804A rs1344706 and CACNA1C rs1006737 on dimen-
sional schizotypy as a phenotypic psychosis proneness marker,
considering sex-dependent modulations. Secondly, we tested the op-
posing models of (a) the relatively stable personality trait schizotypy
mediating genetic influence on attention, expecting the Cognitive-Per-
ceptual dimension to particularly affect cognition as recently suggested
(Stotesbury et al., 2018) and (b) attentional variationmediating genetic
influence on schizotypal traits, as derived from recent studies of cogni-
tion in schizophrenia (Toulopoulou et al., 2018, 2015).
2. Material and methods
2.1. Sample
We analysed data of 615 healthy Central European subjects (age
18–65 years, mean = 32.77, standard deviation (SD) = 12.50) drawn
from the FOR2107 cohort, a multi-centre study, recruiting through
newspaper advertisements and mailing lists from the areas of Marburg
andMuenster in Germany (Kircher et al., 2018). Ethics approvalwas ob-
tained from the ethics committees of theMedical Schools of the Univer-
sities of Marburg and Muenster, respectively, in accordance with the
Declaration of Helsinki. All subjects volunteered to participate in the
study and provided written informed consent. Subjects of non-
European origin were excluded from the analyses because of known
population differences in the studied genetic polymorphisms. Exclusion
criteria were current or former psychiatric disorders (assessed with
SCID-I interviews (Wittchen et al., 1997) by trained raters), history of
neurological or other severe medical disorders, verbal IQ b80 (Multiple
ChoiceWord Test-B (Lehrl, 1995)), or current psychotropic medication.
The resulting sample comprised 232 (37.7%) male and 383 (62.3%) fe-
male participants.
2.2. Assessment of psychometric schizotypy
Self-reported schizotypy was assessed with the German version
(Klein et al., 1997) of the Schizotypal Personality Questionnaire-Brief
(SPQ-B (Raine and Benishay, 1995)). Based on Raine's original SPQ
(Raine, 1991), it has recently been validated acrossmulti-national stud-
ies, including the German version (Fonseca-Pedrero et al., 2018). Beside
a total schizotypy score, the SPQ-B provides measures on the Cognitive-
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Perceptual, Interpersonal, and Disorganised dimensions delineated by
previous factor analyses (Axelrod et al., 2001; Compton et al., 2009).
For the questionnaire as a whole and its subscores, adequate internal
consistency and criterion validity have been demonstrated (Fonseca-
Pedrero et al., 2018; Klein et al., 2001). In our sample, the SPQ-B showed
acceptable reliability (Cronbach's α = 0.737, for subscore values see
supplementary table S5).
2.3. Neurocognitive testing
Participants underwent standardised neurocognitive testing for
sustained and selective attention with the d2 test of attention
(Brickenkamp, 2002). It is a cancellation test assessing the continuous
ability to focus on task-relevant characteristics while ignoring similar
characters, requiring constant visual perceptual speed and accuracy. De-
spite its simple structure and implementation, the d2 test has been
shown to be a reliable and valid measure of attention capacity, both in
healthy subjects and in schizophrenia patients (Brickenkamp, 2002;
Lee et al., 2017). The concentration performance parameter (the error-
adjusted number of hits) was used in this analysis as it is resistant to de-
ception attempts and has shown high reliability in the reference sample
(Brickenkamp, 2002) and a randomly drawn subset of our own sample
(n = 100, Cronbach's alpha α = 0.981).
2.4. Genotyping and quality control
Genomic DNAwas extracted from blood samples acquired onsite.
Genotyping and further preparation of genomic data was performed
blinded to phenotype data at the Institute of Human Genetics of the
University Hospital Bonn, Germany and at the Max Planck Institute
of Psychiatry, Munich, Germany. Genotyping was conducted using
the Infinium PsychArray BeadChip (Illumina, San Diego, CA, USA),
according to standard protocols. Clustering and initial QC was con-
ducted in GenomeStudio v.2011.1 (Illumina, San Diego, USA) with
the Genotyping Module v.1.9.4. Full QC was performed in PLINK
v1.90b5 (x) and R v3.3.3, based on a larger dataset of which the pres-
ent subjects constituted a subset. Individuals were removed if they
met any of the following criteria: genotyping call rate b98%, gender
mismatches or other X-chromosome-related issues, genetic dupli-
cates, cryptic relatives with pi-hat ≥12.5%, genetic outlier with a dis-
tance from the mean of N4 SD in the first eight ancestry components,
or a deviation of the autosomal or X-chromosomal heterozygosity
from the mean N 4 SD.
2.5. Statistical analyses
Sex differences in schizotypy, age, and neurocognitive performance
were analysed using Student's t-tests for independent samples or
Mann-Whitney U tests where the assumption of normal distribution
was violated. Distributions of allelic frequencies between sexes were
compared with chi-squared (χ2) tests. Associations of genotypes and
schizotypy were analysed via linear regression models, using the IBM
Statistical Package for Social Sciences (SPSS, version 22, IBM, Armonk,
NY) and the PROCESS macro v3.1 for SPSS (Hayes, 2013). Multidimen-
sional scaling (MDS) analyses to estimate population stratification in
the sample were conducted in PLINK (Purcell & Chang; Chang et al.,
2015), the first three MDS components were included as covariates in
SNP association analyses. Leave-one-out cross-validation was used to
calculate the rootmean PRESS (predicted residual error sum of squares)
as a model fit parameter in stepwise regressions (√mPRESS). As SPQ-B
scales are correlated, p-values were adjusted (padj) to correct for multi-
ple comparison according to Bonferroni-Holm (Holm, 1979), using R (R
Core Team, 2018).
3. Results
3.1. Distribution of schizotypy, attention, and allele frequencies
Descriptive statistics for SPQ-B subscores as well as genotype fre-
quencies for ZNF804A rs1344706 and CACNA1C rs1006737 are shown
in Table 1. Neither rs1344706 (χ2(degrees of freedom (df) = 2) =
0.79, p=0.675) nor rs1006737 (χ2(2) = 3.80, p=0.150) showed sig-
nificant differences inminor allele counts between sexes.We also found
no significant sex differences for age (t(613) = −0.379, p = 0.704;
male mean = 32.52, SD = 11.49, female mean = 32.92, SD = 13.09)
or d2 performance (t(613) = −1.45, p = 0.148). Mean d2 scores for
the whole sample (mean = 191.40, SD = 42.25), as well as for males
(mean = 188.24, SD = 41.75) and females (mean = 193.32, SD =
42.49), were within the average range for healthy subjects, according
to standard tables (Brickenkamp, 2002). As observed in previous studies
(Kremen et al., 1998; Raine, 1992), we found significant sex differences
for the SPQ-B Sum score (U= -2.45, p=0.014, padj = 0.028), the Inter-
personal (U = -2.43, p = 0.015, padj = 0.028) and Disorganised (U = -
3.84, p = 1.3 × 10−4, padj = 3.9 × 10−4) subscores, with higher scores
in males than in females; but not for the Cognitive-Perceptual (U =
−0.96, p = 0.336) subscore.
3.2. Associations of ZNF804A, CACNA1C and schizotypy dimensions
To explore the prediction of the three schizotypy dimensions, we
performed separate stepwise multiple regression analyses, entering
the two SNPs, SNP × sex interaction terms, sex, age, and MDS compo-
nents as possible regressors (Table 2, Suppl. Table S1a-1c).
For the Cognitive-Perceptual dimension (model 1a, √mPRESS = 1.12,
Fig. 1), we found a significant effect of age (β=0.018, p=5.05 × 10−7,
padj = 2.53 × 10−6) and rs1344706 × sex (β=0.089, p=0.015, padj =
0.033), with a higher number of C alleles associated with higher Cogni-
tive-Perceptual schizotypy in females (β=0.212, p=0.007), but not in
males (β = −0.071, p = 0.458).
For the Interpersonal dimension (model 1b, √mPRESS = 1.71, Fig. 1),
we also found a significant effect of age (β = 0.011, p = 0.044, padj =
0.044) and rs1006737 × sex (β = −0.150, p = 0.011, padj = 0.033),
with a higher number of A alleles associated with lower Interpersonal
schizotypy in males (β = −0.399, p = 0.035), but not in females (β
= −0.162, p = 0.209).
For theDisorganised dimension (model 1c), only sexwas identified as
a significant regressor (β = −0.390, p = 2.16 × 10−4, padj = 8.64
× 10−4).
Table 1








Sum 3.42 (2.99) 3.78 (3.07) 3.20 (2.93)
Cognitive perceptual 0.90 (1.15) 0.81 (1.03) 0.95 (1.21)
Interpersonal 1.72 (1.72) 1.92 (1.76) 1.60 (1.68)








AA 217 (35.3) 85 (36.6) 132 (34.5)
AC 295 (48.9) 106 (45.7) 189 (49.3)
CC 103 (16.7) 41 (17.7) 62 (16.2)
CACNA1C rs1006737
GG 292 (47.5) 118 (50.9) 174 (45.4)
AG 267 (43.4) 99 (42.7) 168 (43.9)
AA 56 (9.1) 15 (6.5) 41 (10.7)
a SD = standard deviation.
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Total schizotypywas neither associatedwith ZNF804A rs1344706 (β
= −0.317, p = 0.591) nor CACNA1C rs1006737 (β = −0.227, p =
0.120).
3.3. Associations of ZNF804A, CACNA1C, schizotypy dimensions and
attention
To explore significant predictors of d2 performance, we calculated a
separate stepwise multiple regression model 2 with the two SNPs, SNP
× sex interaction terms, sex, age, the three schizotypy subscores, and
MDS components as possible regressors (√mPRESS = 37.99, Table 2,
Suppl. Table S2). Here, age (β = −1.342, p = 7.82 × 10−25, padj =
3.14 × 10−24), Cognitive-Perceptual schizotypy (β = −4.509, p =
0.001, padj = 0.003), ZNF804A rs1344706 (β = −15.551, p = 0.003,
padj = 0.006) and rs1344706 × sex (β = 6.553, p = 0.026, padj =
0.026), with a higher number of rs1344706-C associated with lower
d2 performance in males (β = −8.145, p = 0.017) but not in females
(β = −3.041, p = 0.292), were detected as significant regressors.
3.4. Mediation models of ZNF804A, schizotypy and attention
To analyse the proposed mediating relationship of schizotypy and
attention, we hypothesised two models, derived from the associations
detected in the regression models 1a-c and 2. Model 3a (Fig. 2, Suppl.
Table S3) proposes Cognitive-Perceptual schizotypy as a risk factor for
impaired cognition, thus mediating the effect of rs1344706 on d2 per-
formance (F(3,611) = 48.78, p b 1 × 10−100, R2 = 0.197). We found a
significant direct effect of the dosage of ZNF804A rs1344706-C (c′ =
−5.038, t(611) = −2.31, p = 0.021, padj = 0.032) as well as a
significant indirect effect of the SNP via Cognitive-Perceptual schizotypy
(β = −4.210, t(611) = −2.94, p = 0.003, padj = 0.013) on d2 perfor-
mance. However, the latter was again moderated by sex: Only for fe-
males (β = −0.890) but not for males (β = 0.300), a bootstrap-based
Table 2
Summary of model specifications for models 1a, 1b and 2. Full documentation in suppl.
Tables S1–S2.
model 1a (F(2,614) = 16.00, p = 1.7 × 10−7, R2 = 0.050)
prediction ofCognitive-Perceptual schizotypy √mPRESSb = 1.12
coefficient (sea) t p padj
age 0.018 (0.004) 4.34 5.05 × 10−7 2.53 × 10−6
rs1344706 × sex 0.283 (0.124) 2.28 0.015 0.033
rs1344706 (sex = m) −0.073 (0.094) −0.74 0.458
rs1344706 (sex = f) 0.212 (0.079) 2.79 0.007
model 1b (F(2,614) = 16.58, p = 0.003, R2 = 0.015)
prediction of Interpersonal schizotypy √mPRESSb = 1.71
coefficient (sea) t p padj
age 0.011 (0.006) 2.02 0.044 0.044
rs1006737 × sex 0.283 (0.124) −2.57 0.011 0.033
rs1006737 (sex = m) −0.399 (0.188) −2.13 0.035
rs1006737 (sex = f) −0.162 (0.129) −1.26 0.209
model 2 (F(4,610) = 38.89, p = 5.13 × 10−29, R2 = 0.203)













rs1344706 × sex 6.553 (2.944) 2.23 0.026 0.026
rs1344706 (sex = m) −8.145
(3.399)
−2.40 0.017








In bold Bonferroni-Holm-adjusted p-values after correction.
a SE = standard error.
b √mPRESS = root mean predicted residual sum of squares.
Fig. 1. Sex-moderated models 1a and 1b of the effect of ZNF804A rs1344706-C and
CACNA1C rs1006737-A on differential schizotypy dimensions. b1-3 indicate
unstandardised regression coefficients for each path; statistically significant paths are
shown in bold.
Fig. 2. Sex-moderated mediation model 3a of the effect of ZNF804A rs1344706-C on d2
performance, mediated by Cognitive-Perceptual schizotypy. Conceptual (A) and statistical
(B) diagram. a1−d2 indicate unstandardised regression coefficients for each path;
statistically significant paths are shown in bold.
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confidence interval calculated using 10,000 bootstrap samples was con-
sistently below zero, confirming a conditional indirect effect.
We additionally considered the opposingmodel, assuming cognition
at an intermediate position between genes and phenotype. We tested
this assumption in our data, with d2 performance mediating the sex-
moderated effect of rs1344706-C on Cognitive-Perceptual schizotypy.
This model 3b (Fig. 3, suppl. Table S3), although significant, explained
a smaller proportion of the variance (F(5,609) = 6.90, p = 2.4 × 10−6,
R2 = 0.071) than model 3a. Post hoc t-tests comparing absolute z-
transformed bootstrapped coefficient estimates from models 3a and 3b
revealed a stronger effect of rs1344706 on Cognitive-Perceptual
schizotypy than on d2 performance (mean absolute difference (mad,
3a) = 0.130, SD = 0.117; mad(3b) = 0.134, SD = 0.117) in both
models (t(9999) = −111.49, p b 1 × 10−100; t(9999) = −114.47, p
b 1 × 10−100, respectively).
There was no indication of a mediating effect of Interpersonal
schizotypy on the association of CACNA1C rs1006737-A on attention
or vice versa (suppl. Table S4a-b).
4. Discussion
This is the first large-scale study addressing the interplay between
candidate susceptibility genes for psychotic disorders with different di-
mensions of schizotypy and neurocognitive performance as a putative
endophenotype for psychosis in healthy subjects. Our analysis provides
first support for a multivariate model of the interaction of genotype,
phenotype, and cognition, linking schizotypy in the general population
to a dimensional schizophrenia model. This includes two major find-
ings: We observe, for the first time, a sex-moderated association of
ZNF804A rs1344706 with the SPQ-B Cognitive-Perceptual dimension
and of CACNA1C rs1006737 with the SPQ-B Interpersonal dimension.
We suggest a moderated mediation model showing that in women,
the effect of rs1344706 on attention is mediated by Cognitive-Perceptual
schizotypy. Our results have implications for the role of ZNF804A
rs1344706 and CACNA1c rs1006737 in schizotypy and cognitive func-
tion, and suggest a sex-modulated interaction between them.
Concurrent with previous findings (Stefanis et al., 2013; Yasuda
et al., 2011), we further confirmed ZNF804A rs1344706 as susceptibility
SNP for schizotypy.While this association has previously been reported,
we provide a more detailed link to particular schizotypy dimensions,
modulated by sex. Initially, Yasuda et al., reported a positive relationship
between ZNF804A rs1344706-A and Disorganised schizotypal traits in
healthy subjects (Yasuda et al., 2011). Concurrent with our own find-
ings, however, Stefanis et al. reported an inverse relationship, with a
higher number of rs1344706-A associated with decreased schizotypy.
This effect was found for a primarily “positive” schizotypy
endophenotype, including referential ideas and perceptual aberrations
(Stefanis et al., 2013), in line with our results linking rs1344706 to the
Cognitive-Perceptual dimension. Differences to Yasuda's findings might
be attributed to divergent study populations and genetic backgrounds
(Japanese vs. Central-European) and different A allele frequencies in
those populations (38% and 61%, respectively (Clarke and Cardon,
2010; Yasuda et al., 2011)).
We now extend the simple model of a direct dependence of
schizotypal features on rs1344706 allelic load by introducing sex as
moderator. While previous studies on rs1344706 were either confined
to all male samples (Stefanis et al., 2013) or did not test for such an in-
teraction (Yasuda et al., 2011), a similar finding for another schizophre-
nia susceptibility SNP of ZNF804A (rs7597593, in medium linkage
disequilibrium with rs1344706; r2 = 0.395 calculated with LDlink for
the CEU population (Machiela and Chanock, 2015)) has recently been
reported, as only female C allele carriers showed elevated schizotypy
levels compared to A-homozygotes (de Castro-Catala et al., 2017).
Sex-dependent effects of rs7597593 are also evident in clinical mea-
sures and post-mortem brain mRNA expression levels in schizophrenia
(Zhang et al., 2011). Thus, our findings can be explained with clinical
and molecular mechanisms causing sex × SNP interactions for
ZNF804A in the development of schizotypal traits.
In addition, we confirmed recent findings relating ZNF804A
rs1344706 to neurocognitive function in general, and attention in par-
ticular (Chang et al., 2017). In healthy participants, the A allele and A/
A genotypewas associatedwith deficits in the executive control dimen-
sion of attention (Balog et al., 2011). Proposing a neural correlate of
functional alterations, rs1344706-A homozygotes showed reduced
thickness within the anterior cingulate cortex (Voineskos et al., 2011)
and changes in functional coupling of the dorsolateral prefrontal cortex
with the hippocampus (Esslinger et al., 2009; Paulus et al., 2013). Inter-
estingly, in patients with schizophrenia, A allele load has been associ-
ated with fewer cognitive deficits (Van Den Bossche et al., 2012;
Walters et al., 2010) and decreased cortical alteration (Schultz et al.,
2014). It has been suggested that ZNF804A rs1344706may enhance sus-
ceptibility to a certain schizophrenia subtypewith less cognitive impair-
ment (Walters et al., 2010), but also that the effects of rs1344706might
differ between healthy participants and patients (Hargreaves et al.,
2012).
While Stefanis et al. linked ZNF804A SNPs to schizotypy, they did not
detect an effect of rs1344706 on neurocognition (Stefanis et al., 2013).
Differences in test batteries aside, the discrepancy between their find-
ings and our ownmay be caused bymarked differences in sample char-
acteristics. Their sample comprised of young male army recruits while
ours combined female and male participants within a wide range of
age. Given the well-known age effects on neurocognitive measures
(Lufi et al., 2015), a very selective sample with reduced variance
might thus underestimate correlation or regression measures.
Despite evidence linking ZNF804A rs1344706 to illness susceptibility
and psychosis proneness, neurocognitive functions, and variations in
brain structure and function, its exact biological pathway is still unclear.
ZNF804A is expressed widely in the human brain (Sun et al., 2015), es-
pecially within the dorsolateral prefrontal cortex and the hippocampus
(Hill and Bray, 2012). Rs1344706 is non-coding but thought to have ef-
fects on ZNF804A expression (Hill and Bray, 2011), particularly during
early prenatal brain development (Hill and Bray, 2012). ZNF804A has
Fig. 3. Sex-moderated mediation model 3b of the effect of ZNF804A rs1344706-C on
Cognitive-Perceptual schizotypy, mediated by d2 performance. Conceptual (A) and
statistical (B) diagram. a1−d2 indicate unstandardised regression coefficients for each
path; statistically significant paths are shown in bold.
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also been associated with regulation of dopamine receptors (Girgenti
et al., 2012), and alterations of dopamine concentration, and expression
of dopaminergic genes have been linked to psychosis etiology (Howes
and Kapur, 2009) and schizotypy (Grant et al., 2014; Mohr and
Ettinger, 2014). In addition, sex-specific effects of genes involved in do-
pamine transmission have been discussed in schizophrenia, with
oestrogens and androgens differentially modifying the development of
schizophrenia symptoms through dopaminergic pathways (Godar and
Bortolato, 2014). Similar mechanismsmight influence the development
of subclinical symptoms in schizotypy and thus explain sex-dependent
effects of ZNF804A on schizotypal traits.
Taken together, compelling evidence suggests that effects of
ZNF804A rs1344706 polymorphisms have a relevant impact long before
potential illness manifestation. Affected brain areas and neurocognitive
functions have shown to be relevant for schizophrenia as well as
schizotypy. Using genetic modelling in twin samples, Toulopoulou
et al. showed that a substantial part of the phenotypic overlap between
schizophrenia and cognition is explained by shared genetic variability
(Toulopoulou et al., 2007). The authors concluded that the next step
would be to identify specific genes that influence schizophrenia to-
gether with cognitive quantities. Our results support ZNF804A
rs1344706 as such a genetic variant relevant for schizotypy, an interme-
diate schizophrenia phenotype. As has been reported recently
(Stotesbury et al., 2018), we particularly regard the Cognitive-Perceptual
dimension as a risk factor for attentional difficulties.
However, Toulopoulou et al. subsequently argued that schizophre-
nia liability is partially expressed through cognitive deficits
(Toulopoulou et al., 2015) and that cognitive functions lie upstream of
schizophrenia (Toulopoulou et al., 2018). Relevant loci should then
have a bigger effect on cognitive function than on schizophrenia
(Toulopoulou et al., 2015). Our results, however, fail to confirm this pre-
diction for the schizotypy phenotype. In both models tested, ZNF804A
rs1344706 showed a larger effect on schizotypy than on cognitive func-
tion. While aware that this cannot definitively be resolved in our cross-
sectional study, we believe that our results should inspire further dis-
section of the proposed models. Considerably, Toulopoulou's model is
based on net genetic influences rather than single risk variants. It also
relies on patient data and thus on the schizophrenia phenotype rather
than schizotypy (Hargreaves et al., 2012) and ZNF804A expression
seems to differ between schizophrenia patients and healthy controls
(Guella and Vawter, 2014). The underlying mechanisms of schizophre-
nia and schizotypy are overlapping, but most likely not identical. Be-
sides a balanced proportion of male and female participants, the
application of multiple measures of both schizotypy and cognitive per-
formance should be considered to overcome limitations of our own
study.
We further showed a sex-modulated association of the psychosis
susceptibility variant rs1006737 in CACNA1C with the Interpersonal
schizotypy dimension. While sex-dependent effects of rs1006737 or
its proxy rs10774035 have been reported for schizophrenia-spectrum
disorders (Heilbronner et al., 2015) and emotional lability and resilience
(Strohmaier et al., 2013), this is, to our knowledge, the first study de-
tecting a sex-dependent effect of rs1006737 on schizotypy. In contrast
to previous studies (Roussos et al., 2013, 2011), associating
rs1006737-Awith higher Paranoid Ideation, we find an inverse relation-
ship, i.e. with lower Interpersonal schizotypy scores in men only. Beside
the possibility of chance findings, this might be due to differences in
sample characteristics, as both studies by Roussos et al. analysed
young male army recruits, while our sample comprised males and fe-
males of a wide age range. Other discrepancies include the schizotypy
measures and possible population differences (Greek vs. Central
European) across studies (Clarke and Cardon, 2010).
As CACNA1C is suggested to be a susceptibility gene for a more gen-
eral risk for mental illness (Cross-Disorder Group of the Psychiatric Ge-
nomics Consortium, 2013), divergent effects in different studies might
represent a less specific impact of the SNP. This would implicate the
need for more studies with diverse samples. However, CACNA1C
rs1006737 has repeatedly been associated with socially relevant tasks
like emotion recognition and processing (Nieratschker et al., 2015;
Soeiro-de-Souza et al., 2012; Tesli et al., 2013), as well as alterations in
social interaction in animal models (Dedic et al., 2018; Moon et al.,
2018). Thus, variations in rs1006737 seem to affect social functioning
on a behavioural level, as well as brain structural and functional corre-
lates. It might be concluded that rs1006737 primarily affects the Inter-
personal and, as such, social dimension of schizotypy.
The results from our study provide evidence for the involvement of
schizophrenia genetic susceptibility variants in psychometric
schizotypy, a risk phenotype for psychosis. Our findings further provide
an account of how those risk variants might modulate different dimen-
sions of individual schizotypal traits even in healthy subjects, affecting
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Abstract
Background. Schizotypy, a putative schizophrenia endophenotype, has been associated with
brain-structural variations partly overlapping with those in psychotic disorders. Variations in
precuneus structure have been repeatedly reported, whereas the involvement of fronto-striatal
networks – as in schizophrenia – is less clear. While shared genetic architecture is thought to
increase vulnerability to environmental insults, beneficial factors like general intelligence
might buffer their effect.
Methods. To further investigate the role of fronto-striatal networks in schizotypy, we exam-
ined the relationship of voxel- and surface-based brain morphometry and a measure of
schizotypal traits (Schizotypal Personality Questionnaire, with subscores Cognitive-
Perceptual, Interpersonal, Disorganised) in 115 healthy participants [54 female, mean age
(S.D.) = 27.57(8.02)]. We tested intelligence (MWT-B) as a potential moderator.
Results. We found a positive association of SPQ Cognitive-Perceptual with putamen volume
(p = 0.040, FWE peak level-corrected), moderated by intelligence: with increasing IQ, the
correlation of SPQ Cognitive-Perceptual and striatal volume decreased (p = 0.022).
SPQ Disorganised was positively correlated with precentral volume (p = 0.013, FWE peak
level-corrected). In an exploratory analysis (p < 0.001, uncorrected), SPQ total score was
positively associated with gyrification in the precuneus and postcentral gyrus, and SPQ
Disorganised was negatively associated with gyrification in the inferior frontal gyrus.
Conclusions. Our findings support the role of fronto-striatal networks for schizotypal features
in healthy individuals, and suggest that these are influenced by buffering factors like intelli-
gence. We conclude that protective factors, like general cognitive capacity, might attenuate
the psychosis risk associated with schizotypy. These results endorse the idea of a continuous
nature of schizotypy, mirroring similar findings in schizophrenia.
Introduction
Current dimensional models of psychopathology (e.g. Kotov et al., 2017) suggest that phenom-
ena associated with clinical syndromes and disorders are continuous in nature and extend also
into the realm of health as dimensions of personality. This suggestion, however, is not new
(e.g. Eysenck, 1952), and regarding psychotic disorders, relevant traits are most commonly
subsumed under the (wide) rubric of schizotypy or psychosis-proneness (Rado, 1953;
Meehl, 1962; Claridge, 1997; Grant et al., 2018). Evidence of associations between variations
in different brain circuits shared between clinical entities like schizophrenia (Bakhshi and
Chance, 2015) and states of ultra-high risk as well as schizotypal traits in healthy individuals
(Ettinger et al., 2015; Nenadic et al., 2015a) support this notion.
Like all traits, schizotypy is seen as a relatively stable personality framework that, like
schizophrenia, consists of three major sub-facets, namely positive, negative and disorganised
facets (Vollema and van den Bosch, 1995; Oezgen and Grant, 2018). The positive facet resem-
bles positive symptoms of psychosis (e.g. as magical ideation and unusual experiences), is
linked to psychotic-like experiences (PLEs) (Kline et al., 2012) and has been suggested as
an endophenotype of psychosis-in-schizophrenia (Howes and Kapur, 2009; Barrantes-Vidal
et al., 2015; Grant, 2015).
Negative and disorganised schizotypy, however, have been suggested as more related to
schizophrenia-liability than mere proneness to psychotic and PLEs, as these facets – unlike posi-
tive schizotypy (Tarbox and Pogue-Geile, 2011; Tarbox et al., 2012) – are also elevated in patients
with psychotic disorders and their healthy relatives (Brosey and Woodward, 2015). Schizotypy,
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albeit sharing variance with schizophrenia-liability, is a relatively
stable trait (Venables and Raine, 2015; Janssens et al., 2016), with
low conversion rates into the clinical domain (Kwapil et al.,
2013). This is, however, expected (Meehl, 1990; Grant et al.,
2018) and, thus, does not disqualify schizotypy as an important
construct for understanding schizophrenia-spectrum pathology
(Debbané and Mohr, 2015; Kwapil and Barrantes-Vidal, 2015).
Additionally, familial association studies underline the necessity
of distinguishing between positive and negative/disorganised facets
of schizotypy (Tarbox and Pogue-Geile, 2011; Tarbox et al., 2012).
This is in line with findings by Schultze-Lutter and co-workers,
showing that conversion form clinical high risk (CHR) to frank
psychosis is best predicted by negative/disorganised schizotypy
(Flückiger et al., 2016, 2019).
Nonetheless, psychometrically-assessed estimates of schizo-
typy (like schizotypal traits, measured through scales based on
DSM-criteria for Schizotypal Personality Disorder) have, repeat-
edly, been associated with variations in brain structures also
implicated in schizophrenia. One finding replicated in several
studies is that of structural and functional variation within the
precuneus: Evidence for an association of schizotypy and schizo-
typal traits with increased grey matter volume (GMV) in the pre-
cuneus has been reported in several structural imaging studies
(Modinos et al., 2010, 2018; Nenadic et al., 2015b), although
not in all (Ettinger et al., 2012; Kühn et al., 2012). Furthermore,
PLEs have been shown to be associated with increased precuneus
activation (van Lutterveld et al., 2014).
Additionally, there is growing evidence for fronto-striatal cir-
cuits to be involved in the generation of PLEs. Recent studies
have suggested positive schizotypal traits to be associated with var-
iations in frontal volume, but the direction is unclear, with
increases (Kühn et al., 2012; Nenadic et al., 2015b; Modinos
et al., 2018) as well as decreases (Ettinger et al., 2012; DeRosse
et al., 2015) being reported. As most studies have focused on varia-
tions in volumetric parameters, apart from one study finding
increased right prefrontal lobe gyrification in participants scoring
above v. below a clinical cut-off (Stanfield et al., 2008), there is
no study using a dimensional approach to schizotypy and folding
analysis. Those, however, are of particular interest as cortical fold-
ing, happening early during brain development (Chi et al., 1977),
might indicate disruption in neurodevelopmental processes
(Nenadic et al., 2014), and has also been reported to be altered in
psychosis and high risk (Spalthoff et al., 2018; Zuliani et al., 2018).
Striatal regions have also been reported to correlate with the
level of subclinical psychotic-like traits or symptoms: Psychotic
experiences in healthy subjects are associated with smaller puta-
men volumes (Mittal et al., 2013), and psychoticism has been
shown to be correlated with greater activation in putamen and
pallidum (Ettinger et al., 2013), while positive schizotypy has
been linked to reduced BOLD signal during antisaccades
(Aichert et al., 2012). Interpersonal schizotypal traits have been
associated with decreased task-related activation in the striatum
and amygdala (Yan et al., 2016).
In addition, highlighting the role of the fronto-striatal net-
work, positive and negative schizotypy have recently been asso-
ciated with variations in cortico-striatal resting state functional
connectivity (Rössler et al., 2018; Wang et al., 2018; Waltmann
et al., 2019). SPQ Disorganised has, furthermore, been associated
with a higher availability of striatal dopamine (Chen et al., 2012).
Together, these findings – to some extent – mirror those in
psychotic disorder. Specifically, schizophrenia patients, and (to
a lesser degree) their unaffected siblings, show increased volume
of striatal regions putamen and pallidum (Mamah et al., 2008;
Okada et al., 2016; van Erp et al., 2016) and greater putamen
volume variability compared to healthy controls (Brugger and
Howes, 2017). Pallidum volume has been positively associated
with symptom severity in schizophrenia patients (Spinks et al.,
2005) and there is evidence for altered extra-striatal functional
connectivity in schizophrenia patients during a psychotic episode
(Peters et al., 2017).
It has been suggested that these overlaps in phenotype and
concurring neuroanatomy might be, at least partially, explained
by overlapping genetic architecture (Walter et al., 2016). The cur-
rent literature, however, also implies that genetic risk is not lin-
early represented through overall schizotypal traits, as studies
show only marginal associations with polygenic risk scores in
healthy individuals, and an influence of environmental factors
like stress contexts (Hatzimanolis et al., 2018).
Those findings fit well into a model by Siever and Davis, pro-
posing that common genetic variants increase schizophrenia risk
through elevated vulnerability for environmental insults, leading
to brain structural changes within temporal or striatal regions
(Siever and Davis, 2004). In contrast to schizophrenia patients,
however, in schizotypal individuals, independent genetic variants
and/or beneficial environmental contexts, leading to preserved or
increased frontal volume or cognitive protectors like general intel-
ligence, buffer the effect of susceptibility variants and thus lead to
a subclinical level of PLEs (Siever and Davis, 2004). The issue of a
moderating effect of intelligence has also been suggested by Brod
(1997) – regarding highly creative individuals – and substantiated
by findings that intelligence moderates the tendency of highly
positive schizotypal individuals to see meaning in random noise
(Grant et al., 2014a).
Indeed, dysfunctions in prefrontal networks are often reported
in psychotic disorders (Dandash et al., 2017). Dysregulation of the
striatum, a centre for the integration of high-level cognitive,
motor and limbic processes (Simpson et al., 2010), seems to be
contributing to the manifestation of psychotic symptoms in
schizophrenia (Howes and Kapur, 2009) and possibly also (posi-
tive) schizotypy (Ettinger et al., 2013; Mohr and Ettinger, 2014).
To further examine the relationship of morphometric varia-
tions in fronto-striatal networks with dimensional schizotypal
traits, we analysed voxel- and surface-based brain structural para-
meters in association with psychometrically-assessed schizotypy
in healthy individuals. We hypothesised associations of frontal
and striatal volume variations with both positive and negative
schizotypal traits. Based on a fronto-thalamo-striatal model of
the psychosis continuum, brain structural effects in both medial
and lateral prefrontal cortex are observed in both positive and
negative dimensions of schizophrenia, and in the thalamus for
the negative dimension (Koutsouleris et al., 2008; Nenadic
et al., 2010, 2015c). Assuming the possibility of general cognitive
capacity buffering psychosis risk (Brod, 1997; Siever and Davis,
2004), we also tested for a moderating effect of intelligence on
the relationship of brain morphometry and schizotypal traits.
This is, to our knowledge, the first study investigating intelligence




We analysed data of N = 115 healthy participants [54 female, aged
18–50 years, mean age = 27.57 years (S.D. = 8.02)], recruited
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through advertisements in and around Munich, Germany. All
experimental procedures were approved by the research ethics
committee of the Faculty of Medicine at the University of
Munich, in accordance with the current division of the
Declaration of Helsinki. Participants were included after thorough
clinical screening and only if they did not meet any of the exclu-
sion criteria: any DSM-IV Axis I disorders, first-grade relatives
with psychotic disorders, former or current neurological disor-
ders, current physical conditions, current medication except for
contraceptives, uncorrected visual impairments. Further inclusion
criteria were age between 18 and 55 and German as a first lan-
guage. All subjects volunteered to take part in the study, gave writ-
ten informed consent and received a financial compensation for
their participation.
Psychometric assessment of schizotypal traits and IQ
All participants completed theGerman version (Klein et al., 1997) of
the Schizotypal PersonalityQuestionnaire (SPQ,Raine, 1991), asses-
sing schizotypal traits on the three dimensions Cognitive-Perceptual
(measuring positive schizotypy), Disorganised (related to eccentri-
city and – somewhat – disorganised schizotypy) and Interpersonal
(tapping into negative schizotypy) as delineated by previous factor
analyses (Axelrod et al., 2001; Compton et al., 2009). For the ques-
tionnaire as awhole and its subscores, adequate internal consistency
and criterion validity have been demonstrated (Klein et al., 2001;
Fonseca-Pedrero et al., 2018). In our sample, the SPQ subscales
showed acceptable to good reliability (Cronbach’s α for the total
score α = 0.882, for the subscales Disorganised α = 0.832, Negative
α = 0.848, Positive α = 0.757).
For an estimation of intelligence, we applied the Multiple
Choice Word Test-B (MWT-B, Lehrl, 1995). The MWT-B con-
sists of 37 items in ascending difficulty, each requiring identifica-
tion of one truly existing word opposed to three distractors. It has
been shown to be an economic, easy to administer and robust esti-
mate of global crystallised intelligence, highly correlated with both
verbal and general intelligence measured with extensive tests like
the HAWIE, the German version of the Wechsler Adult
Intelligence Scale (Satzger et al., 2002). In our sample, the
MWT-B showed an internal consistency of Cronbach’s α = 0.664.
Image acquisition and preprocessing
We acquired high-resolution, T1-weighted structural images on a
3T MAGNETOM Verio scanner (Siemens, Erlangen, Germany)
using a 12-channel head matrix Rx-coil. We used a three-
dimensional MPRAGE sequence with a repetition time of TR =
2400 ms, echo time TE = 3.06 ms, flip angle = 9 degrees with 160
slices, slice thickness = 1.0 mm, voxel size = 1.0 × 1.0 × 1.0 mm,
field of view FOV = 256 mm.
Images were preprocessed with the CAT12 toolbox
(Computation Anatomy Toolbox for SPM, v12.3, build r1318,
http://www.neuro.uni-jena.de/cat), based on SPM12 v7219
(Statistical Parametric Mapping, version 12) running under
MATLAB R2017a (The MathWorks, Natick, MA, USA). Images
were spatially registered using tissue probability maps implemented
in SPM12, segmented and spatially normalised using the optimised
shooting algorithm (Ashburner and Friston, 2011), with an inhomo-
geneity correction of 0.5. All images passed visual quality inspection
formovement artefacts and imagequality, aswell as the qualityassur-
ance protocols implemented in CAT12 (grade B or higher). During
preprocessing, total intracranial volume (TIV) was calculated.
Additionally, we extracted gyrification parameters to analyse
surfaced-based morphometry with the CAT12 toolbox, using a
recently developed algorithm to calculate cortical surface para-
meters (Dahnke et al., 2013), based on absolute mean curvature
(Luders et al., 2006). Gyrification images were smoothed with a
Gaussian kernel of 20 mm (FWHM).
Statistical analyses
Statistical analyses were conducted using general linear regression
models (GLM) in SPM and CAT12. Given the discussed specifi-
city of the different schizotypy dimensions (Tarbox and
Pogue-Geile, 2011; Grant, 2015), we conducted separate GLMs
for each of the subscores. We further tested a GLM using SPQ
total score as a regressor. In a supplementary analysis, we entered
all three subscores into the GLM (and set + 1/−1 in the contrast)
to assess the overall effect of schizotypal traits (see online
Supplementary SF1).
For both VBM and gyrification analyses, we used age and sex
as covariates (setting them to zero to remove related variance),
and for VBM we additionally defined TIV as a covariate to
remove global brain size differences. For all analyses, we consid-
ered significance at p < 0.05 FWE peak level-corrected threshold.
For gyrification analyses, that did not survive FWE peak level cor-
rection, we conducted additional exploratory analyses at p < 0.001
uncorrected.
To test for a modulating effect of IQ on the association of
SPQ-levels and structural variation, we set up a moderation
model using the PROCESS macro v3.3 (Hayes, 2013) running
on IBM Statistical Package for Social Sciences (SPSS, version 24,
IBM, Armonk, NY, USA). It is unclear, whether particular aspects
of intelligence or cognitive functions might serve as better factors
or predictors in such models. Given the limited availability of cog-
nitive data from this data set, we therefore focused on IQ to be
included as a moderator in the model. For schizotypal traits,
the respective dimension scores were entered, while for structural
data we considered a wider cluster comprising peak and sur-
rounding voxels at an uncorrected p < 0.001 threshold, taking
into consideration voxels might not reach corrected significance
in direct association statistics (due to the assumed moderation
effects), but might add to moderation. Here, we used extracted
eigenvariate values as an approximation of mean volume inside
the clusters, a weighted mean more robust to heterogeneous
voxel values. Correcting for the two models tested, significance
was assumed at p < 0.025.
Results
Descriptive statistics and intercorrelations
Demographic details and descriptive statistics for SPQ sum
score and subscores are shown in Table 1. IQ was significantly
negatively correlated with SPQ Cognitive-Perceptual (r = −0.196,
p = 0.036), indicating that higher IQ is associated with lower
schizotypy scores. There were no significant correlations of
IQ with the Disorganised (r = −0.030, p = 0.746) or Interpersonal
(r =−0.104, p = 0.268) dimensions.
Voxel-based morphometry
Regression analyses showed significant correlations of the positive
and disorganised dimensions of the SPQ with GMV (Fig. 1a, b).
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Cognitive-Perceptual was positively correlated with GMV in a
cluster containing the right pallidum and putamen (k = 6 voxels,
x/y/z = 22/−12/−2, T = 4.75, p = 0.040 FWE peak level-corrected).
Disorganised was positively correlated with GMV in a cluster
including the left precentral gyrus (k = 67 voxels, x/y/z =−40/
−12/42, T = 4.90, p = 0.013 FWE peak level-corrected). There
were no significant negative correlations of the two subscales
with GMV and not any significant associations of GMV and
the SPQ total score, the Interpersonal SPQ dimension, or
the GLM including all three subscores after FWE-peak-level-
correction (see online Supplementary Fig. SF1).
Surface-based analysis of gyrification
We did not find any significant associations at p < 0.05 FWE peak
level-correction for gyrification with either total SPQ score or
subscores. In a subsequent, exploratory analysis (p < 0.001,
uncorrected, see online Supplementary Fig. SF2), however, we
found a positive correlation of the SPQ total score with gyrifica-
tion in the left precuneus (k = 10 voxels, x/y/z =−19/−65/25,
T = 3.31, p < 0.001 uncorrected), as well as a negative correlation
with the gyrification in the right postcentral gyrus (k = 57 voxels,
x/y/z = 28/−34/69, T = 3.70, p < 0.001 uncorrected). Additionally,
we found a negative association of the Disorganised score
with gyrification in the right inferior frontal gyrus (k = 22 voxels,
x/y/z =−43/29/−1, T = 3.47, p < 0.001 uncorrected).
Moderation analysis
We tested whether intelligence, as a measure for general cognitive
capacity, has a moderating effect on the association of striatal
structure and schizotypy. Based on the results of the voxel-
based-morphometry analyses, we tested this assumption for the
association of the cluster around the detected peak voxel in a clus-
ter containing the putamen and pallidum and Cognitive-
Perceptual, with age, sex and TIV as covariates (model 1). This
Table 1. Demographic characteristics of the sample
Mean (S.D.) Range Kurtosis Skewness
Sex 54 female/61 male − − −
Age 27.57 (8.02) 18–50 0.34 1.17
IQ 112.54 (12.26) 88–143 −0.47 0.57
SPQ total score 8.14 (7.11) 0–35 2.03 1.37
SPQ Cognitive-Perceptual 3.15 (3.08) 0–15 1.36 2.1
SPQ Disorganised 2.28 (2.99) 0–14 3.81 1.92
SPQ Interpersonal 3.67 (3.82) 0–18 2.59 1.61
Fig. 1. Clusters of positive correlation between grey matter volume and the SPQ Cognitive-Perceptual dimension in the striatum (a, upper panel) and the
Disorganised dimension in the pre- and postcentral gyri (b, lower panel); for illustration purposes and highlighting the putamen/pallidum cluster selected for mod-
eration analysis, these images are thresholded at p < 0.001 (uncorrected). Note that parts of both clusters also survive p < 0.05 FWE peak level-correction (illustra-
tion prepared with MRIcroGL; www.nitrc.org/projects/mricrogl and depicted in radiological orientation).
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model was significant overall [F(6,108) = 6.93, p < 0.001, R
2 = 0.28]
and furthermore revealed a significant moderation effect of
MWT-B IQ estimation on the association of striatal volume and
Cognitive-Perceptual [regression coefficient b =−5.41, F(1,108) =
5.38, p = 0.022]: With increasing MWT-B values, the association
between striatal structure and schizotypy decreased (Fig. 2). In a
separate model, we tested the equivalent assumption of the associ-
ation of the Disorganised dimension and the significant paracentral
cluster being moderated by IQ. This model, however, was not sig-
nificant [F(6,108) = 1.13, p = 0.350, R
2 = 0.06].
Discussion
We found an association of the positive dimension of the SPQ
with greater right striatal volume in healthy controls, which was
moderated by IQ as a measure of general cognitive capacity.
Additionally, we found an association of the Disorganised factor
with increased volume of the left precentral gyrus.
In several previous studies, primarily variations in precuneus
structure and function have, repeatedly, been associated with
schizotypal traits and subclinical PLEs (Modinos et al., 2010,
2018; van Lutterveld et al., 2014; Falkenberg et al., 2015;
Nenadic et al., 2015b). It is, therefore, unexpected that we did
not find any association with any of the SPQ dimensions in
this region in our data.
We did, however, find further evidence of fronto-striatal cir-
cuits to be involved in the aetiology of PLEs in healthy indivi-
duals. Our finding echoes previous studies suggesting that
variations in striatal structure and function are associated with
psychotic experiences in healthy subjects (Chen et al., 2012;
Ettinger et al., 2013; Mittal et al., 2013), partially paralleling find-
ings in frank psychosis: In a mega-analysis by the ENIGMA
schizophrenia consortium, patients with schizophrenia showed
greater pallidum volumes than healthy controls, and putamen
and pallidum volumes were correlated with illness duration
(van Erp et al., 2016). Further support comes from several studies
showing that similar to schizophrenia patients, their healthy rela-
tives also show increased GMV within the putamen (Knöchel
et al., 2016). In healthy controls, the genetic risk for schizophrenia
and bipolar disorder has been associated with volumetric abnor-
malities within those regions (Caseras et al., 2015). It has, thus,
been suggested that striatal size might be an important endophe-
notype for psychosis (Chemerinski et al., 2013). Putamen size and
function might even play a role in risk stratification, predicting
clinical course: Subjects at CHR for psychosis showed increased
striatal cerebral blood flow (Hubl et al., 2018) and in CHR sub-
jects, smaller putamen volume was associated with the reduction
of positive symptoms over a course of six months (Hong et al.,
2015).
Dopaminergic neurotransmission is central to striatal func-
tioning, and findings from several (although not all; Ettinger
et al., 2012) experimental and pharmacological studies implicate
an association of altered dopamine neurotransmission with
schizotypy and psychosis-proneness (Ettinger et al., 2013, 2014;
Mohr and Ettinger, 2014). Schizotypy has, additionally, been
associated with expression levels of dopaminergic genes (Grant
et al., 2014b) and dopamine receptor gene polymorphisms
(Ettinger et al., 2006; Grant et al., 2013; Gurvich et al., 2016),
including additive effects thereof (Grant et al., 2015). Taken
together, those findings suggest that the dopamine hypothesis
of schizophrenia (Howes et al., 2017) also extends into the healthy
domain (Grant et al., 2015).
Additionally, we detected an association of greater GMV with
higher levels of disorganised schizotypy in the left precentral
gyrus. Previous findings linking this region to schizotypy are lim-
ited. There is some evidence for reduced paracentral volume in
individuals with schizotypal personality disorder (Koo et al.,
2006). Another study in subjects with high risk for psychosis
and first episode patients also found reduced precentral volume
compared to healthy controls (Chang et al., 2016).
Those regions have primarily been associated with motor
functions, and while there is clear evidence for motor
Fig. 2. Scatterplot, depicting the association of extracted
grey matter values within the significant striatal cluster
and the level on the SPQ Cognitive-Perceptual dimen-
sion, dependent on IQ. The colour of the dots represents
IQ value. To illustrate the moderating effect of IQ, regres-
sion lines have been fitted for IQ values of 85, 100, 115
and 130, represented by the colour of the lines in accord-
ance with the figure legend. Illustration prepared with
the ggplot2 package (Wickham, 2016) in RStudio
v1.1.456 (RStudio Team, 2016).
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dysfunctions in schizophrenia and other psychotic disorders
(Peralta and Cuesta, 2001; Cuesta et al., 2018; Hirjak et al.,
2018), there is limited evidence in schizotypy (Roché et al.,
2015). As motor functions were not assessed in this study, we
can neither assume nor exclude such an association in our data.
It should be noted, however, that the reported cluster lies within
the lateral frontal eye field and that schizotypy has repeatedly been
associated with impairments in oculomotor function (Aichert
et al., 2012; Meyhöfer et al., 2015).
An additional perspective comes from functional imaging
studies, suggesting connections of striatal regions with areas in
the pre- and postcentral gyri. Several functional connectivity stud-
ies – in healthy subjects as well as schizophrenia patients – have
indeed shown important projections from striatal regions to
motor areas in the pre- and postcentral cortex, and caudate and
putamen seeds were reported to predict resting state activity in
pre- and postcentral regions (Postuma and Dagher, 2006; Di
Martino et al., 2008; White et al., 2016). Given the focus of
grey matter structure in our study, however, we can only speculate
on similar associations in our sample.
Further evidence for the notion that brain networks, rather than
single structures are involved in the generation of psychotic experi-
ences comes from recent studies analysing resting state connectivity
in schizotypy. Several studies report reduced functional connectivity
of striatal and cortical regions in associationwith (primarily positive)
schizotypy, indicating an association of this dimension with striatal
hypoconnectivity or cortico-striatal decoupling (Wang et al., 2018;
Waltmann et al., 2019). Such dysconnectivity might be facilitated
by altered striatal dopamine levels, as has been suggested based on
results in animal studies (Grace et al., 2007; Waltmann et al.,
2019). There is, in fact, evidence for striato-cortical decoupling asso-
ciated with positive schizotypy being induced by altered dopamin-
ergic neurotransmission (Rössler et al., 2018).
Our results also indicate, however, that protective factors may
act as a buffer to decrease the risk for psychotic experiences
induced by striatal alterations, in line with arguments by Brod
(1997) or Siever and Davis (2004). The model assumes that gen-
etic risk variants render the vulnerability for the impact of envir-
onmental factors, but can be attenuated by other genetic variants
leading to preserved frontal volume or capacity, possibly
expressed in an elevated cognitive capacity like general intelli-
gence (Siever and Davis, 2004). Indeed, even though we did not
find any association of schizotypy dimensions with GMV in
frontal regions, our moderation model showed that IQ (as a meas-
ure for cognitive capacity known to be associated with frontal lobe
structure, Colom et al., 2013) influences the association of pallidal
volume and positive schizotypy: With higher IQ, that association
decreased to the point of non-significance. This fits well in line
with evidence of cognitive performance or IQ having substantial
predictive value for the outcome of individuals at risk for psych-
osis and with schizophrenia (Leeson et al., 2009; Woodberry et al.,
2010; Ziermans et al., 2014; Metzler et al., 2016). However, we
would like to stress that, both in our results and in previous
work; it might be that general intelligence rather acts as a proxy
for other, possibly psycho-social, resilience factors.
We did not find an association of SPQ scores with gyrification
patterns at corrected threshold levels, but the exploratory, uncor-
rected analysis revealed associations in regions thought to be rele-
vant for psychosis as well as schizotypy (Honea et al., 2005;
Ettinger et al., 2015; Nenadic et al., 2015a). It might be speculated
that while those effects indeed are of interest, our analysis did not
provide the necessary power for them to reach statistical
significance. This should spark further studies in larger samples.
So far, our findings do not provide robust evidence for gyrifica-
tion to show a dimensional relationship with schizotypy.
Limitations to the generalisation of our findings arise from the
relatively restricted sample size and the fact that our participants
showed rather low to moderate SPQ levels, compared to a recent
validation sample (Barron et al., 2018). This, however, only leads
to a reduction in statistical power, but does not invalidate our
findings (Eysenck, 1952).
Additionally, since the SPQ is derived from clinical criteria of
schizotypal personality disorder (Raine, 1991), it differs in both
conceptualisation and phenotypal characterisation from other
self-rating measures, which needs to be taken into account (for
further details, see Gross et al., 2014; Grant et al., 2018). While
the Cognitive-Perceptual dimension of the SPQ seems to map
well on positive schizotypy, the Interpersonal factor taps into
negative schizotypy less specifically and includes aspects of
Neuroticism, which could account for the lack of associations
with this dimension in our analysis in contrast to previous work.
Furthermore, we have to consider that the MWT-B is only an
approximating measure of particularly crystallised intelligence,
necessitating further studies to replicate the moderation model
with the use of an extensive intelligence battery. As due to the
study design, several risk factors for psychotic diseases, but also
for schizotypy were excluded to rule out confounding influences,
our results might only represent part of the subclinical spectrum.
Taken together, our findings suggest that the involvement of
fronto-striatal circuits in psychosis aetiology extends into the
healthy domain of schizotypy and PLEs, thus, supporting a con-
tinuous model of the psychosis spectrum.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291719002459
Financial support. This work was partially supported through a FlexiFunds
grant (I.N. and P.G., FCMH grant number 2017_2_1_5); and the German
Research Foundation (DFG) (I.N., grant number FOR2107 NE 2254/1-2)
(U.E. grant number ET 31/2-1).
Conflict of interest. None.
Ethical standards. The authors assert that all procedures contributing to
this work comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008.
References
Aichert DS, Williams SCR, Möller H-J, Kumari V and Ettinger U (2012)
Functional neural correlates of psychometric schizotypy: an fMRI study
of antisaccades. Psychophysiology 49, 345–356.
Ashburner J and Friston KJ (2011) Diffeomorphic registration using geodesic
shooting and Gauss-Newton optimisation. NeuroImage 55, 954–967.
Axelrod SR, Grilo CM, Sanislow C and McGlashan TH (2001) Schizotypal
personality questionnaire-brief: factor structure and convergent validity in
inpatient adolescents. Journal of Personality Disorders 15, 168–179.
Bakhshi K and Chance SA (2015) The neuropathology of schizophrenia: a
selective review of past studies and emerging themes in brain structure
and cytoarchitecture. Neuroscience 303, 82–102.
Barrantes-Vidal N, Grant P and Kwapil TR (2015) The role of schizotypy in
the study of the etiology of schizophrenia spectrum disorders. Schizophrenia
Bulletin 41(suppl 2), Oxford: Oxford University Press, S408–S416.
BarronD, VoracekM, TranUS, OngHS,MorganKD, Towell T and SwamiV
(2018) A reassessment of the higher-order factor structure of the German
6 Tina Meller et al.
available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002459
Downloaded from https://www.cambridge.org/core. Forschungsinstitut fuer deutsche Sprache "Deutscher Sprachatlas", on 18 Sep 2019 at 10:30:55, subject to the Cambridge Core terms of use,
52
schizotypal personality questionnaire (SPQ-G) in German-speaking adults.
Psychiatry Research 269, 328–336.
Brod JH (1997) Creativity and schizotypy. In Claridge G (ed), Schizotypy –
Implications for Illness and Health. Oxford: Oxford University Press, pp.
274–298.
Brosey E and Woodward ND (2015) Schizotypy and clinical symptoms, cog-
nitive function, and quality of life in individuals with a psychotic disorder.
Schizophrenia Research 166, 92–97.
Brugger SP and Howes OD (2017) Heterogeneity and homogeneity of
regional brain structure in schizophrenia: a meta-analysis. JAMA
Psychiatry 74, 1104–1111.
Caseras X, Tansey KE, Foley S and Linden D (2015) Association between
genetic risk scoring for schizophrenia and bipolar disorder with regional
subcortical volumes. Translational Psychiatry 5, e692–e692.
Chang M, Womer FY, Bai C, Zhou Q, Wei S, Jiang X, Geng H, Zhou Y,
Tang Y and Wang F (2016) Voxel-based morphometry in individuals at
genetic high risk for schizophrenia and patients with schizophrenia during
their first episode of psychosis. PLoS ONE 11, e0163749.
Chemerinski E, Byne W, Kolaitis JC, Glanton CF, Canfield EL,
Newmark RE, Haznedar MM, Novakovic V, Chu K-W, Siever LJ and
Hazlett EA (2013) Larger putamen size in antipsychotic-naïve individuals
with schizotypal personality disorder. Schizophrenia Research 143, 158–164.
Chen KC, Lee IH, Yeh TL, Chiu NT, Chen PS, Yang YK, Lu R-B and
Chen CC (2012) Schizotypy trait and striatal dopamine receptors in healthy
volunteers. Psychiatry Research: Neuroimaging 201, 218–221.
Chi JG, Dooling EC and Gilles FH (1977) Gyral development of the human
brain. Annals of Neurology 1, 86–93.
Claridge G (1997) Theoretical background and issues. In G Claridge (ed),
Schizotypy – Implications for Illness and Health. Oxford, NY: Oxford
University Press, pp. 3–18.
Colom R, Burgaleta M, Román FJ, Karama S, Álvarez-Linera J, Abad FJ,
Martínez K, Quiroga MÁ and Haier RJ (2013) Neuroanatomic overlap
between intelligence and cognitive factors: morphometry methods provide
support for the key role of the frontal lobes. NeuroImage 72, 143–152.
Compton MT, Goulding SM, Bakeman R and McClure-Tone EB (2009) An
examination of the factorial structure of the Schizotypal Personality
Questionnaire-Brief (SPQ-B) among undergraduate students. Schizophrenia
Research 115, 286–289.
Cuesta MJ, García de Jalón E, Campos MS, Moreno-Izco L,
Lorente-Omeñaca R, Sánchez-Torres AM and Peralta V (2018) Motor
abnormalities in first-episode psychosis patients and long-term psycho-
social functioning. Schizophrenia Research 200, 97–103.
Dahnke R, Yotter RA and Gaser C (2013) Cortical thickness and central sur-
face estimation. NeuroImage 65, 336–348.
DandashO, Pantelis C and FornitoA (2017)Dopamine, fronto-striato-thalamic
circuits and risk for psychosis. Schizophrenia Research 180, 48–57.
Debbané M and Mohr C (2015) Integration and development in schizotypy
research: an introduction to the special supplement. Schizophrenia
Bulletin 41(suppl. 2), S363–S365.
DeRosse P, Nitzburg GC, Ikuta T, Peters BD, Malhotra AK and Szeszko PR
(2015) Evidence from structural and diffusion tensor imaging for fronto-
temporal deficits in psychometric schizotypy. Schizophrenia Bulletin 41,
104–114.
Di Martino A, Scheres A, Margulies DS, Kelly AMC, Uddin LQ, Shehzad Z,
Biswal B, Walters JR, Castellanos FX and Milham MP (2008) Functional
connectivity of human Striatum: a resting state fMRI study. Cerebral Cortex
18, 2735–2747.
Ettinger U, Joober R, DE Guzman R and O’Driscoll GA (2006) Schizotypy,
attention deficit hyperactivity disorder, and dopamine genes. Psychiatry and
Clinical Neurosciences 60, 764–767.
Ettinger U, Williams SCR, Meisenzahl EM, Möller H-J, Kumari V and
Koutsouleris N (2012) Association between brain structure and psycho-
metric schizotypy in healthy individuals. The World Journal of Biological
Psychiatry 13, 544–549.
Ettinger U, Corr PJ, Mofidi A, Williams SCR and Kumari V (2013)
Dopaminergic basis of the psychosis-prone personality investigated with
functional magnetic resonance imaging of procedural learning. Frontiers
in Human Neuroscience 7, 130.
Ettinger U, Meyhöfer I, Steffens M, Wagner M and Koutsouleris N (2014)
Genetics, cognition, and neurobiology of schizotypal personality: a review of
the overlap with schizophrenia. Frontiers in Psychiatry 5, 18.
Ettinger U, Mohr C, Gooding DC, Cohen AS, Rapp A, Haenschel C and
Park S (2015) Cognition and brain function in schizotypy: a selective
review. Schizophrenia Bulletin 41, S417–S426.
Eysenck HJ (1952) The Scientific Study of Personality. Routledge & Kegan Paul
Ltd.: London.
Falkenberg I, Chaddock C, Murray RM, McDonald C, Modinos G,
Bramon E, Walshe M, Broome M, McGuire P and Allen P (2015)
Failure to deactivate medial prefrontal cortex in people at high risk for
psychosis. European Psychiatry 30, 633–640.
Flückiger R, Ruhrmann S, Debbané M, Michel C, Hubl D,
Schimmelmann BG, Klosterkötter J and Schultze-Lutter F (2016)
Psychosis-predictive value of self-reported schizotypy in a clinical high-risk
sample. Journal of Abnormal Psychology 125, 923–932.
Flückiger R, Michel C, Grant P, Ruhrmann S, Vogeley K, Hubl D,
Schimmelmann BG, Klosterkötter J, Schmidt SJ and Schultze-Lutter F
(2019)The interrelationshipbetween schizotypy, clinical high risk forpsychosis
and related symptoms: cognitive disturbances matter. Schizophrenia Research
210, 188–196
Fonseca-Pedrero E, Ortuño-Sierra J, Lucas-Molina B, Debbané M,
Chan RCK, Cicero DC, Zhang LC, Brenner C, Barkus E, Linscott RJ,
Kwapil T, Barrantes-Vidal N, Cohen A, Raine A, Compton MT,
Tone EB, Suhr J, Bobes J, Fumero A, Giakoumaki S, Tsaousis I,
Preti A, Chmielewski M, Laloyaux J, Mechri A, Lahmar MA,
Wuthrich V, Larøi F, Badcock JC, Jablensky A, Barron D, Swami V,
Tran US and Voracek M (2018) Brief assessment of schizotypal traits: a
multinational study. Schizophrenia Research 197, 182–191.
Grace AA, Floresco SB, Goto Y and Lodge DJ (2007) Regulation of firing of
dopaminergic neurons and control of goal-directed behaviors. Trends in
Neurosciences 30, 220–227.
Grant P (2015) Is schizotypy per se a suitable endophenotype of schizophre-
nia? – Do not forget to distinguish positive from negative facets. Frontiers in
Psychiatry 6, 143.
Grant P, Balser M, Munk AJL, Linder J and Hennig J (2014a) A false-
positive detection bias as a function of state and trait schizotypy in inter-
action with intelligence. Frontiers in Psychiatry 5, 135.
Grant P, Kuepper Y, Mueller EA, Wielpuetz C, Mason O and Hennig J (2013)
Dopaminergic foundations of schizotypy as measured by the German version
of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) – a
suitable endophenotype of schizophrenia. Frontiers in Human Neuroscience
7, 1.
Grant P, Gabriel F, Kuepper Y, Wielpuetz C and Hennig J (2014b)
Psychosis-proneness correlates with expression levels of dopaminergic
genes. European Psychiatry 29, 304–306.
Grant P, Judith Leila Munk A, Kuepper Y, Wielpuetz C and Hennig J
(2015) Additive genetic effects for schizotypy support a fully-dimensional
model of psychosis-proneness. Journal of Individual Differences 36,
87–92.
Grant P, Green MJ and Mason OJ (2018) Models of schizotypy: the import-
ance of conceptual clarity. Schizophrenia Bulletin 44(suppl_2), S556–S563.
Gross GM, Mellin J, Silvia PJ, Barrantes-Vidal N and Kwapil TR (2014)
Comparing the factor structure of the Wisconsin schizotypy scales and
the schizotypal personality questionnaire. Personality Disorders: Theory,
Research, and Treatment 5, 397–405.
Gurvich C, Bozaoglu K, Neill E, Van Rheenen TE, Tan EJ, Louise S and
Rossell SL (2016) The dopamine D1 receptor gene is associated with
negative schizotypy in a non-clinical sample. Psychiatry Research 235,
213–214.
Hatzimanolis A, Avramopoulos D, Arking DE, Moes A, Bhatnagar P,
Lencz T, Malhotra AK, Giakoumaki SG, Roussos P, Smyrnis N,
Bitsios P and Stefanis NC (2018) Stress-dependent association between
polygenic risk for schizophrenia and schizotypal traits in young army
recruits. Schizophrenia Bulletin 44, 338–347.
Hayes A (2013) Introduction to Mediation, Moderation, and Conditional
Process Analysis: A Regression-Based Approach, 2nd edn. New York, US:
The Guilford Press.
Psychological Medicine 7
available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002459
Downloaded from https://www.cambridge.org/core. Forschungsinstitut fuer deutsche Sprache "Deutscher Sprachatlas", on 18 Sep 2019 at 10:30:55, subject to the Cambridge Core terms of use,
53
Hirjak D, Kubera KM, Thomann PA and Wolf RC (2018) Motor dysfunc-
tion as an intermediate phenotype across schizophrenia and other psychotic
disorders: progress and perspectives. Schizophrenia Research 200, 26–34.
Honea R, Crow TJ, Passingham D and Mackay CE (2005) Regional deficits
in brain volume in schizophrenia: a meta-analysis of voxel-based morph-
ometry studies. American Journal of Psychiatry 162, 2233–2245.
Hong SB, Lee TY, Kwak YB, Kim SN and Kwon JS (2015) Baseline putamen
volume as a predictor of positive symptom reduction in patients at clinical
high risk for psychosis: a preliminary study. Schizophrenia Research 169,
178–185.
Howes OD and Kapur S (2009) The dopamine hypothesis of schizophrenia:
version III – the final common pathway. Schizophrenia Bulletin 35, 549–
562.
Howes OD, McCutcheon R, Owen MJ and Murray RM (2017) The role of
genes, stress, and dopamine in the development of schizophrenia.
Biological Psychiatry 81, 9–20.
Hubl D, Schultze-Lutter F, Hauf M, Dierks T, Federspiel A, Kaess M,
Michel C, Schimmelmann BG and Kindler J (2018) Striatal cerebral
blood flow, executive functioning, and fronto-striatal functional connectiv-
ity in clinical high risk for psychosis. Schizophrenia Research 201, 231–236.
Janssens M, Boyette L-L, Heering HD, Bartels-Velthuis AA, Lataster T,
Kahn RS, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W,
Meijer C and Myin-Germeys I (2016) Developmental course of subclinical
positive and negative psychotic symptoms and their associations with gen-
etic risk status and impairment. Schizophrenia Research 174, 177–182.
Klein C, Andresen B and Jahn T (1997) Erfassung der schizotypen
persönlichkeit nach DSM-II-R: psychometrische eigenschaften einer autori-
sierten deutschsprachigen Übersetzung des ‘Schizotypal Personality
Questionnaire’ (SPQ) von Raine. Diagnostica 43, 347–369.
Klein C, Andresen B and Jahn T (2001) Konstruktvalidierung der deutsch-
sprachigen adaptation des Schizotypal Personality Questionnaires (SPQ)
von Raine (1991). In B Andresen and R Maß (eds), Schizotypie.
Psychometrische Entwicklungen und Biopsychologische Forschungsansätze.
Göttingen: Hogrefe, pp. 349–378.
Kline E, Wilson C, Ereshefsky S, Nugent KL, Pitts S, Reeves G and
Schiffman J (2012) Schizotypy, psychotic-like experiences and distress: an
interaction model. Psychiatry Research 200, 647–651.
Knöchel C, Stäblein M, Prvulovic D, Ghinea D, Wenzler S, Pantel J,
Alves G, Linden DEJ, Harrison O, Carvalho A, Reif A and
Oertel-Knöchel V (2016) Shared and distinct gray matter abnormalities
in schizophrenia, schizophrenia relatives and bipolar disorder in association
with cognitive impairment. Schizophrenia Research 171, 140–148.
Koo M-S, Dickey CC, Park H-J, Kubicki M, Ji NY, Bouix S, Pohl KM,
Levitt JJ, Nakamura M, Shenton ME and McCarley RW (2006) Smaller
neocortical gray matter and larger sulcal cerebrospinal fluid volumes in
neuroleptic-naive women With schizotypal personality disorder. Archives
of General Psychiatry 63, 1090.
Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM,
Brown TA, Carpenter WT, Caspi A, Clark LA, Eaton NR, Forbes MK,
Forbush KT, Goldberg D, Hasin D, Hyman SE, Ivanova MY,
Lynam DR, Markon K, Miller JD, Moffitt TE, Morey LC,
Mullins-Sweatt SN, Ormel J, Patrick CJ, Regier DA, Rescorla L,
Ruggero CJ, Samuel DB, Sellbom M, Simms LJ, Skodol AE, Slade T,
South SC, Tackett JL, Waldman ID, Waszczuk MA, Widiger TA,
Wright AGC and Zimmerman M (2017) The Hierarchical Taxonomy of
Psychopathology (HiTOP): a dimensional alternative to traditional nosolo-
gies. Journal of Abnormal Psychology 126, 454–477.
Koutsouleris N, Gaser C, Jäger M, Bottlender R, Frodl T, Holzinger S,
Schmitt GJE, Zetzsche T, Burgermeister B, Scheuerecker J, Born C,
Reiser M, Möller H-J and Meisenzahl EM (2008) Structural correlates of
psychopathological symptom dimensions in schizophrenia: a voxel-based
morphometric study. NeuroImage 39, 1600–1612.
Kühn S, Schubert F and Gallinat J (2012) Higher prefrontal cortical thickness in
high schizotypal personality trait. Journal of Psychiatric Research 46, 960–965.
Kwapil TR and Barrantes-Vidal N (2015) Schizotypy: looking back and mov-
ing forward. Schizophrenia Bulletin 41, S366–S373.
Kwapil TR, Gross GM, Silvia PJ and Barrantes-Vidal N (2013) Prediction of
psychopathology and functional impairment by positive and negative
schizotypy in the Chapmans’ ten-year longitudinal study. Journal of
Abnormal Psychology 122, 807–815.
Leeson VC, Barnes TRE, Hutton SB, Ron MA and Joyce EM (2009) IQ as a
predictor of functional outcome in schizophrenia: a longitudinal, four-year
study of first-episode psychosis. Schizophrenia Research 107, 55–60.
Lehrl S (1995) Mehrfachwahl-Wortschatz-Intelligenztest MWT-B. Hogrefe:
Göttingen.
Luders E, Thompson PM, Narr KL, Toga AW, Jancke L and Gaser C (2006)
A curvature-based approach to estimate local gyrification on the cortical
surface. NeuroImage 29, 1224–1230.
MamahD, HarmsMP,Wang L, Barch D, Thompson P, Kim J, Miller MI and
Csernansky JG (2008) Basal ganglia shape abnormalities in the unaffected
siblings of schizophrenia patients. Biological Psychiatry 64, 111–120.
Meehl PE (1962) Schizotaxia, schizotypy, schizophrenia. American
Psychologist 17, 827–838.
Meehl PE (1990) Toward an integrated theory of schizotaxia, schizotypy, and
schizophrenia. Journal of Personality Disorders 4, 1–99.
Metzler S, Dvorsky D, Wyss C, Nordt C, Walitza S, Heekeren K, Rössler W
and Theodoridou A (2016) Neurocognition in help-seeking individuals at
risk for psychosis: prediction of outcome after 24 months. Psychiatry
Research 246, 188–194.
Meyhöfer I, Steffens M, Kasparbauer A, Grant P, Weber B and Ettinger U
(2015) Neural mechanisms of smooth pursuit eye movements in schizotypy.
Human Brain Mapping 36, 340–353.
Mittal VA, Orr JM, Turner JA, Pelletier AL, Dean DJ, Lunsford-Avery J and
Gupta T (2013) Striatal abnormalities and spontaneous dyskinesias in non-
clinical psychosis. Schizophrenia Research 151, 141–147.
Modinos G, Mechelli A, Ormel J, Groenewold NA, Aleman A and
McGuire PK (2010) Schizotypy and brain structure: a voxel-based morph-
ometry study. Psychological Medicine 40, 1423–1431.
Modinos G, Egerton A, McLaughlin A, McMullen K, Kumari V,
Lythgoe DJ, Barker GJ, Aleman A and Williams SCR (2018)
Neuroanatomical changes in people with high schizotypy: relationship to
glutamate levels. Psychological Medicine 48, 1880–1889.
Mohr C and Ettinger U (2014) An overview of the association between
schizotypy and dopamine. Frontiers in Psychiatry 5, 184.
Nenadic I, Sauer H and Gaser C (2010) Distinct pattern of brain structural
deficits in subsyndromes of schizophrenia delineated by psychopathology.
NeuroImage 49, 1153–1160.
Nenadic I, Yotter RA, Sauer H and Gaser C (2014) Cortical surface complex-
ity in frontal and temporal areas varies across subgroups of schizophrenia.
Human Brain Mapping 35, 1691–1699.
Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR,
Sauer H, Gaser C and Smesny S (2015a) Brain structure in people at
ultra-high risk of psychosis, patients with first-episode schizophrenia, and
healthy controls: a VBM study. Schizophrenia Research 161, 169–176.
Nenadic I, Lorenz C, Langbein K, Dietzek M, Smesny S, Schönfeld N,
Fañanás L, Sauer H and Gaser C (2015b) Brain structural correlates of
schizotypy and psychosis proneness in a non-clinical healthy volunteer
sample. Schizophrenia Research 168, 37–43.
Nenadic I, Yotter RA, Sauer H and Gaser C (2015c) Patterns of cortical thin-
ning in different subgroups of schizophrenia. British Journal of Psychiatry
206, 479–483.
Oezgen M and Grant P (2018) Odd and disorganized – comparing the factor
structure of the three major schizotypy inventories. Psychiatry Research 267,
289–295.
Okada N, Fukunaga M, Yamashita F, Koshiyama D, Yamamori H, Ohi K,
Yasuda Y, Fujimoto M, Watanabe Y, Yahata N, Nemoto K, Hibar DP,
van Erp TGM, Fujino H, Isobe M, Isomura S, Natsubori T, Narita H,
Hashimoto N, Miyata J, Koike S, Takahashi T, Yamasue H, Matsuo K,
Onitsuka T, Iidaka T, Kawasaki Y, Yoshimura R, Watanabe Y,
Suzuki M, Turner JA, Takeda M, Thompson PM, Ozaki N, Kasai K
and Hashimoto R (2016) Abnormal asymmetries in subcortical brain vol-
ume in schizophrenia. Molecular Psychiatry 21, 1460–1466.
Peralta V and CuestaMJ (2001)Motor features in psychotic disorders. I. Factor
structure and clinical correlates. Schizophrenia Research 47, 107–116.
Peters H, Riedl V, Manoliu A, Scherr M, Schwerthöffer D, Zimmer C,
Förstl H, Bäuml J, Sorg C and Koch K (2017) Changes in extra-striatal
8 Tina Meller et al.
available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002459
Downloaded from https://www.cambridge.org/core. Forschungsinstitut fuer deutsche Sprache "Deutscher Sprachatlas", on 18 Sep 2019 at 10:30:55, subject to the Cambridge Core terms of use,
54
functional connectivity in patients with schizophrenia in a psychotic
episode. British Journal of Psychiatry 210, 75–82.
Postuma RB and Dagher A (2006) Basal ganglia functional connectivity based
on a meta-analysis of 126 positron emission tomography and functional
magnetic resonance imaging publications. Cerebral Cortex 16, 1508–1521.
Rado S (1953) Dynamics and classification of disordered behavior. The
American Journal of Psychiatry 110, 406–416.
Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality
based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555–564.
Roché MW, Fowler ML and Lenzenweger MF (2015) Deeper into schizotypy
and motor performance: investigating the nature of motor control in a non-
psychiatric sample. Psychiatry Research 228, 20–25.
Rössler J, Unterassner L, Wyss T, Haker H, Brugger P, Rössler W and
Wotruba D (2018) Schizotypal traits are linked to dopamine-induced
striato-cortical decoupling: a randomized double-blind placebo-controlled
study. Schizophrenia Bulletin 45, 680–688.
RStudio: Integrated Development for R. (2016) RStudio, Inc.: Boston, MA
1.1.456.
Satzger W, Fessmann H and Engel RR (2002) Liefern HAWIE-R, WST und
MWT-B Vergleichbare IQ-Werte?. Zeitschrift für Differentielle und
Diagnostische Psychologie 23, 159–170.
Siever LJ and Davis KL (2004) The pathophysiology of schizophrenia disorders:
perspectives from the spectrum. American Journal of Psychiatry 161, 398–413.
Simpson EH, Kellendonk C and Kandel E (2010) A possible role for the
Striatum in the pathogenesis of the cognitive symptoms of schizophrenia.
Neuron 65, 585–596.
Spalthoff R, Gaser C and Nenadić I (2018) Altered gyrification in schizophre-
nia and its relation to other morphometric markers. Schizophrenia Research
202, 195–202.
Spinks R, Nopoulos P, Ward J, Fuller R, Magnotta VA and Andreasen NC
(2005) Globus pallidus volume is related to symptom severity in neuroleptic
naive patients with schizophrenia. Schizophrenia Research 73, 229–233.
Stanfield AC, Moorhead TWJ, Harris JM, Owens DGC, Lawrie SM and
JohnstoneEC (2008) Increased right prefrontal cortical folding in adolescents
at risk of schizophrenia for cognitive reasons. Biological Psychiatry 63, 80–85.
Tarbox SI and Pogue-Geile MF (2011) A multivariate perspective on schizo-
typy and familial association with schizophrenia: a review. Clinical
Psychology Review 31, 1169–1182.
Tarbox SI, Almasy L, Gur RE, Nimgaonkar VL and Pogue-Geile MF (2012)
The nature of schizotypy among multigenerational multiplex schizophrenia
families. Journal of Abnormal Psychology 121, 396–406.
van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD,
Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I,
Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S,
McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MWJ,
Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH,
Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A,
Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ,
Sponheim SR, Shoemaker JM, van Haren NEM, Hulshoff Pol HE,
Pol HEH, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B,
Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC,
McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM and
Turner JA (2016) Subcortical brain volume abnormalities in 2028 indivi-
duals with schizophrenia and 2540 healthy controls via the ENIGMA con-
sortium. Molecular Psychiatry 21, 547–553.
van Lutterveld R, Diederen KMJ, Otte WM and Sommer IE (2014) Network
analysis of auditory hallucinations in nonpsychotic individuals. Human
Brain Mapping 35, 1436–1445.
Venables PH and Raine A (2015) The stability of schizotypy across time and
instruments. Psychiatry Research 228, 585–590.
Vollema MG and van den Bosch RJ (1995) The multidimensionality of
schizotypy. Schizophrenia Bulletin 21, 19–31.
Walter EE, Fernandez F, Snelling M and Barkus E (2016) Genetic consider-
ation of schizotypal traits: a review. Frontiers in Psychology 7, 1769.
Waltmann M, O’Daly O, Egerton A, McMullen K, Kumari V, Barker GJ,
Williams SCR andModinosG (2019)Multi-echo fMRI, resting-state connect-
ivity, and high psychometric schizotypy. NeuroImage: Clinical 21, 101603.
Wang Y, Ettinger U, Meindl T and Chan RCK (2018) Association of schizo-
typy with striatocortical functional connectivity and its asymmetry in
healthy adults. Human Brain Mapping 39, 288–299.
White TP, Wigton R, Joyce DW, Collier T, Fornito A and Shergill SS (2016)
Dysfunctional striatal systems in treatment-resistant schizophrenia.
Neuropsychopharmacology 41, 1274–1285.
Wickham H (2016) ggplot2: Elegant Graphics for Data Analysis. Springer
Verlag: New York.
Woodberry KA, Seidman LJ, Giuliano AJ, Verdi MB, Cook WL and
McFarlane WR (2010) Neuropsychological profiles in individuals at clinical
high risk for psychosis: relationship to psychosis and intelligence.
Schizophrenia Research 123, 188–198.
Yan C, Wang Y, Su L, Xu T, Yin D, Fan M, Deng C, Wang Z, Lui SSY,
Cheung EFC and Chan RCK (2016) Differential mesolimbic and prefrontal
alterations during reward anticipation and consummation in positive and
negative schizotypy. Psychiatry Research: Neuroimaging 254, 127–136.
Ziermans T, de Wit S, Schothorst P, Sprong M, van Engeland H, Kahn R
and Durston S (2014) Neurocognitive and clinical predictors of long-term
outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up.
PLoS ONE 9, e93994.
Zuliani R, Delvecchio G, Bonivento C, Cattarinussi G, Perlini C, Bellani M,
Marinelli V, Rossetti MG, Lasalvia A, McIntosh A, Lawrie SM,
Balestrieri M, Ruggeri M, Brambilla P and PICOS Veneto Group
(2018) Increased gyrification in schizophrenia and non affective first epi-
sode of psychosis. Schizophrenia Research 193, 269–275.
Psychological Medicine 9
available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291719002459
Downloaded from https://www.cambridge.org/core. Forschungsinstitut fuer deutsche Sprache "Deutscher Sprachatlas", on 18 Sep 2019 at 10:30:55, subject to the Cambridge Core terms of use,
55
56 
iii. STUDY III: Manuscript 
 
Brain structural correlates of schizotypal signs and subclinical 
schizophrenia nuclear symptoms in healthy individuals 
Tina Mellera,b, Simon Schmitta,b, Ulrich Ettingerc, Phillip Grantd,e, Frederike 
Steina,b, Katharina Broscha,b, Dominik Grotegerdf, Katharina Dohmf, Susanne 
Meinertf, Katharina Försterf, Tim Hahnf, Andreas Jansena,b,g, Udo Dannlowskif, 
Axel Kruga,b,h, Tilo Kirchera,b,h, Igor Nenadića,b,h 
a Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Rudolf-Bultmann-Str. 8, 
35039 Marburg, Germany 
b Center for Mind, Brain and Behavior (CMBB), Hans-Meerwein-Str. 6, 35032 Marburg, Germany 
c Department of Psychology, University of Bonn, Kaiser-Karl-Ring 9, 53111 Bonn, Germany 
d Psychology School, Fresenius University of Applied Sciences, Marienburgstr. 6, 60528 Frankfurt am 
Main, Germany 
e Faculty of Life Science Engineering, Technische Hochschule Mittelhessen University of Applied 
Sciences, Giessen, Germany 
f Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Albert-
Schweitzer-Campus 1, Building A9, 48149 Münster, Germany 
g Core-Facility BrainImaging, Faculty of Medicine, Rudolf-Bultmann-Str. 8, 35039 Philipps-Universität 
Marburg 
h Marburg University Hospital – UKGM, Rudolf-Bultmann-Str. 8, 35039 Marburg, Germany 
 
 
Key words: SCL-90R; psychotic-like experiences; schizotypy; brain structure; 






Subclinical psychotic-like experiences, resembling key symptoms of psychotic 
disorders, are common throughout the general population and possibly associated with 
psychosis risk. There is evidence that such symptoms are also associated with 
structural brain changes.  
In 672 healthy individuals, we assessed psychotic-like experiences and associated 
distress with the symptom-checklist-90R (SCL-90R) scales “schizotypal signs” (STS) 
and “schizophrenia nuclear symptoms” (SNS) and analysed associations with voxel- 
and surfaced-based brain structural parameters derived from structural MRI at 3T with 
CAT12.  
For SNS, we found a positive correlation with the volume in the left superior parietal 
lobule and the precuneus, and a negative correlation with the volume in the right 
inferior temporal gyrus (p<0.05, FWE cluster level-corr.). For STS, we found a negative 
correlation with the volume of the left and right precentral gyrus (p<0.05, FWE cluster 
level-corr.). Surface-based analyses did not detect any significant clusters with the 
chosen statistical threshold of p<0.05. However, in explorative analyses (p<0.001, 
uncorrected) we found a positive correlation of SNS with gyrification in the left insula 
and rostral middle frontral gyrus and of STS with the left precuneus and insula, as well 
as a negative correlation of STS with gyrification in the left temporal pole. Our results 
show that brain structures in areas implicated in schizophrenia are also related to 
psychotic-like experiences and its associated distress in healthy individuals. This 







Suspiciousness, paranoid thinking, as well as feelings of alienation and isolation are 
key symptoms of psychotic disorders like schizophrenia. However, it is well-established 
that reports of psychotic-like experiences are also frequently found in the general 
population, sparking a continuum model of psychosis-proneness (Claridge, 1997; van 
Os, Hanssen, Bijl, & Ravelli, 2000). In contrast to the schizophrenia prevalence of ~1% 
(Simeone, Ward, Rotella, Collins, & Windisch, 2015), psychotic symptoms (e.g. 
hallucinations) in the absence of the disorder have a lifetime prevalence of ~6-7% in 
the general population (Linscott & van Os, 2013; McGrath et al., 2015), and are 
considered a risk phenotype for psychosis (Kelleher & Cannon, 2011). A considerable 
~34% of healthy individuals between the age of 20 and 41 report at least mild psychotic 
signs (Rössler et al., 2015), in child cohorts even up to >60% (Downs, Cullen, 
Barragan, & Laurens, 2013).  
The subclinical psychosis spectrum comprises different domains: The construct of a 
stable, multidimensional set of schizophrenia-like personality traits is often 
conceptualised as “schizotypy” and seen as continuous phenotypic marker of 
psychosis proneness (Barrantes-Vidal, Grant, & Kwapil, 2015; Martin Debbané & 
Barrantes-Vidal, 2015; Grant, 2015). The expression of psychotic experiences in non-
clinical populations is conceptually closer to (but not necessarily associated with) the 
clinical disorder and is often referred to as “psychotic-like experiences” (PLEs) (van Os, 
Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009). In contrast to the rather 
stable nature of schizotypy, in the majority of individuals, PLEs remit over time and only 
persist in about 20%, while ~7% of affected individuals convert into a psychotic 
disorder (Linscott & van Os, 2013). Lastly, the concept of “clinical” or “ultra-high risk” 
captures risk factors and clinical features relevant for early detection and prevention of 
transition into psychosis (Schultze-Lutter et al., 2015). These concepts have also been 
linked with variations in cognitive functions (Fusar-Poli et al., 2012; Siddi, Petretto, & 
Preti, 2017; Simons, Jacobs, Jolles, van Os, & Krabbendam, 2007) that are impaired in 
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schizophrenia (Nuechterlein et al., 2004). These concepts overlap substantially and 
may coincide, such as in clinical high risk and high schizotypy (Debbané et al., 2015; 
Michel et al., 2019), where combined assessment improves psychosis prediction 
(Flückiger et al., 2016). 
A recent line of research (Rössler et al., 2007) delineates two dimensions of state-like, 
subclinical psychotic experiences: schizotypal signs versus schizophrenia nuclear 
symptoms (Bakhshaie, Sharifi, & Amini, 2011; Breetvelt et al., 2010; Rössler et al., 
2015; Rössler, Hengartner, Ajdacic-Gross, Haker, & Angst, 2013, 2014; Rössler, 
Hengartner, et al., 2011; Rössler, Vetter, et al., 2011; Zhornitsky, Tikàsz, Rizkallah, 
Chiasson, & Potvin, 2015). Assessed with the widely used SCL-90R symptom checklist 
(Derogatis, 1977), a questionnaire capturing subjective distress symptoms across 
several psychological and physical dimensions, they show good internal consistency 
and validity (Rössler et al., 2015; Rössler et al., 2007). 
The schizotypal signs (STS) scale addresses distress evoked by interpersonal 
deficiencies, reduced capacity for close relationships, suspiciousness and paranoid 
ideation, resembling the criteria for schizotypal personality disorder and positive and 
negative dimensions of schizotypy. Schizophrenia nuclear symptoms (SNS) assess 
distress caused by delusions of control, auditory hallucinations, thought-broadcasting 
and thought-intrusion, representing nuclear symptoms of schizophrenia (see Figure 1).  
Although the two scales partially overlap with measures of schizotypy, rather than 
assessing a general personality disposition, they measure the level of distress caused 
by such experiences in a recent temporal interval. This level may vary across time, as 
suggested by studies investigating courses of PLE, STS and SNS (Linscott & van Os, 
2013; Rössler et al., 2007). By focussing on symptom distress during the last four 
weeks, STS and SNS close a gap between extremely variable mood and stable 






Figure 1. Psychosis continuum model incorporating the STS vs SNS dimensions.  
Upper half (modified from Claridge & Beech (Claridge & Beech, 1995) shows a model of the psychosis 
continuum where, from the non-clinical towards the clinical parts of the spectrum symptoms like 
suspiciousness, thought broadcasting, alienations and hallucinations increase in intensity in the general 
population. The model emphasises a dimensional transition across this spectrum, where distress may play 
an important role in conversion probability. 
Lower half: Within the non-clinical part of the spectrum, different concepts like schizotypy, PLEs and ultra-
high risk have been used to capture either trait-like person features or state-related clinical aspects (left). 
The model on the right, depicting STS and SNS, specifically focuses on the distress caused by more trait-
related, distress-associated schizotypal personality features (STS) vs. schizophrenia nuclear symptoms 
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(SNS) closer to the clinical part of the spectrum (right). The overlap of STS and SNS acknowledges the 
dimensional nature of this alternative approach.  
While the temporally restricted assessment implies state-like rather than trait-like 
character of the scales, longitudinal studies show high expression of STS or SNS in 
adolescence is associated with a higher risk for common mental disorders in later life 
(Rössler, Hengartner, et al., 2011). 
This suggests that the variability of state expression can be (partially) attributed to 
latent, stable traits and shows “the trait in action”, possibly representing responses to 
environmental challenges (Barrantes-Vidal et al., 2015; Rössler et al., 2013).  
Growing evidence suggests that both state- (PLEs) and trait-like (schizotypy) 
expression of such attributes is associated with morphometric variation in certain brain 
regions, particularly in inferior and superior frontal and superior and medial temporal 
cortical areas and the precuneus. Variations in these regions have been consistently 
shown to be associated with schizotypy (Ettinger et al., 2012; Modinos et al., 2010; 
Nenadic, Lorenz, et al., 2015; Wang et al., 2015; Wiebels, Waldie, Roberts, & Park, 
2016), and PLE in healthy individuals (Schmidt et al., 2015; van Lutterveld, Diederen, 
Otte, & Sommer, 2014; van Lutterveld, van den Heuvel, et al., 2014), as well as 
individuals at ultra-high risk for psychosis (Dietsche, Kircher, & Falkenberg, 2017; 
Fusar-Poli et al., 2011; Nenadic, Dietzek, et al., 2015). This suggests that PLEs might 
have common neuroanatomical correlates along the psychosis spectrum (Modinos et 
al., 2010), as those regions also overlap with alterations in schizophrenia (Siever & 
Davis, 2004). While previous literature strongly supports volumetric correlates of PLEs, 
the association with brain surface morphometry, such as cortical folding or gyrification, 
still remains largely unknown. Opposed to the high plasticity of volumetric structure, 
cortical folding, determined during early brain development (Chi, Dooling, & Gilles, 
1977), is thought to be a sensitive and stable marker of neurodevelopmental variation 
(Nenadic, Yotter, Sauer, & Gaser, 2014; Yotter, Nenadic, Ziegler, Thompson, & Gaser, 
2011). It might thus indicate neuronal processes long before symptom onset and serve 
as a surrogate of early neurodevelopmental insult. As altered gyrification patterns 
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within superior temporal, prefrontal, and cingulate cortex have been identified both in 
psychosis and high risk, the parameter has been suggested as a neurodevelopmental 
marker for psychosis (Damme et al., 2019; Zuliani et al., 2018).  
STS and SNS are psychometrically well-validated, whereas their neuroanatomical 
correlates still remain unclear. Therefore, the aim of the present study was to test in a 
large, healthy cohort drawn from the general population the hypothesis that the 
phenomenologically delineated dimensions schizotypal signs and schizophrenia 
nuclear symptoms are associated with volume- and surface-based brain structural 
correlates similar to those found for schizophrenia and PLEs. Based on current 
evidence from brain imaging studies, we hypothesised reduced volume in frontal and 
medial temporal cortical areas and increased volume in the precuneus with increasing 
symptom load. In addition, we tested the hypothesis that altered gyrification in part of 
these regions, as seen in schizophrenia (Spalthoff, Gaser, & Nenadić, 2018), would be 




We analysed data from 672 healthy participants (424 female (63.1%), 248 male 
(36.9%); mean age=32.51 years, SD=12.23), a subset of the FOR2107 cohort (Kircher 
et al., 2018), a multi-centre study recruiting from the areas of Marburg and Münster in 
Germany. All experimental procedures were approved by the local ethics committees 
of the Medical Schools of the Universities of Marburg and Münster, respectively, in 
accordance with the current version of the Declaration of Helsinki. We included healthy 
adults between the age of 18 and 65 years. Exclusion criteria were current or former 
psychiatric disorders (assessed with SCID-I interviews (Wittchen, Wunderlich, 
Gruschwitz, & Zaudig, 1997) by trained raters), neurological, or other severe medical 
disorders, current drug use, verbal IQ<80 (estimated with Multiple Choice Word Test-B 
(Lehrl, 1995)) as well as common MRI contraindications. All participants volunteered to 
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take part in the study, gave written informed consent and received a financial 
compensation afterwards.  
2.2 Assessment of schizotypal signs and schizophrenia nuclear symptoms 
All participants completed the German version (Franke, 1995) of the SCL-90R-checklist 
(Derogatis, 1977) as part of a larger test battery (Kircher et al., 2018) within 14 days of 
MRI scanning. The SCL-90R is a well-established self-report questionnaire assessing 
the distress of 90 psychological symptoms across nine dimensions on a five-point 
Likert scale, including the dimensions psychoticism and paranoid thinking. Participants 
were asked to rate symptoms over the past four weeks.  Based on previous studies 
(Rössler et al., 2015; Rössler et al., 2013, 2007), we computed the sum of the scales 
“schizotypal signs” (STS; 8 items) and “schizophrenia nuclear symptoms” (SNS; 4 
items) that were derived from factor analysis in a large longitudinal cohort study, based 
on the items of the original SCL-90R scales “paranoid ideation” and “psychoticism” 
(Rössler et al., 2007). Table 1 shows a list of items for both scales and respective 
descriptive statistics. SCL-90R has been shown to possess good internal consistency 
and test-retest-reliability (Derogatis & Cleary, 1977; Schmitz, Hartkamp, & Franke, 
2000). The STS and SNS subscales have been derived and validated in 
epidemiological studies (Rössler et al., 2015; Rössler et al., 2007). 
 
2.3 MRI acquisition 
High resolution, T1-weighted structural images were acquired on a 3T MRI system in 
Marburg (12-channel head matrix Rx-coil; Tim Trio, Siemens, Erlangen, Germany) or 
Münster (20-channel head matrix Rx-coil; Prisma, Siemens, Erlangen, Germany). At 
each site, a three-dimensional MPRAGE sequence with a repetition time of TR=1.9ms, 
echo time TE=2.26ms, inversion time TI=900ms, flip angle=9° with 176 slices, slice 
thickness=1.0mm, voxel size=1.0 x 1.0 x 1.0mm, field of view FOV=256mm was used. 
Imaging data from both centres were pooled based on extensive quality assurance 
protocols (Vogelbacher et al., 2018).  
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2.4 MRI data pre-processing 
Pre-processing and voxel-based morphometry (VBM) analyses (Ashburner & Friston, 
2000) were executed using the pipeline of the CAT12 toolbox (version 1184, Structural 
Brain Mapping group, Jena University Hospital, Jena, Germany) building on SPM12 
(Statistical Parametric Mapping, Institute of Neurology, London, UK), running under 
MatLab (v2017a, The MathWorks, USA) with default parameter settings.  
For VBM analyses, images were segmented into grey matter, white matter and 
cerebrospinal fluid and spatially normalised with the DARTEL algorithm (Ashburner, 
2007). All images passed visually quality control (inspection for artefacts and image 
quality) and the homogeneity control implemented in the CAT12 toolbox. Images were 
smoothed with a Gaussian kernel of 10mm (FWHM). 
We extracted surfaced-based morphometry (SBM) parameters with the CAT12 toolbox, 
that uses a novel algorithm to extract the cortical surface (Dahnke, Yotter, & Gaser, 
2013), allowing to calculate additional information on cortical parameters. We analysed 
cortical gyrification, based on absolute mean curvature (Luders et al., 2006). 
Gyrification images were smoothed with a Gaussian kernel of 20mm (FWHM). 
 
2.5 Statistical analyses 
Statistical analyses were conducted using general linear models (GLM) in CAT12 with 
a multiple regression design. For both SCL-90R subscales (STS, SNS), separate 
models were set up to test for associations with grey matter volume (GMV) and 
gyrification, respectively. To control for the influence of confounding variables, age, sex 
and site were included in the model as nuisance variables. We also accounted for an 
Rx coil change after 386 of 445 scans at the Marburg site by including head coil as an 
additional nuisance variable (Vogelbacher et al., 2018). In VBM analyses, total 
intracranial volume was included as an additional covariate. We analysed positive and 
negative correlations of SCL-90R subscale sum values (STS, SNS) with morphometric 
parameters in whole-brain analyses. Results were considered significant at p<0.05, 
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FWE cluster level-corrected for multiple comparisons after an initial cluster-forming 
threshold of p<0.001.  
 
3. Results 
3.1 Demographic characteristics 
Neither SNS nor STS were correlated with sex (r=0.041, p=0.289; r=-0.030, p=0.433, 
respectively). STS was correlated with age (r=0.077, p=0.046), but SNS was not 
(r=0.001, p=0.971). SNS and STS showed a significant intercorrelation (r=0.355, 
p=1.9×10-21). There were significant differences in age (p=7.3×10-11) and SNS 
(p=0.023) between the Marburg and Münster sub-cohorts.  
 
 
Table 1. Items of the SCL-90R scales schizotypal signs and schizophrenia nuclear 
symptoms with group means and standard deviations (SD). 
 
Items are rated („How much were you distressed by…“) over the last 4 weeks on a 5 point Likert scale 
between 0 (“not at all”), 1 (“a little bit”), 2 (“moderately”), 3 (“quite a bit”), and 4 (“extremely”) for each item, 





















item no. schizophrenia nuclear symptoms scale mean (SD) 
7 Someone else can control your thoughts. 0.03 (0.21) 
0.11 (0.47) 
16 Hearing voices other people do not hear 0.00 (0.06) 
35 Other people being aware of your private thoughts 0.05 (0.25) 
62 Having thoughts that are not your own 0.03 (0.22) 
 
SCL-90R 
item no. schizotypal signs scale 
 
mean (SD) 
8 Others are to blame for your troubles 0.15 (0.44) 
1.68 (2.48) 
18 Feeling most people cannot be trusted 0.16 (0.51) 
43 Feeling you are watched by others 0.16 (0.45) 
68 Having ideas others do not share 0.18 (0.45) 
76 Others not giving you proper credit 0.32 (0.62) 
77 Feeling lonely even when with people 0.24 (0.58) 
83 Feeling people take advantage of you 0.22 (0.52) 
88 Never feeling close to another person 0.25 (0.62) 
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3.2 VBM results 
Regression analyses revealed significant correlations between the two scales and 
clusters in the following brain regions (see Figure 2): 
Schizophrenia Nuclear Symptoms (SNS) 
SNS were positively correlated with GMV in the left superior parietal lobe, including 
parts of the precuneus (k=406 voxels, x/y/z=-18/-62/45, T=4.56, p<0.05 FWE cluster 
level-corrected); and negatively correlated with the GMV within the right inferior 
temporal gyrus, extending into fusiform gyrus (k=915 voxels, x/y/z=36/-8/-50, T=3.92, 
p<0.05 FWE cluster level-corrected).  
Schizotypal Signs (STS) 
STS were negatively correlated with the GMV in the right (k=1035, voxels, x/y/z=38/-
10/70, T=4.16) and left (k=298 voxels, x/y/z=-34/-10/75, T=3.86) precentral gyrus (all 





Figure 2. Clusters of 
significant positive (red) and 
negative (blue) correlation 
between grey matter volume 
and SCL-90R-scales 
schizophrenia nuclear 
symptoms (upper panel) and 
schizotypal signs (lower 
panel) at p<0.05, FWE 
cluster level-corrected 










3.3 SBM results 
Schizophrenia Nuclear Symptoms (SNS) 
There were no significant FWE cluster level-corrected associations of the SNS score 
with gyrification. However, performing an exploratory analysis (p<0.001 uncorrected), 
we identified a positive correlation of SNS with gyrification in the left insula (k=27 
voxels, x/y/z=-34/-24/5, T=3.32) and the left rostral middle frontal gyrus (k=13 voxels, 
x/y/z=-23/38/34, T=3.30, see Figure 3).  
Schizotypal Signs (STS) 
There were no significant FWE cluster level-corrected associations of STS with 
gyrification. An exploratory analysis (p<0.001 uncorrected), however, revealed that 
STS was positively correlated with gyrification in the insula (k=29 voxels, x/y/z=40/-2/0, 
T=3.31) and the precuneus (k=13 voxels, x/y/z=23/-62/21, T=3.27), as well as 
negatively correlated with gyrification in the inferior/middle temporal gyrus (k=42 









Figure 3. Clusters of significant positive (red) 
and negative (blue) correlation between 
gyrification and SCL-90R-scales schizophrenia 
nuclear symptoms (upper panel) and 
schizotypal signs (lower panel) revealed in the 





In the present study, we demonstrated that the level of distress related to psychotic-like 
experiences in healthy adults is correlated with brain structural variation, similar to 
previously reported findings for measures of schizotypy and PLEs. Schizophrenia 
nuclear symptoms (SNS), capturing primarily positive, subpsychotic aspects closer to 
the clinical spectrum, were positively correlated with precuneus volume and negatively 
correlated with the volume in the inferior temporal gyrus. Schizotypal signs (STS), 
reflecting a milder, personality trait-associated dimension of negative and positive 
symptoms, were negatively correlated with precentral volume.  
A main finding of our study is the disentangling of precuneus volume being linked to 
distress associated with positive, psychotic-like symptoms (SNS), but not to personality 
related STS. This reinforces a spectrum model (shown in Figure 1) in which sub-
psychotic features closer to the clinical spectrum (as captured in SNS) are associated 
with precuneus variation. Therefore, our results provide strong evidence for differential 
brain structural associations of schizotypy and PLEs. 
To date, this is the largest study analysing the association of brain structure and 
experiences from the schizotypal spectrum in a cohort of healthy individuals, including 
a broader demographic spectrum than most preceding studies. Our results further 
endorse a dimensional model of neural correlates of schizotypy and psychosis-
proneness, and highlight the role of emotional appraisal of psychotic-like experiences 
in the healthy spectrum. This closes an existing gap between psychometrically-
assessed schizotypy (Claridge, 1997; Grant, 2015) and clinically-derived concepts 
(PLEs, ultra high risk).  
Importantly, the level of distress associated with psychotic experiences, rather than the 
symptom level, has a higher predictive value for conversion into clinical stages and 
psychotic disorders (Hanssen, Bak, Bijl, Vollebergh, & Van Os, 2005; Hanssen, 
Krabbendam, De Graaf, Vollebergh, & Van Os, 2005). Schizotypy appears to play a 
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crucial role in differentiating between those two subgroups, as it moderates the 
association between PLEs and distress: Individuals showing high levels of schizotypy 
reported more PLEs, but at the same time less distress associated with them, 
compared to individuals with low trait schizotypy (Kline et al., 2012). 
Our finding of the association with precuneus structure thus suggests its crucial role in 
mediating a higher risk stage. Precuneus structure has previously been linked to 
psychometrically-assessed schizotypy, indeed this is one of the few findings that has 
been replicated across several studies (Modinos et al., 2010; Gemma Modinos et al., 
2018; Nenadic, Lorenz, et al., 2015). There is also evidence of links to functional 
changes: Non-clinical individuals with verbal hallucinations show increased precuneus 
activation (van Lutterveld, van den Heuvel, et al., 2014), and individuals at clinical high 
risk for psychosis show a failure to deactivate the precuneus in a working memory task 
(Falkenberg et al., 2015). These structural and functional findings corroborate the role 
of the precuneus for symptoms within the psychosis spectrum.  
The precuneus, part of the medial parietal cortex, has vast structural and functional 
connections with multiple brain regions and is thought to be involved in various higher-
order cognitive processes (Cavanna & Trimble, 2006; Leech & Sharp, 2014; Zhang & 
Li, 2012). Its involvement in self-reflection, discrimination of self-versus-others, and 
cognitive biases like thought-action fusion, reality distortion and self-referential ideas 
has been shown in studies in obsessive-compulsive disorder and the psychosis 
spectrum (Cavanna & Trimble, 2006; Jones & Bhattacharya, 2014; Rikandi et al., 
2017). Those findings are in line with our own results, linking precuneus volume to 
thought intrusion and broadcasting, verbal hallucinations and control delusions, as 
assessed by the SCL-90R schizophrenia nuclear symptoms scale. 
In line with our finding of a negative correlation between SNS and inferior temporal 
grey matter volume, cortical thinning in the inferior temporal gyrus (ITG) has been 
linked to PLEs, i.e. verbal hallucinations in nonclinical individuals (van Lutterveld, van 
den Heuvel, et al., 2014). In one smaller study, volume reductions were also 
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associated with attenuated psychotic symptoms in UHR individuals (Nenadic, Dietzek, 
et al., 2015). ITG reductions were also part of a pattern distinguishing at-risk individuals 
with later conversion from non-converters (Koutsouleris et al., 2010), and have been 
shown as longitudinal changes following transition from risk status to psychosis onset 
(Borgwardt et al., 2008). 
While these findings suggest PLEs and clinically-derived markers to be associated with 
ITG structural variations, there is no evidence for such an association with schizotypy. 
This is consistent with the notion that SNS and STS might tap different parts of the 
psychosis spectrum. Given the overall low SNS scores in our sample, these findings 
appear all the more impressive, suggesting similar neuroanatomical correlates of even 
subtle subclinical variations as shown across the psychosis spectrum.  
In our data, associations with the schizotypal signs scale were less prominent and 
restricted to a negative correlation in a cluster within the right and left precentral gyrus. 
While precentral gyrus volume decreases are generally associated with motor 
dysfunctions in schizophrenia (Tanskanen et al., 2010), and one study found a similar 
pattern in high risk and first episode individuals compared to healthy controls (Chang et 
al., 2016), it does not generally feature in studies of PLEs in nonclinical individuals. 
There is, however, evidence for variations in adjacent regions, as reduced grey matter 
density in the dorsolateral prefrontal cortex has been reported in high vs. low 
schizotypy (Wang et al., 2015) and postcentral grey matter reduction was reported in 
women with vs. without schizotypal personality disorder (Koo et al., 2006).  
We did not detect associations of the STS scale with areas recently linked to 
psychometrically-assessed schizotypy, such as the precuneus, prefrontal or temporal 
structures. STS in parts certainly overlaps with commonly used schizotypy measures, 
still there are distinct differences: While other measures also often imply distress-
proneness, the STS primarily and directly rates the distress level rather than that of the 
symptoms causing it. Also, blending of positive (e.g. suspiciousness) and negative (e.g. 
social anhedonia) dimensions rather than distinguishing them may dilute effects. While 
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there is compelling evidence for the role of distress in conversion to clinical 
dimensions, as well as elevated distress and impaired quality of life in both long-term 
and first episode schizophrenia patients (Addington, Penn, Woods, Addington, & 
Perkins, 2008; Gaite et al., 2002) and clinical high risk states (Paolo Fusar-Poli et al., 
2015; Hui et al., 2013), in schizotypy, the association to quality of life seems to be less 
distinct and more dimension-specific (Cohen, Auster, MacAulay, & McGovern, 2014; 
Fumero, Marrero, & Fonseca-Pedrero, 2018).  
Taken together, we show distinct associations with neuroanatomical correlates 
between SNS and STS, and to recent findings in schizotypy. The spectrum of 
psychotic-like experiences towards psychotic symptoms is often seen as a continuum 
(Claridge, 1997). This phenomenological continuum, however, is likely not monotonic 
and unidimensional, but falls into several (potentially overlapping) dimensions or facets 
(Grant, Green, & Mason, 2018), represented by different brain structural (and 
functional) correlates and networks. It has been suggested that there are partially 
distinct susceptibilities to the schizophrenia spectrum (Barrantes-Vidal et al., 2015): 
While shared genetic variations render certain vulnerabilities to environmental events, 
other factors might buffer this influence and decrease the impact of schizophrenia risk 
factors by preserved or increased regional brain volume or stabilised neurotransmitter 
activity (Siever & Davis, 2004). These models have been mostly explored in 
schizophrenia versus schizotypal personality disorder patients, but should be extended 
to the full spectrum including schizotypy in healthy individuals. Our study further 
highlights the role of emotional appraisal that might modulate the impact of psychotic-
like experiences on brain structure and subclinical vs. clinical course. 
While we did not find an association of the SNS and STS scales with gyrification 
patterns at corrected threshold levels, the exploratory, uncorrected analysis is of 
interest due to the associations with the precuneus as well as frontal and temporal 
regions. So far, there are no cortical folding or gyrification studies analysing 
associations of those dimensions with developmentally early and rather stable brain 
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structural patterns, so additional studies are warranted. Although the SNS and STS are 
state-dependent, longitudinal analyses in a large, general population study showed that 
their variability is largely (75-89%) associated by stable traits (Rössler et al., 2013). 
This, in line with our results, hints to a possible association of the scales with early, 
developmental markers, possibly indicating a vulnerability to the psychosis spectrum. 
In a developmental approach, it has also been argued that an underlying high level of 
psychometrically-assessed schizotypy may constitute an increased liability to state-like 
subclinical PLE, suggesting an overlap of the partially distinct concepts (Debbané & 
Barrantes-Vidal, 2015).  
Our study addresses the nonclinical spectrum of schizotypal and sub-psychotic 
symptoms; therefore, as expected, the population shows low symptom loadings and 
restricted variance. This, however, only reduces statistical power, but should not 
invalidate the findings (Eysenck, 1952) as it speaks to a robustness of the effects.  
Taken together, our results support the notion that structural brain abnormalities in 
psychosis occur prior to or even independent of the development of full-blown 
symptoms, may progressively worsen over the course of the illness (Jung, Borgwardt, 
Fusar-Poli, & Kwon, 2012) and are modulated by emotional appraisal. As such, the 
phenomenological continuum seems to be reflected in a (at least partial) continuum of 
neurobiological correlates. It has to be pointed out, however, that the idea of a 
monotonic linear continuum appears to be overly simplified. Further, the existence of 
different concepts and phenomenological definitions as well as the use of instruments 
based thereon might contribute to mixed findings in current research, highlighting the 
importance of concise conceptualisation (Grant et al., 2018; Lee et al., 2016; Oezgen & 
Grant, 2018). 
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Schizotypy is a putative risk phenotype for psychosis liability. While sharing some risk 
genes with schizophrenia, the overlap of genetic architectures is poorly understood. 
We tested the hypothesis that dimensions of schizotypy (assessed with the SPQ-B) are 
associated with a polygenic risk score (PRS) for schizophrenia in a sample of 623 
psychiatrically healthy, non-clinical subjects from the FOR2107 multi-centre study and 
a second sample of 1133 blood donors. We did not find a correlation of schizophrenia 
PRS with either overall SPQ or specific dimension scores, nor with adjusted schizotypy 
scores derived from the SPQ (addressing inter-scale variance). Also, PRS for affective 
disorders (bipolar disorder and major depression) were not significantly associated with 
schizotypy. This important negative finding demonstrates that despite some overlap in 
single risk alleles, schizotypy might share less mutual genetic risk factors with 
schizophrenia than previously assumed (and possibly less compared to psychotic-like 
experiences), but might rather reflect a risk phenotype with some overlap in particular 
genetic variants across the psychosis spectrum. 
Key words: bipolar disorder; depression; major depressive disorder; schizophrenia; 
schizotypy; psychosis; psychosis proneness 
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Introduction 
Genetic studies of schizophrenia (SZ) have typically focused on case-control study 
designs, comparing samples with a diagnosis of schizophrenia to those without. The 
recent surge of large genome-wide association studies (GWAS) using this case-control 
design has led to a dramatic improvement of our understanding of the genetic 
architecture of common versus rare genetic variants (Henriksen et al., 2017, Hyman, 
2018, Sullivan and Geschwind, 2019). The identification of schizophrenia-associated 
single nucleotide polymorphisms (SNP) has also allowed the construction of polygenic 
risk scores (PRS) allowing the quantification of SNP-based genetic risk for 
schizophrenia. So far, however, linking these PRS to putative biomarkers of SZ has 
proven difficult (Mistry et al., 2017). In contrast to case-control designs, dimensional 
models of psychopathology are based state or trait markers present not only in patients 
but across the general population. Hence, they can serve as risk phenotypes to study 
neurobiological continuum models across both non-clinical and clinical populations. 
Schizotypy is a trait that can be assessed psychometrically (through self-report) and is 
considered to reflect psychosis proneness and schizophrenia liability (Grant et al., 
2018). Given the ease of applying reliable and valid schizotypy questionnaires in large 
population studies, schizotypy lends itself as a candidate risk phenotype for the 
psychosis/schizophrenia spectrum (Barrantes-Vidal et al., 2015). Schizotypy does not 
imply a psychiatric diagnosis; in fact, schizotypy is neither identical nor conceptually 
congruent with schizotypal personality disorder, which is a clinical condition that has 
often been used to study the schizophrenia spectrum (Siever and Davis, 2004). Rather, 
schizotypy is conceptualized as a trait distributed throughout the general population 
and associated with proneness for psychosis (Flückiger et al., 2019, Nelson et al., 
2013). As such, schizotypy is a complex phenotype that encompasses multiple 
domains relevant to the schizophrenia spectrum, including positive, negative, and 
disorganized domains of variation in cognition, emotion, and behavior (Ettinger et al., 
2015, Fonseca-Pedrero et al., 2018, Oezgen and Grant, 2018) as well as subclinical 
81 
features such as delayed motor development (Filatova et al., 2018). It is more frequent 
in first-degree relatives of schizophrenia patients (Soler et al., 2019) and prodromal 
states (Racioppi et al., 2018). 
Importantly, there are are several lines of evidence that schizotypy is associated with 
variation in biological markers of the schizophrenia spectrum, including cognitive, brain 
imaging, and genetic parameters (Ettinger et al., 2015, Walter et al., 2016). Non-clinical 
subjects who are high in schizotypy (i.e., without a psychiatric diagnosis) show lower 
performance in attention, working memory, and executive functions in general (Lui et 
al., 2018, Matheson and Langdon, 2008, Siddi et al., 2017, Steffens et al., 2018). Also, 
higher schizotypy in psychiatrically healthy cohorts has been associated with brain 
structural variation in brain areas identified to show grey matter loss prefrontal cortices 
(similar to schizophrenia, Ettinger et al., 2012), as well as precuneus and other areas 
(Modinos et al., 2010, Nenadic et al., 2015). Functional imaging has demonstrated 
similar effects with high-schizotypy subjects showing changes in fronto-striatal systems 
intermediate between low-schizotypy and clinical schizophrenia subjects (Taurisano et 
al., 2014), paralleled by recent resting state fMRI studies(Waltmann et al., 2019, Wang 
et al., 2018), anti-saccade fMRI (Aichert et al., 2012), as well as studies on the 
dopamine system (Rössler et al., 2018, Woodward et al., 2011). 
The molecular genetics of schizotypy are, however, poorly understood (Grant, 2015, 
Walter et al., 2016). There are several studies linking single schizophrenia risk genes 
to psychometric schizotypy. Such effects have been shown for risk markers like 
ZNF804A (Meller et al., 2019, Soler et al., 2019, Stefanis et al., 2013a, Yasuda et al., 
2011), DTNBP1 (Kircher et al., 2009, Stefanis et al., 2007), ERBb4 (Stefanis et al., 
2013b), GLRA1 (Vora et al., 2018), MMP16 (Morton et al., 2017), and other 
schizophrenia-linked risk loci like CACNA1C (Roussos et al., 2013). Altogether, 
however, these studies provide some evidence that schizotypy shares part of its 
genetic architecture with schizophrenia. At the same time, several of these risk markers 
have also been linked to other psychiatric disorders, which parallels the overlap of 
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genetic risk for schizophrenia with risk for other psychiatric conditions, especially 
bipolar disorder (Smeland et al., 2019). Only few studies have used genome-wide 
approaches to study the genetic overlap of schizotypy and schizophrenia, which might 
quantify the intersection (Fanous et al., 2007). A genome-wide association study of 
4269 nonpsychotic subjects from the Northern Finland Birth Cohort of 1966 found an 
association of a schizotypy-related measure (Chapman scale) with schizophrenia risk 
genes (incl. CACNA1C, Ortega-Alonso et al., 2017). In one study of male army recruits, 
PRS for schizophrenia was shown to be negatively associated with positive and 
disorganized schizotypy, but only under stressful conditions (Hatzimanolis et al., 2018). 
This is paralleled by studies of related risk phenotypes, such as psychotic-like 
experiences (PLEs), showing an inverse relationship with GWAS-derived genetic 
schizophrenia-risk in healthy adults, and in part also with studies in adolescents (Pain 
et al., 2018, Sieradzka et al., 2014). Taken together, despite some initial evidence, it is 
still unclear whether and to what extent schizotypal traits overlap genetically with the 
risk for schizophrenia (at whole-genome level), and in particular with polygenic risk 
scores that have been used to relate endophenotypes or subclinical phenotypes to 
schizophrenia risk (Mistry et al., 2017). 
In the present study, we tested the hypothesis of an association of SNP-related 
polygenic risk for schizophrenia with schizotypal traits in non-clinical subjects of the 
multi-centre FOR2107 cohort and a replication sample of blood donors. We tested for 
associations for overall schizotypal traits, which we followed up with post-hoc analyses 
for the three dimensions thereof. Also, we controlled for relative specificity by testing 




For the test sample, we analysed data from 623 healthy subjects recruited into the 
multi-center cohort study FOR2107, as part of the Marburg and Münster affective 
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cohort study (MACS, Kircher et al., 2018). All subjects gave written informed consent to 
a study protocol approved by the local ethics committees of the Philipps-University 
Marburg and Westfälische-Wilhelms-Universität Münster.  
Both samples included nonclinical psychiatric healthy subjects (without life-time 
psychiatric disorder), all of whom had undergone the Structured Clinical Interview for 
DSM-IV Axis I Disorders (SCID-I, Wittchen et al., 1997) to confirm absence of a 
psychiatric axis I diagnosis. Additional exclusion criteria were history of traumatic brain 
injury, current or previous neurological disease of the central nervous system, 
uncontrolled general medical diseases, current or previous substance abuse or 
dependence, as well as current psychotropic medication. Subjects were recruited from 
the local communities in Marburg and Münster, respectively.  
This sample of N=623 included 392 (62.9%) female and 231 (37.1%) male participants; 
mean age was 32.62 years (SD=12.47), ranging from 18 to 65 years. There was no 
indication of differences in sex-distribution across sites (Marburg 151 male, 253 female; 
Münster 80 male, 139 female; chi-square-test one tailed, p=.835). As participants 
recruited in Münster were significantly (F(1,622)=44.535, p=5.54×10-11) younger 
(M=28.24, SD=10.35) than Marburg participants (M=34.99, SD=12.89), we included 
age as a covariate in all analyses. We administered clinical interviews and schizotypy 
assessments and obtained blood samples for genetic analysis within a week. 
The Mannheim replication sample consisted of a control cohort of n=1133 subjects 
(mean age=44.63, SD=12.85, range 18–70 years; 516 male (45.5%), 617 female 
(54.5%)) recruited at blood donation events in the state of Baden-Württemberg, 
Germany. Written informed consent was obtained from all subjects, and the study was 
approved by the local ethics committee of the Medical Faculty Mannheim, University of 
Heidelberg. Subjects were handed a questionnaire assessing demographic information 
and information about their mental and somatic health at the blood donation event 
which they then mailed back to the study centre.  
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Phenotyping / Assessment of schizotypal traits 
We administered the SPQ-B (Schizotypal Personality Questionnaire, brief version) to 
assess schizotypy through self-report. The SPQ-B is the short form of the well-
validated SPQ questionnaire first introduced by Raine (Raine, 1991). It has been 
validated in its German translation in previous studies (Barron et al., 2018, Fonseca-
Pedrero et al., 2017, Klein et al., 1997). In addition to providing an overall assessment 
of schizotypal traits, the SPQ-B also allows analysis of the three major dimensions 
thereof: a Cognitive-Perceptual factor (measuring positive schizotypy), a Disorganized 
factor (measuring mainly eccentricity), and an Interpersonal factor (tapping into 
negative schizotypy and neuroticism). These dimensions reflect the three-factor 
structure seen in many other schizotypy questionnaires (Asai et al., 2011, Gross et al., 
2014, Oezgen and Grant, 2018).  
Given that psychometric assessments of schizotypy often tend to show substantial 
overlap with facets of neuroticism (e.g., Gross et al., 2014, Macare et al., 2012), we 
also calculated an adjusted schizotypy score, along with scores for its three dimensions 
(Oezgen and Grant, 2018), and adapted for the brief version of the SPQ. These 
adjusted factors aim to reduce variance between schizotypy measures (due to slight 
conceptual differences) by re-assigning items to higher-order factors thought to mirror 
the common ground between the inventories. The resulting scales are: Adjusted 
Positive, Adjusted Negative, Adjusted Cognitive and Adjusted Eccentricity. These 
adjusted schizotypy scores were used for additional testing to confirm that the 
association was not driven by conceptual contaminants and to enable generalisation 
across instruments (Oezgen and Grant, 2018). 
Genotyping and polygenic risk score (PRS) calculation 
Genotyping from blood samples in all subjects of the MACS test sample was performed 
according to previously published methods using the Infinium PsychArray-24 v1.3 
BeadChip (Opel et al., 2018). Quality control was conducted in PLINK v1.90b5 (Chang 
et al., 2015) and R v3.3.3. Individuals were removed if they met any of the following 
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criteria: genotyping call rate <98%, gender mismatches or other X-chromosome-related 
issues, genetic duplicates, cryptic relatives with pi-hat ≥0.125, genetic outlier with a 
distance from the mean of >4 SD in the first eight ancestry components, or a deviation 
of the autosomal or X-chromosomal heterozygosity from the mean >4 SD. Genotype 
data were imputed to the 1000 Genomes Phase 3 reference panel using SHAPEIT and 
IMPUTE2 (Delaneau et al., 2011, Howie et al., 2012, Howie et al., 2009).  
PRS for schizophrenia (SZ), bipolar disorder (BPD), and major depression (MDD) were 
calculated in R v3.33 by summing the minor allele dosages of the linkage 
disequilibrium (LD)-independent SNPs in our test sample, weighted by GWAS effect 
sizes (SZ: Ripke et al., 2014, BD: Stahl et al., 2019, MDD: Wray, 2018). The weighted 
PRS thus represent an estimation of cumulative, additive risk. PRS were calculated at 
p-value thresholds that showed the best discrimination of case-control status in the 
original GWAS (SZ: p=.05, BD: p=.01, MDD: p=.05).  
To adjust for genetic heterogeneity within our sample, we computed multi-dimensional 
scaling (MDS) components based on the pairwise identity-by-state distance matrix 
calculated on the genotype data in PLINK v1.90b5. Based on screeplot inspection, the 
first three components (C1–C3) were included as covariates in the analyses.  
The Mannheim replication sample served as part of the control cohort in the framework 
of a case-control GWAS of Borderline Personality Disorder for which details have been 
published previously (Witt et al., 2017). Analyses in the present manuscript are based 
on an updated quality control and imputation carried out using the RICOPILI GWAS 
pipeline (Lam et al., 2019). 
Individuals and SNPs were removed if they met any of the following exclusion criteria in 
the first round of quality control: genotyping call rate for given SNPs or individuals 
<98%, difference in SNP genotyping call rate between cases and controls >2%, 
deviation for the autosomal heterozygosity from the mean (|Fhet|>0.2), or a deviation 
from Hardy-Weinberg equilibrium (p<1x10−10 in cases; p<1x10−6 in controls). Genotype 
data were imputed using a publicly available reference panel consisting of 54,330 
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phased haplotypes with 36,678,882 variants from the haplotype reference consortium 
(EGAD00001002729) with the pre-phasing/imputation stepwise approach in 
EAGLE/MINIMAC3  (default parameters and a variable chunk size of 132 genomic 
chunks, Das et al., 2016, Loh et al., 2016) . In the second round of quality control, 
relatedness testing and population structure analysis were performed using a SNP 
subset that fulfilled strict quality criteria after imputation (INFO >0.8, missingness <1%, 
minor allele frequency >0.05), and which had been subjected to LD pruning (r2>0.02). 
This subset comprised 66,240 SNPs. For cryptic relatives with pi-hat >0.2, one 
member of each pair was removed at random following the preferential retention of 
cases over controls. To obtain a highly informative SNP set with minimal statistical 
noise for PRS calculation, the following were excluded: low frequency SNPs (minor 
allele frequency <0.1), low-quality variants (INFO <0.9), and indels in each of three 
GWAS (SZ: Ripke et al., 2014, BD: Stahl et al., 2019, MDD: Wray, 2018). 
Subsequently, the remaining SNPs were clumped. From the major histocompatibility 
complex region, only one variant with the strongest significance was retained. These 
SNPs were then used as weights to calculate PRS for each individual in the cohort. 
Five MDS components (C1–C4 and C7) were used to adjust for genetic heterogeneity 
within the Mannheim cohort along with sex and age in subsequent analysis. 
 
Statistical analysis 
Statistical analysis was performed using SPSS (SPSS, version 24, IBM, Armonk, NY) 
and R/Rstudio(R Core Team, 2018, RStudio Team, 2015). Distributions of sex and 
differences in age and SPQ scores were assessed using chi-square tests and 
univariate and multivariate analyses of variance (ANOVA), respectively. As is to be 
expected, schizotypy scores showed substantial skewness that remained after 
common transformation attempts. Schizotypy scale variables were z-transformed to 
ensure comparability between test and replication samples. 
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To test our main hypothesis, we performed a multiple regression analysis between 
schizophrenia PRS and the SPQ-B total score; with age, sex, and MDS components 
(C1–C3 in test sample, C1–C4 and C7 in replication sample) as covariates. We then 
tested separate multiple regression models post-hoc with each of the three SPQ-B 
dimensions and the adjusted schizotypy scores as the outcome variable. To account 
for the remaining skewness in the variables, robust standard errors were calculated 
using bootstrapping (N=1000) and bootstrapped p-values are reported.  
To aggregate results across samples, combined p-values were calculated with the 
Stouffer meta-analysis method(Stouffer et al., 1949) using the R package gmeta 
(https://cran.r-project.org/web/packages/gmeta/index.html) to weight by the different 
sample sizes (N=623 vs. N=1133).  
Finally, given the genetic overlap between schizophrenia and affective disorders, we 
examined potential associations with affective disorders using the PRS for bipolar 
disorder and for major depression as independent variables in further multiple 
regression models. Since SPQ-B scales (as well as adjusted factors) display significant 
intercorrelations, p-value thresholds were adjusted to account for multiple comparisons 
according to the Bonferroni-Holm method for the eight schizotypy scores tested for 
each of the PRS (Eichstaedt et al., 2013). 
 
Power Analysis for Correlations 
Based on the literature reported, we expected small local effect sizes of PRS prediction 
of schizotypy scores (Cohen’s f2≥0.02). To determine the effect size we were able to 
detect with our data, we conducted an a posteriori power analysis, using the sensitivity 
test in GPower (v3.1.9.4,(Faul et al., 2007)) for multiple regression models. Given the 
sample size of N=623 (N=1133), an alpha level of 0.05 and a power of 0.80, in a linear 
multiple regression model with one tested predictor and six (eight) predictors in total, 
resulting in 616 (1124) degrees of freedom, we would have had enough power to 
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detect a local effect size of Cohen’s f2≥0.013 (test sample), f2≥0.007 (replication 
sample), respectively.  
 
Results 
Distribution of schizotypal traits 
Descriptive statistics for the original scales and adjusted schizotypy scores are shown 
in table 1. Both age (F(1,622)=4.95, padj=.026, partial Eta2 (η²)=.008) and sex 
(F(1,622)=6.61, padj=.020, η²=.010) were significantly associated with total schizotypy. 
Therefore, both variables were included into subsequent correlation analyses.  
Table 1. Distribution of schizotypy scores 
Schizotypy scale 
MACS sample Mannheim sample 
Mean 
(SD) Range Skewness 
Mean 
(SD) Range Skewness 
SPQ-B total score 3.38 (2.97) 0–16 1.07 
3.58 




(1.16) 0–6 1.48 
1.54 
(1.64) 0-10 1.24 
  Interpersonal 1.70 (1.70) 0–8 1.06 
2.14 
(2.11) 0-10 0.94 
  Disorganized 0.78 (1.25) 0–6 1.81 
0.54 
(1.05) 0-6 2.32 
Adj. Positive 0.14 (0.19) 0–1.05 1.54 
0.16 
(0.20) 0-1.05 1.33 
Adj. Negative 0.23 (0.25) 0–0.94 0.63 
0.24 
(0.25) 0-0.94 0.68 
Adj. Cognitive 0.18 (0.26) 0–1.25 1.76 
0.23 
(0.31) 0-1.25 1.49 
Adj. Eccentricity 0.16 (0.19) 0–0.83 1.38 
0.14 
(0.18) 0-0.97 1.86 
 
Note. SD=standard deviation 
 
Association of PRS-SZ and schizotypal traits 
Neither the SPQ-B total score, nor the subscores Cognitive-Perceptual, Interpersonal, 
or Disorganized showed significant associations with the schizophrenia PRS in any of 
the two samples (see Table 2 for details). This observation was also confirmed by 
meta-analysing the p-values of each sample. Likewise, analyses of the adjusted factors 
showed no significant correlation with the PRS for schizophrenia. 
89 
Table 2. Model statistics of regression models with PRS SZ as predictor. 
dependent variable 
MACS sample Mannheim sample 
comb. 













SPQ-B total score 0.003 9.2×10-6 0.955 -0.045 0.002 0.340 0.818 
  Cognitive-
Perceptual 0.006 3.8×10
-5 0.873 -0.028 0.001 0.228 0.610 
  Interpersonal 0.007 5.0×10-5 0.882 -0.035 0.001 0.223 0.618 
  Disorganized -0.007 5.0×10-5 0.851 -0.002 4.3×10-6 0.882 0.942 
Adj. Positive 0.019 3.0×10-4 0.635 -0.003 9.4×10-6 0.339 0.480 
Adj. Negative -0.013 1.7×10-4 0.743 0.000 3.3×10-8 0.956 0.952 
Adj. Cognitive -0.012 1.4×10-4 0.807 -0.005 2.6×10-5 0.258 0.561 
Adj. Eccentricity 0.009 8.2×10-5 0.833 -0.001 1.1×10-6 0.588 0.800 
 
Note. Age, sex, and MDS components C1–C3 (MACS)/C1–C4 (Mannheim) were included as covariates in 
all models. All p- and ß- values after z-transformation and bootstrapping with N=1000. *p-values were 
combined with the Stouffer meta-analysis method. All p-values are above the threshold for statistical 
significance (pT=.00625–.05). 
 
Association of PRS-BD and schizotypal traits 
In follow-up analyses testing the association of the PRS for bipolar disorder (BD) with 
schizotypy, we did not find a significant correlation between BD PRS and any of the 
SPQ dimensions in either of the samples (see Table 3).  
 
Association of MDD PRS and schizotypal traits 
Findings for associations of the PRS for major depression (MDD) and schizotypy were 
inconsistent, as we detected a significant association only in the Mannheim sample. 
However, all combined p-values were above the significance thresholds after correcting 





Table 3. Model statistics of regression models with PRS BD as predictor. 
dependent variable 
MACS sample Mannheim sample 
comb. 













SPQ-B total score -0.010 1.0×10-4 0.824 0.067 0.005 0.044 0.292 
  Cognitive-
Perceptual -0.044 0.002 0.247 0.038 0.002 0.203 0.142 
  Interpersonal 0.007 5.0×10-5 0.871 0.065 0.004 0.117 0.483 
  Disorganized 0.009 8.4×10-5 0.801 0.033 0.001 0.060 0.308 
Adj. Positive -0.034 0.001 0.384 0.006 3.8×10-5 0.147 0.171 
Adj. Negative -0.014 2.0×10-4 0.734 0.005 2.6×10-5 0.330 0.552 
Adj. Cognitive 0.014 2.0×10-4 0.715 0.013 1.7×10-4 0.041 0.204 
Adj. Eccentricity 0.003 9.2×10-6 0.940 0.004 1.7×10-5 0.194 0.688 
 
Note. Age, sex, and MDS components C1–C3 (MACS)/C1–C4 (Mannheim) were included as covariates in 
all models. All p- and ß- values after z-transformation and bootstrapping with N=1000. *p-values were 




Table 4. Model statistics of regression models with PRS MDD as predictor. 
dependent variable 
MACS sample Mannheim sample 
comb. 













SPQ-B total score -0.026 6.9×10-4 0.543 0.328 0.114 0.001 0.017 
  Cognitive-
Perceptual -0.039 0.002 0.348 0.130 0.018 0.002 0.010 
  Interpersonal -0.012 1.4×10-4 0.762 0.185 0.035 0.001 0.046 
  Disorganized -0.008 6.6×10-5 0.848 0.089 0.009 0.002 0.095 
Adj. Positive -0.042 0.002 0.325 0.008 6.7×10-5 0.104 0.113 
Adj. Negative -0.020 4.1×10-4 0.632 0.020 4.2×10-4 0.001 0.258 
Adj. Cognitive 0.013 1.7×10-4 0.743 0.022 5.0×10-4 0.007 0.101 
Adj. Eccentricity -0.021 4.5×10-4 0.607 0.018 3.5×10-4 0.001 0.023 
 
Note. Age, sex, and MDS components C1–C3 (MACS)/C1–C4 (Mannheim) were included as covariates in 
all models. All p- and ß- values after z-transformation and bootstrapping with N=1000. *p-values were 
combined with the Stouffer meta-analysis method. Only p-values in bold are below the threshold for 





In this study, we provide a large-scale analysis in two independent samples testing the 
hypothesis that schizotypy is significantly associated with the SNP-based polygenic risk 
for schizophrenia. Neither overall SPQ scores nor subscores / dimensions or adjusted 
schizotypy factors were associated with PRS for SZ, BP, or MDD. This finding 
contributes important new aspects to our understanding of the psychosis spectrum at 
both the phenotype and genotype levels, thus extending previous findings 
(Hatzimanolis et al., 2018, Zammit et al., 2014). 
For the interpretation of our findings, we will discuss the use of schizotypy in 
phenotypic characterization across the psychosis spectrum (contrasting findings in 
schizotypy vs. those in PLEs), factors related to the timing of impact of genetic risk (i.e., 
schizotypy and PLEs in adolescence vs. adult life), as well as methodological factors. 
Schizotypal traits are increasingly used as a phenotypic marker of psychosis liability 
improving our understanding of the psychosis spectrum (Nelson et al., 2013). They 
share variance with other measures, such as PLEs and clinical criteria of subjects at 
ultra-high risk for psychosis (Barrantes-Vidal et al., 2013, Flückiger et al., 2019). In 
contrast to a growing number of association studies of schizotypy with clinical or 
cognitive phenotypes or endophenotypes of schizophrenia (Ettinger et al., 2015, 
Nenadic et al., 2015), there have hardly any genetic studies investigating more than 
one risk gene in relation to schizotypy (for overview, see Meller et al., 2019)).  
First, our findings diverge from association studies using PLEs as subclinical markers. 
While schizotypy is linked to clinical risk for psychosis (Flückiger et al., 2016, Kwapil et 
al., 2013), thus emphasising its predictive clinical utility in prodromal 
screening(Schultze-Lutter et al., 2019), it is not fully congruent with PLEs or at-risk 
states. Most high- schizotypy individuals are likely not to convert to psychotic disorders 
(Chapman et al., 1994, Gooding et al., 2007, Kwapil et al., 2013), suggesting 
schizotypy to encompass more than just schizophrenia liability. In addition, we also 
need to consider that different schizotypy instruments are based on somewhat 
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incongruent conceptual backgrounds. For example, the SPQ is based on early DSM 
criteria of schizotypal personality disorder, while other questionnaires, such as the 
Multi-Dimensional Schizotypy Scales (MSS) are developed with an explicitly multi-
dimensional approach to study the general population (Kwapil et al., 2018). 
A recent large study of psychosis proneness using multiple psychometric measures 
found an association with physical anhedonia and hypomanic features but not with 
other core aspects of schizotypy (Ortega-Alonso et al., 2017); also, the study only 
found modest heritability across the phenotypes. Findings from the ALSPAC study 
have suggested that polygenic risk for schizophrenia links to anxiety and negative 
symptoms in adolescence but not depressive or psychotic symptoms (Jones et al., 
2016). Furthermore, a recent study from the UK biobank using a health questionnaire 
on frank psychotic experiences in non-clinical subjects found an indication for 
associations of psychotic experiences with PRS for schizophrenia, but also 
associations with PRS for bipolar disorder and major depressive disorder, as well as 
schizophrenia copy number variants (CNV, Legge et al., 2019). Importantly, these 
phenotypes reflect a more state-related emergence of quasi-psychotic symptoms, 
which is different from the enduring trait-like quality of core schizotypy features. Our 
findings could, thus, be reconciled considering the difference between state- versus 
trait-like features of liability markers. Across the phenotype itself, cognitive 
disorganization and anhedonia might show higher SNP-heritability than more narrow 
positive symptom dimensions (Pain et al., 2018), which is consistent with some older 
twin studies examining “Meehlian”-based measures of schizotypy (Hay et al., 2001). 
Incidentally, analyses of (fully) dimensional schizotypy conceptualizations show similar 
heritability estimates of positive and negative schizotypy by individual latent genetic 
factors, which both equally explain variance in disorganized schizotypy (Linney et al., 
2003). 
However, studies identifying associations between subclinical psychosis symptoms in 
population-drawn samples have either failed to show associations with schizophrenia 
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PRS (Sieradzka et al., 2014, Zammit et al., 2014) or have shown such associations 
only when pooling patients and controls, but not in non-clinical samples only (Derks et 
al., 2012). It has to be considered, however, that those studies are based on the first-
wave GWAS data that relied on a smaller sample and therefore significantly less power 
than the following GWAS. So far, a comprehensive study assessing both state and trait 
features of the psychosis spectrum is still lacking. Overall, our findings suggest that 
neither total schizotypy nor individual dimensions of the construct are substantially 
related to genetic psychosis risk. In contrast to other studies using the SPQ as a 
measure for schizotypy, which differs conceptually from “true” schizotypy, we also used 
the adjustment method suggested by Oezgen and Grant to reduce inter-scale 
conceptual variance und, potentially, provide a closer approximation of „true“ 
schizotypy from the SPQ-items (Oezgen and Grant, 2018). It is unclear whether the 
above spectrum phenotypes might be related to polygenic risk for other psychiatric 
disorders like major depression, as suggested from a recent systematic review of 
studies (Ronald and Pain, 2018), since unlike our study, many other previous studies 
did not include PRS scores for other disorders in their analyses. The significant positive 
association of schizotypy scales and MDD-PRS suggests further research is needed to 
understand a potential link to genetic risk for affective disorders. 
The lower heritability of psychosis spectrum features (schizotypal traits vs. PLEs) also 
points to the problem of the timing of emerging risk phenotypes and the interaction with 
environmental risk. Association studies have variably used adolescent and adult 
samples. For example, the ALSPAC study relied on population-drawn cohorts of 
adolescents (Jones et al., 2016), while other mentioned studies analysed adult data 
(e.g., Ortega-Alonso et al., 2017). Some schizotypal features show only moderate 
temporal stability in late adolescence only, which might make them more prone to 
variation than other phenotypes, while others are more temporally stable (Ericson et 
al., 2011, Rosa et al., 2000, Venables and Raine, 2015). 
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The different risk backgrounds of genetic association studies of psychosis proneness 
also point to environmental risk factors as mediators of genetic risk. Like psychosis, 
schizotypy as a trait emerges from complex gene-environment interactions (Barrantes-
Vidal et al., 2015). Indeed, particularly those subjects scoring high on both types of risk 
factors might be at particular risk of developing manifest psychosis. Such effects for 
schizotypy and other risk phenotypes have been demonstrated for interactions with 
environmental risk factors like stress (Hatzimanolis et al., 2018) or urban environment 
(Grech et al., 2017).  
The current understanding of the genetic architecture of the psychosis continuum has 
largely benefited from recent studies linking particular risk phenotypes like PLEs to 
schizophrenia PRS. Our findings indicate that schizotypy as one of the main spectrum 
phenotypes may not be robustly linked to schizophrenia polygenic risk. In the non-
clinical part of the psychosis spectrum, this emphasizes the role of other factors, 
including environmental risk (Karcher et al., 2019, van Os et al., 2019). This is in 
accordance with the limited variance of common intermediate phenotypes that PRS 
explain (Mistry et al., 2018), however, they do not capture the genetic contribution of 
rare variants like copy number variants (Mowry and Gratten, 2013), but only account 
for the additive risk deriving from common SNPs. We also need to consider the 
possibility that polygenic risk factors, while successful in case-control studies, might be 
inherently limited in quantitative measures or risk phenotypes. While integrating 
multiple biological pathways, only part of the genes and pathways of a PRS might be 
relevant to schizotypy. However, part of these relevant gene groups might have 
transdiagnostic impact, which is not limited to the psychosis spectrum (Ronald and 
Pain, 2018). This ultimately results in a multi-dimensional continuum or continua (van 
Os, 2014, van Os and Reininghaus, 2016), especially considering transdiagnostic 
overlap with affective disorders. 
A methodological aspect to consider in view of our negative results is the sample 
variance. Correlational or regression-based analyses will often lead to null results when 
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sample-variance is low. As these methods depend on shared variance between 
variables, low variance in the variables will lead to null results, although the true 
correlation may, in fact, be higher. The short scales of inventories, such as the SPQ-B, 
are inherently less capable of capturing the same amount of variance as are full scales 
(Oezgen and Grant, 2018); therefore, also the adjustment method by Oezgen and 
Grant cannot perform as well when short scales are used (compared to full scales). 
Thus, our findings may have been different, had more schizotypal variance been 
captured within a sample not as ardently screened for psychiatric health. Yet, even 
within the Mannheim replication sample, in which in which no filtering was performed 
with regard to psychiatric phenotypes, no association with SZ-PRS was found. 
Additionally, as the effect-size of the (putative) association between schizotypy and the 
PRS for schizophrenia is, so far unknown, our sample may have lacked the power 
necessary to detect it. In comparison, Hatzimanolis and colleagues found a relationship 
between full SPQ scores and PRS for schizophrenia (albeit an inverse one), but only in 
a male sample almost twice as large as ours, under stressful conditions for the 
participants (i.e., army recruits) and avoiding potential gender effects (their sample was 
entirely male, Hatzimanolis et al., 2018). 
In conclusion, the findings of our multi-centre study call for a reappraisal of suitable risk 
phenotypes and delineation within polygenic risk factors for both schizophrenia as well 
as affective disorders for an improved understanding of the biological continuum model 
of psychosis. Instead, understanding schizotypy as a wider phenotype (compared to 
merely harbouring risk for schizophrenia or psychosis) and gathering data in a fashion 
more suitable to this wider understanding of the schizotypy construct may be an 
important step forward. This is not only crucial for understanding those aspects of 
schizotypy that are, indeed, associated with schizophrenia liability, but also (and maybe 
even more) those factors that are not, or even protective with regards to 
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Objective: While single, genetic and environmental, risk factors for psychosis have 
been studied for their impact on brain structure and function, there is little 
understanding of how they interact to generate psychosis liability on the neural level. 
Direct associations between cumulative genetic risk scores and risk phenotypes are 
often weak, and analyses of G×E interactions are scarce. We developed and tested a 
multivariate model, in which the effects of cumulative environmental and genetic risk on 
a dimensional phenotype are mediated by brain structural variation. 
Methods: In a data set of 440 non-clinical subjects, we tested a moderated mediation 
model with an interaction of an environmental (ERS) and a polygenic risk score (PRS) 
for schizophrenia, impacting on the subclinical psychosis spectrum phenotype 
schizotypy. We propose this effect to be mediated by grey matter volume variation, 
derived from voxel-based morphometry. In addition, cognitive function was considered 
as a potential moderator. 
Results: We identified a significant multivariate model (R2=10.91%, p=4.9×10-5) in 
which precuneus/posterior cingulate volume mediated the impact of a PRS×ERS 
interaction on the positive schizotypy dimension. Furthermore, variation in executive 
function modulated this effect (p=0.027).  
Conclusions: Our finding is the first to integrate polygenic and poly-environmental 
markers with MRI parameters to demonstrate that the interaction of these cumulated 
risk factors leads to the emergence of subclinical symptoms through changes in brain 





Multiple genetic and environmental risk factors for psychosis impact different neuronal 
circuits to modulate risk for disease or expression of risk phenotypes1. Although 
aetiological models agree on multivariate interactions of risk and protective factors 
across multiple levels2, the majority of studies conducted univariate associations of 
single risk factors. Thus, the complex interplay of different factors, as well as their 
cumulative effects, has often been neglected. Partially, the interplay of risk factors is 
addressed in gene by environment (G×E) interaction studies, yet often restricted to 
single risk factors1. Multivariate models are, therefore, needed to integrate different risk 
factors and their effects on the neurocircuit level into a joint framework.  
Genetic liability may modulate environmental vulnerability by affecting brain structure 
and function, while protective influences and compensatory processes may buffer the 
impact of genetic risk3,4. Surprisingly, previous studies analysing the impact of 
polygenic risk on brain structure in non-clinical or clinical cohorts show only weak 
effects5, and statistically tested models of gene by environment (G×E) interactions, 
including specific pathways, are scarce. Such models are required to establish a 
mechanistic account for the emergence and maintenance of psychopathology.  
While most studies of G×E interactions in psychiatry have focussed on depression1, 
there is also a growing number of research within the psychosis spectrum. For 
example, polymorphisms in risk genes COMT and FKBP5 affect the outcome in 
schizophrenia spectrum disorders depending on cannabis consume and early life 
stress, respectively6. Moreover, interactions between genetic variants involved in 
serotonergic neurotransmission and neurodevelopment and the exposure of early and 
late life environmental risk factors modulate the risk for first episode psychosis7. While 
studies focussing on single genetic and environmental factors are valuable for 
analysing specific pathways, none of these exert their effects in isolation, but are part 
of complex interactions. On the genetic level, genome-wide association studies 
(GWAS) have provided polygenic risk scores as cumulative expression of common 
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single nucleotide polymorphism-related risk8. Recently, aggregated scores integrating 
multiple environmental risk pathways have been developed9. This creates a multi-
dimensional space, in which pathways of risk and protective factors unfolding during a 
subject’s life-time can be explored. 
Another limitation of previous studies is the lack of dimensionality in analysed 
phenotypes, as many studies relied on case-control designs. In view of psychosis-
spectrum models10, the case/control approach can only explain minor parts of the total 
phenotypic variation11. In addition to the heterogeneity within clinical dimensions, it is 
well established that the expression of psychotic or psychotic-like symptoms also 
extends to the non-clinical population4. Well-established dimensional phenotypes are, 
for example, dimensions of schizotypy, which can be assessed in healthy subjects, yet 
share a fully dimensional relationship with schizophrenia10,12. With schizotypy as a risk 
phenotype, G×E interactions established in schizophrenia can also be extended to the 
non-clinical spectrum. Recent examples include interactions of cannabis use and 
variants of DRD213, and childhood maltreatment and FKBP5 variants14. Similarly, 
polygenic risk for schizophrenia impacts schizotypy in interaction with stressful life 
conditions15 and the shared environment of siblings15.  
For most of these associations, it is unclear how effects unfold on the neural level. Both 
disease status and dimensional markers like schizotypy are associated with brain 
structural and functional variation. Key regions seem to be inferior and superior frontal, 
superior and medial temporal cortices, as well as the precuneus16–19. Those are also 
shown in non-clinical samples, where confounding effects of disease onset or 
medication are avoided. This concurs with the (early) idea that even severe 
psychopathological alterations are preceded by subtle variations of healthy brain 
structure and function20. Such alterations might mediate the association of G×E 
interactions and phenotypes. Studies are limited8, but, for example, indicate an 
interaction of polygenic risk and cannabis on cortical thickness in females21.  
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The present study sought to develop and test a multivariate model that would 
overcome some of the limitations of previous studies. In this model, we incorporated 
both cumulative genetic and environmental risk scores as well as structural brain 
imaging data and cognition to explain variance in psychopathology, using schizotypy as 
a dimensional phenotype. Based on the central assumption of a relationship of genetic 
risk and psychopathology, we constructed a model that incorporates the mediation of 
this relationship through brain structural parameters, while allowing moderation by 
environmental risk and cognitive function (figure 1). The latter has been proposed as a 
buffer against emerging psychopathology in schizophrenia spectrum models3 with 
empirical evidence in schizotypy22, at-risk individuals23, and schizophrenia24. 
 
 
Figure 1. Conceptual moderated mediation model of the effect of genetic x environmental risk on 





We analysed data of N=440 healthy subjects with complete data in all necessary 
markers (age 18-65 years, mean=32.77, standard deviation (SD)=12.12; 172 (39.1%) 
male and 268 (60.9%) female), who were part of the FOR2107 cohort, a bi-centre 
study recruiting from the areas of Marburg and Muenster, Germany25. All procedures 
were approved by the ethics committees of the Medical Schools of the Universities of 
Marburg and Muenster, in accordance with the Declaration of Helsinki. Participants 
were thoroughly screened for exclusion criteria, i.e., current or former psychiatric 
disorders (tested by trained raters through SCID-I interviews26), neurological or other 
severe medical disorders, current drug use, verbal IQ<80 (estimated with Multiple 
Choice Word Test-B27) and common MRI contraindications. All subjects volunteered to 
take part in the study, gave written informed consent and received a financial 
compensation for participation.  
Magnetic resonance imaging (MRI) data acquisition and voxel-based morphometry 
(VBM) pre-processing 
We acquired high resolution, T1-weighted structural images on a 3T MRI system in 
both Marburg (12-channel head matrix Rx-coil; Tim Trio, Siemens, Erlangen, Germany) 
and Münster (20-channel head matrix Rx-coil; Prisma, Siemens, Erlangen, Germany). 
We used a 3D MPRAGE sequence with slice thickness=1.0mm, voxel 
size=1.0x1.0x1.0mm, field of view FOV=256mm and the following parameters in 
Marburg: repetition time of TR=1.9s, echo time TE=2.26ms, inversion time TI=900ms, 
flip angle=7°; and Münster: TR=2.13s, TE=2.28ms, TI=900ms, flip angle=8°. Based on 
extensive quality assurance protocols27, imaging data from both centres were pooled.  
Pre-processing and voxel-based morphometry (VBM) analyses were executed using 
the pipeline of the CAT12 toolbox (version 1184, Gaser, Structural Brain Mapping 
group, Jena University Hospital, Jena, Germany) building on SPM12 (Statistical 
109 
Parametric Mapping, Institute of Neurology, London, UK), running under MatLab (The 
MathWorks, USA) with default parameter settings. Images were segmented into grey 
matter, white matter, and cerebrospinal fluid and spatially normalised with the DARTEL 
algorithm. All images passed visually quality control (inspection for artefacts and image 
quality) and the quality and homogeneity controls implemented in CAT12. Images were 
smoothed with a Gaussian kernel of 8mm (full width at half maximum, FWHM). 
 
Assessment of dimensional schizotypy 
Schizotypy was assessed with the German version28 of the Schizotypal Personality 
Questionnaire-Brief (SPQ-B). This short version of the original SPQ has been validated 
in cohorts of multiple nationalities29. We calculated adjusted dimensional scores (table 
1) for positive (AdjPos), negative (AdjNeg), cognitive (AdjCog) and eccentricity 
(AdjEcc) facets of schizotypy. Those adjusted scores have been constructed based on 
a factorial analysis of the major schizotypy instruments to identify their overlapping 
common ground, and represent a more instrument-independent, general account of 
those dimensions30. 
 
Table 1. Sample descriptives. 
 
 mean SD range 
ERS score -0.35 2.71 -4.5 - 7.0 
schizotypy dimensions    
positive 0.15 0.19 0.00 - 1.05 
negative 0.25 0.26 0.00 - 0.94 
cognitive disorganisation 0.17 0.26 0.00 - 1.25 
eccentricity 0.15 0.19 0.00 - 0.83 
SD = standard deviation 
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Polygenic risk score (PRS): Genotyping, quality control, and PRS calculation 
Genotyping was performed with genomic DNA extracted from blood samples using the 
Infinium PsychArray-24 v1.3 BeadChip. Quality control was conducted in PLINK 
v1.90b531 and R v3.3.3. Individuals were removed if they met any of the following 
criteria: genotyping call rate <98%, gender mismatches or other X-chromosome-related 
issues, genetic duplicates, cryptic relatives with pi-hat ≥12.5%, genetic outlier with a 
distance from the mean of >4 SD in the first eight ancestry components, or a deviation 
of the autosomal or X-chromosomal heterozygosity from the mean >4 SD.  
Schizophrenia PRS was calculated by summing the minor allele dosage of LD-
independent single nucleotide polymorphisms, weighted by GWAS-derived effect size,  
in R. PRS was calculated based on variants surpassing a GWAS p-value threshold of 
pT=0.05, which showed the best discrimination between schizophrenia cases and 
controls in the original GWAS32. Multi-dimensional scaling (MDS) components were 
calculated in PLINK and included as covariates to adjust for population stratification.  
 
Environmental risk score (ERS) calculation 
Calculation of the environmental risk score (ERS) was conducted according to the 
Maudsley Environmental Risk Score for Psychosis9 (see table 1 for descriptives). For 
this score, six environmental risks were selected based on the amount of replicated 
evidence, exposure before illness onset and relatively easy assessment: ethnic 
minority status, urbanicity, high paternal age, obstetric complications, cannabis use, 
and childhood adversity. Point scores for categorical levels of each risk factor have 
been calculated by Vassos and colleagues based on relative risks (RR) compared to 
an “average” exposure, (as only a marginal proportion of the population are not 
exposed to any risk), rescaled, multiplied and rounded to construct a simpler scale9 
(see table 2). The resulting categories, respective point values, and operationalisations 
are shown in table 2. The ERS was calculated by summing the points of each category, 
111 
resulting in a range from -4.5 (lowest risk) to 16 (maximum risk), where 0 equals an 
average risk for psychosis.   
Table 2. Operationalisation and respective point values for environmental risk factors in 























‡Lederbogen urbanicity score46; †CTQ: childhood trauma questionnaire47 
 
 








(Lederbogen‡ score 15) 
-1.5 
medium 
(Lederbogen‡ score 15-30) 
0 
high 








birth weight ≥ 2.5kg and no other 
complications 0 
birth weight < 2.5kg or any other 
complication 2 
cannabis 
no exposure -1 
little to moderate 0 
high exposure 3 
childhood 
adversity 
no exposure  
(no CTQ† scale above cut-off) 
-1.5 
any exposure  




As an indicator of working memory and executive function, we chose a subtest of the 
Wechsler Adult Intelligence Scale (WAIS, German version), the letter-number-
sequencing task (LNS). Participants are asked to recall a given sequence of letters and 
numbers in increasing (numbers) and alphabetical (letters) order, respectively. The 
LNS indexes working memory and executive function, assessing sequential 
processing, cognitive flexibility, and fluid intelligence, and compared to traditional 




VBM analysis  
To identify clusters of grey matter volume significantly affected by the interaction effect 
of schizophrenia PRS and ERS, we conducted a whole-brain analysis using general 
linear modelling (GLM) in SPM12/CAT12 with a full factorial design. Age, sex, site, total 
intracranial volume (TIV), and MDS components were included as covariates to control 
for potentially confounding effects. We accounted for an Rx coil change after 247 of 
296 scans at the Marburg site by including head coil as an additional nuisance 
variable35.  
As interactions can only be tested between one continuous variable and categorical 
variables in SPM, we categorised participants into three groups (low, medium, high) 
according to their ERS score: Scores ≤0.5 were considered as “low” (63.4%), scores 
between 0.5 and 3.5 as “medium” (29.5%), and scores >3.5 as “high” (6.4%). 
Categorisation cut-offs were chosen similar to suggestions by Vassos et al.9, resulting 
in an expected distribution of the three categories. Results were considered significant 
at p<0.05 FWE (Family Wise Error) cluster level-correction for multiple comparisons, 
after an initial cluster-forming threshold of p<0.001. 
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Moderated mediation model 
Testing of the moderated mediation model was conducted with multiple linear 
regression models, using the PROCESS macro v3.4 for SPSS36, running under IBM 
Statistical Package for Social Sciences (SPSS, version 24, IBM, Armonk, NY). In the 
model (figure 1), PRS was entered as the predictor, schizotypy dimension score as the 
outcome, extracted cluster values as a mediator, and ERS and LNS as moderators.  
Age, sex, MDS components, site, TIV, and head coil were entered as covariates.  
Results 
Voxel-based morphometry (VBM) analysis of PRS X ERS interaction 
The VBM analysis detected a significant interaction effect of PRS x ERS in a cluster 
(figure 2; k=910, x/y/z=-4/-50/33, p=0.024 FWE cluster-level corrected) including the 
left precuneus (Pc, 64%), left posterior cingulate gyrus (pcG, 33%) and left superior 
parietal lobule (2%), for the comparison of individuals in category 1 (low risk) to 
category 2 (moderate risk). This cluster did not reach significance, when comparing 
groups 1 (low risk) and 2 (moderate risk) to group 3 (high risk), possibly due to the 
small sample size of group 3.  
 
Figure 2. Cluster of significant association of the interaction of ERS x PRS and grey matter volume in the 
precuneus and posterior cingulate gyrus (p<0.05 FWE cluster level-corrected, illustration prepared with 
MRIcroGL; www.nitrc.org/projects/mricrogl).  
 
Moderated mediation model  
The moderated mediation model was overall significant for the prediction of positive 
(AdjPos) schizotypy (F(17,422)=3.04, p=4.9×10-5, R2=10.91%, figure 3/panel A). In 
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predicting Pc/pcG grey matter value variation (R2=51.69%, p<0.001), the model shows 
that while neither PRS (path a1, b=0.638, p=0.830) nor ERS (a2, b=0.001, p=0.416) had 
a main effect on grey matter variation within the extracted cluster, their interaction was 
significant (a3, b=-3.13, p=0.002; figure 3/panel B): The intensity and direction of the 
effect of PRS on cluster variation was moderated by level of ERS, with a positive slope 
for low ERS (i.e., decreased environmental risk), and a negative slope for high ERS.  
 
Figure 3. A. Statistical moderated mediation model with path coefficients, indicating that the interactive 
effect of ERS x PRS on positive schizotypy is mediated through brain structural variation within a cluster in 
the left precuneus/posterior cingulate gyrus, and moderated by executive function (LNS). Bold print 
indicates significant paths. B. Plot of the path a3, showing a significant interaction of ERS x PRS on cluster 
volume, with fitted regression lines for low, average, and high ERS scores. Colours indicate the ERS level. 
C. Plot of the path b3, a significant interaction of Pc/pcG x LNS on positive schizotypy, with fitted 
regression lines for low, average, and high LNS scores. Colours indicate LNS performance level.  
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In the prediction of positive schizotypy, the direct effects of PRS (c1, b=6.116, p=0.477), 
ERS (c2, b=0.006, p=0.068), and their interaction (c3, b=1.555, p=0.604) were not 
significant (although a trend toward significance was observed for ERS). However, the 
model revealed an indirect effect through brain structural variation, showing a 
significant mediation (index=0.223, bootstrapped [n=10.000] confidence interval lower 
level=0.004, upper level=0.542). Cluster value variation had a significant main effect on 
positive schizotypy (b1, b=-0.277, p=0.049), but was also modulated by the level of 
executive function, with a positive slope for low LNS scores, and a negative slope for 
high LNS scores, showing a second significant interaction (b3, b=-0.070, p=0.027, 
figure 3/panel C). At the same time, the main effect of LNS on positive schizotypy was 
not significant (b2, b=-0.003, p=0.319). 
 
Discussion 
The present study provides proof for a multivariate model predicting the impact of both 
polygenic and poly-environmental risk on a psychosis risk phenotype, mediated 
through brain structure. Extending previous studies focusing on singular risk factors 
(e.g., cannabis use or single risk genes), the particular strength of this model is the 
integration of multiple facets of genetic and environmental risk, intermediate 
phenotypes (brain structure and cognition), as well as a commonly used dimensional 
phenotype for the psychosis spectrum.  
The resulting model provides several novel insights. First, we showed that the 
interaction of polygenic and poly-environmental risk was significantly associated with 
grey matter volume within a cluster in the precuneus/posterior cingulate gyrus (pcG). 
Structural variation in this region has already repeatedly been linked to positive 
schizotypy in non-clinical cohorts18,37,38. As part of the default mode network (DMN), 
connectivity in this region was also altered in high-risk subjects and first-episode and 
chronic schizophrenia across multiple-studies and meta-analyses39,40. We have now 
identified grey matter volume in this region to be affected by a cumulative G×E 
116 
interaction effect – that is detected independently of the phenotype, in a model not 
including a phenotypic variable. 
The precuneus is a highly associative region and has extensive structural and 
functional connections throughout the brain. It is an important node of the default mode 
network, involved in sensory information integration, mental imagery, self-other-
discrimination, and introspection41 – functions relevant to manifestations of psychosis, 
especially the positive symptom domain.  
Interestingly, the precuneus association with genetic and environmental risk is 
bidirectional: While under high environmental risk load, a higher PRS was linked to 
reduced precuneus/pcG volume, this effect was reversed under low environmental risk 
load (figure 3/panel B). These findings indicate higher sensitivity of individuals with high 
PRS not only to adverse, but also to beneficial environmental factors, with opposing 
effects. Conventional diathesis-stress models propose increased vulnerability 
specifically to adverse events; our model extends this to suggest an inverted effect for 
high PRS and low ERS subjects, where regional volumes showed relative increase. 
Under favourable environmental conditions, an increased genetic load might 
paradoxically result in low psychopathology outcomes or gain of function, supporting 
the notion of  genes associated with schizophrenia as “plasticity genes” rather than 
simple risk factors1,42.  
In the framework of our multivariate model, brain structure is shown to act as an 
intermediate modulating the emergence of psychopathology. Such moderation effects 
cannot be detected by simple univariate associations. By extending the interaction 
model to include a (moderated) mediating pathway, we showed that a significant part of 
the phenotypic variance in positive schizotypy could be explained through changes in 
brain structure (precuneus/pcG) arising from G×E interactions.  
Finally, our model confirms cognitive performance as a protective factor. With lower 
executive function, higher precuneus volume was associated with higher positive 
schizotypy; this association changed with increasing executive function, resulting in a 
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reversal at higher levels of cognitive functioning (figure 3/panel C). Cognition, therefore, 
may act as a buffer, although our analyses do not provide a neural-level account for 
this process. Similar findings, however, have been reported for general cognitive 
measures in schizophrenia and schizotypy22,43,44, indicating that above-average levels 
of cognitive function can compensate for dysfunctional processes that arise from 
altered neurodevelopment, potentially leading to a manifest disorder. Such 
compensatory mechanisms are crucial for understanding resilience, as they explain the 
existence of high (positive) symptom load in unaffected individuals.  
Our model explained a substantial amount of variance: while current genetic, PRS-
based schizophrenia case versus control differentiation in large-scale GWAS can 
explain up to ~20%32 of the variance, our model explained ~11% of the phenotypic 
variance even within a non-clinical cohort, thus surpassing other endophenotypic 
markers and measures. To put our findings in perspective, other studies found, for 
example, schizophrenia PRS to explain 9% of the variance between first episode 
psychosis versus control status45, 1% of global functioning in schizophrenia patients 
and healthy controls46, and <1% in cognitive performance in psychotic patients and 
controls47. However, it has to be taken into account that, while schizophrenia and 
dimensional phenotypes are highly polygenic, PRS capture only part of the genetic 
variance, i.e. incorporating only common single nucleotide polymorphisms at a certain 
p-value threshold. PRS do not account for rare genetic variants (e.g., copy number 
variants), epigenetic effects, non-additive risk effects, or gene×gene interactions. Thus, 
an increased genetic risk due to those might still show as a low polygenic risk modelled 
in standard PRS values11. Calculations of PRS also depend on dichotomous case-
/control comparisons, thus not accounting for heterogeneity within each of the 
categories or for diverging pathways of specific symptom dimensions. This limitation 
might be overcome by using gene expression profiles in addition to static genotype 
information. Similarly as is the case for PRS, the ERS score does not fully account for 
E×E interactions.  
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In conclusion, one of the main challenges in biological psychiatry has been to establish 
a link between genetic risk variants and clinical disorders, and current models propose 
a pathway through neurodevelopmental processes. Using a dimensional risk 
phenotype, we present a model of how brain structure mediates the interaction effect of 
environmental and polygenic risk on phenotypic variance. This model can be extended 
to other genotype-phenotype associations. Our results may explain heterogeneous 
results in previous studies and highlight the importance of considering multivariate 
models in the future. These results further advocate the use of schizotypy and other 
dimensional, continuous phenotype markers as a valuable framework for detecting 
multifactorial associations in a dimensional perspective on psychopathology. 
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